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1. Abstract 
Vital and fundamental biological processes are executed by ion channels and other pore-
forming structures spanning the membrane of the cell. Electrical signaling in the nervous 
system by potassium channels1, the contraction of cardiac and smooth muscle cells by voltage 
gated Ca2+ channels2 or the conduction of cellular responses to hormones, neurotransmitters 
or ions by G-protein coupled receptors.3 These extremely complex attributes are intensively 
investigated especially regarding fundamental questions of structure and design.4 60% of drug 
targets are found on the cell surface5 illustrating the significance of these structures. Ion 
selectivity, ionic rectification and ionic gating are the three outstanding characteristics of ion 
channels which inspire for imitating these features.6 Bio-inspired materials, sensor devices and 
mimicking “smart” gates displays a research area of great interest and challenge the 
competences and capabilities of today’s nanoscience field.7 Nanochannels can be 
manufactured from numerous solid-state materials and selectivity towards targets achieved 
with modification of the surface.8  
The presented work focuses on both aspects: the chemical synthesis of a pore-forming 
potassium channel and the design of a smart material combining a chemically synthesized 
sensing peptide with a solid state material.  
Synthesis of ion channels, whether through expression or through chemical synthesis, is not 
straightforward and trivial.9 The herein presented synthesis route towards KcvNTS elucidates 
the challenges and problems faced during synthetic of extremely hydrophobic structures. 
KcvNTS is up-to-date one of the smallest known and full functional viral potassium channels, 
composed of only 82 amino acids. The integration of structures aiding chemical synthesis, 
purification and analytics are discussed, utilized and evaluated. Towards Fmoc-based solid 
phase peptides synthesis (SPPS) of the final product, several steps are taken. The complete 
sequence is divided into three fragments with fragment 1 (KcvNTS(41-82), fragment 2 
KcvNTS(41-82) and fragment 3 KcvNTS(1-15) which are consecutively reunited to yield the 
native sequence using native chemical ligation (NCL). Pseudoprolines, for backbone 
stabilization and to decrease aggregation on resin, are integrated into fragment 1, containing 
the N-terminal Cys moiety. To enable native chemical ligation, fragment 2 is equipped with a 
C-terminal oxo-ester. NCL of fragment 1 and 2 is successfully carried out in NCL buffer 
containing the organic solvent hexafluoroisopropanol, HFIP to enable solubilization of the 
fragments. The product of this NCL is introduced to a further reaction with fragment 3. To 
prepare for NCL, the N-terminal thioporoline, Thz unit is unmasked to yield the needed Cys 
fragment. Fragment 3 is successfully synthesized incorporating a C-terminal solubilizing tail to 
the oxo-ester unit. While the solubilizing tail facilitates synthesis and purification, it is readily 
detached from the sequence during NCL. The second NCL reaction is carried out in ligation 
buffer containing 2,2,2-Trifluoroethanol, TFE to yield the final product KcvNTS(1-82) that is 
analyized using mass spectrometry (MS), sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and circular dichroism (CD) spectroscopy. 
For the design of a sensor, composed of a biological component with sensing ability integrated 
into a stable solid-state material, peptides with heavy metal binding properties were 
synthesized, purified and analyzed. Representatives of the ATCUN family (amino terminal 
Cu(II)- and Ni(II)-binding peptides) exhibit the general sequence Xaa-Xbb-His with the 
mandatory His moiety for the square-planar complex formation with binding of Cu(II) or 
Ni(II).10 We designed four peptides, with sequences Ac-DAP-β-Ala-His-mPEG4 (peptide 1), 
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comprising the original ATCUN motif, Ac-DAP-β-Ala-Ala-mPEG4 (peptide 2) and Ac-
DAP-β-Ala-Asp-mPEG4 (peptide 3), representing non-his containing mutants and 
(5/6)FAM-DAP-β-Ala-His-mPEG4 (peptide 4), a fluorophore containing sequence of peptide 1. 
The maximum binding constants (at optimal pH) from UV-VIS spectroscopy titration data for 
peptides 1 and the non-His containing motifs towards Cu(II) are determined to be in a 
comparable range of K = 1.2 ×105 – 2.5 ×105 l × M-1. Ni(II) binding is evaluated within a 
range of K = 1.3 × 105 3.1 × 105 l × M-1 for the mutants (peptides 2 and 3) and 
K = 2.5 × 107 l × M-1 for peptide 1. We evaluated the titration data to indicate the formation 
of the ATCUN like square-planar complex for all peptides, also the non-His containing.  This is 
interesting due to the mandatory His in position 3 missing in the sequences of peptides 2 and 
3. The Asp unit in peptide 3 can contribute a carboxyl group to the complex formation 
whereas peptide 2, with an Ala unit, is dependent on using an additional backbone amide unit 
to form the 1:1 complex. Peptide 4 is evaluated using fluorescence titration with binding 
constants determined to be K = 2.1 × 109 l × M-1 for Cu(II) and K = 6.1 × 1011 l × M-1 for 
Ni(II) binding. Furthermore, a static quenching process is determined with formation of a 
non-fluorescent complex through Cu(II) and Ni(II) binding. Using peptides 1 and 4, we made 
use of the pH-dependency of complex formation to shift the selectivity towards Cu(II) 
binding. The pH 6.5 is evaluated to yield tight Cu(II) binding (Kpeptide 1 = 3.8 × 106 l × M-1, 
Kpeptide 4 = 6.3 × 106 l × M-1) with negligible Ni(II) binding (Kpeptide 1 = 5.8 × 102 l × M-1, 
Kpeptide 4 = 4.9 × 103 l × M-1) and a limit of detection for peptide 4-Cu(II) in solution of 
13.5 nM. Investigations towards Zn(II) binding shows no indications for the formation of a 
complex. Immobilization of peptide 4 in the nanopores of a PET foil (12 µm thickness, 
conically shaped nanopores with tip ~5 nm and base ~300 nm) facilitates current/voltage, 
I/V measurements with femtomolar detection of Cu(II). Making use of the integrated 
fluorophore and the resulting visualization of the binding event, the designed sensor is 
investigated using confocal laser scanning microscopy, CLSM. It shows re-usability with 
regeneration of the Cu(II) binding event after washing with ethylendiaminetetraacetic acid, 
EDTA. A robust, selective and sensitive sensor system is established, showing re-usability. 
Furthermore, scission behavior of the designed peptides towards dsDNA is investigated. Using 
ascorbate and Cu(II), the DNA strand is cleaved due to the auto-oxidation of ascorbate under 
Cu(I) and reactive oxygen specises (ROS) generation. This cleavage ability is used in the 
design of anti-cancer metallodrugs, such as cisplatin and therefore interesting in regard to 
diagnostic applications.11 Therefore, the scission behavior towards plasmids pUC19, pAKS-
IBA3 and paCYTC2 of all four peptides is investigated. The supercoiled dsDNA is transformed 
to a linearized form through cutting of the DNA strand. All peptides (peptides 1-4) linearize 
all plasmids using ascorbate and Cu(II). In a next step, the region for scission is investigated 
by mapping the plasmids and segmenting the DNA sequences. The plasmid pUC19 is cut in a 
selective region by peptides 1, 2 and 4. Additionally, pASK-IBA3 is cut in a preferred area by 
peptides 2-4. For pACYCT2 a region can be defined in which the sequence stays intact. The 
preferred scission area displays an interesting approach in the straight-forward drug design. 
Furthermore, the ability of peptides 1-4 to linearize DNA can be advanced to the design of 
device. Using the described sensor from Cu(II) sensing, the immobilized peptide can be used 
as a scission device allowing only linearized DNA to translocate through the nanopores of the 
PET foil. In future applications this translocation can additionally be measured, making 
sequencing of the translocated DNA possible. 
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2. Abstract (german) 
Essentielle und fundamentale biologische Prozesse werden von Ionenkanälen ausgeführt. 
Unter anderem werden elektrische Signale des ZNS über Kalium-Kanäle abgebildet1, die 
Kontraktion von kardialen und glatten Muskelzellen werden durch spannungsabhängige 
Calciumkanälen verwirklicht2 und zelluläre Antworten auf Hormone, Neurotransmitter und 
Ionen durch G-Protein gekoppelte Rezeptoren durchgeführt.3 Fundamentale Fragen im Bezug 
auf Struktur und Design dieser hoch komplexen Eigenschaften sind Teil von intensiven 
Studien und Untersuchungen.4 Da 60 % der Drug Targets die Oberfläche der Zelle, also die 
Zellmembran adressieren, sind diese Strukturen von großem Interesse.5 Herausragende 
Eigenschaften von Ionenkanälen sind die extreme Selektivität und Gating Eigenschaften.6 Von 
der Biologie inspirierte Materialien und sensorische Instrumente sind ein dynamischer Bereich 
der Forschung vor allem im Bezug auf die Ideen und Möglichkeiten, die das Thema 
„Nanosciences“ betrifft.7 Stabile und solide Materialien können als Grundlage für Nanoporen 
genutzt werden und mithilfe von Modifikationen der Porenoberfläche eine bestimmte 
Selektivität erhalten.8  
Die hier präsentierten Ergebnisse fokussieren sich auf beide zuvor genannten Aspekte. Zum 
einen wird die Grundlage der Struktur und des Designs von Ionenkanälen durch 
Festphasenpeptidsynthese (SPPS) untersucht, zum anderen ein biologisch inspiriertes, 
smartes Material erstellt, indem solide Nanoporen durch ein sensorisches Peptid modifiziert 
werden. 
Weder die chemische Synthese noch die Expression von Ionenkanälen ist unkompliziert und 
trivial.9 Herausforderungen und Probleme, die während der SPPS auftreten, werden in dieser 
Arbeit im Bezug auf die Synthese des viralen Kaliumkanals KcvNTS herausgearbeitet. Dieser 
Kanal ist, zum heutigen Zeitpunkt, einer der kleinsten bekannten Kaliumkanäle. 
Unterschiedliche Strukturen, welche die Synthese, Aufreinigung und Ligation begünstigen 
und erleichtern sollen, werden verwendet, diskutiert und in deren Kompetenz bewertet. Zum 
finalen Produkt sind mehrere Synthese-Schritte nötig. Vorerst wird die komplette Sequenz in 
drei Fragmente aufgeteilt, Fragment 1 (KcvNTS(41-82), Fragment 2 KcvNTS(41-82) und 
Fragment 3 KcvNTS(1-15), welche mithilfe der nativen chemischen Ligation (NCL) 
aufeinanderfolgend zur finalen Sequenz zusammengefügt werden. Pseudoproline werden zur 
Stabilisierung der Sequenz von Fragment 1 während der Peptidsynthese eingesetzt und 
verhindern ebenfalls die Aggregation am Harz. Weiterhin zeichnet sich Fragment 1 durch eine 
N-teminale Cystein Einheit aus, welche zur NCL Voraussetzung ist. Das Fragment 2 trägt den 
entsprechenden, C-terminalen oxo-ester. Die NCL wird in einem Ligationspuffer, welcher mit 
dem organischem Lösemittel Hexafluoroisopropanol, HFIP versetzt ist, erfolgreich ausgeführt. 
Das daraus resultierende Produkt muss für die darauffolgende NCL mit Fragment 3 
vorbereitet werden. Die N-terminale Thioprolin-Grupppe (Thz), wird in ein Cystein 
umgewandelt und das Produkt für die NCL aktiviert. Fragment 3 kann nur mithilfe der 
Integration eines Löslichkeits-tags erfolgreich synthetisiert werden. Dieser tag befindet sich 
am C-Terminus und wird während NCL Konditionen abgespalten, sodass der oxo-ester von 
Fragment 3 für die NCL zur Verfügung steht. Diese zweite NCL wird in einem Ligationspuffer, 
welcher 2,2,2-Trifluorethanol (TFE) enthält, durchgeführt, um das finale Produkt, 
KcvNTS(1-82) zu generieren. Dieses wird mithilfe von Massenspektrometrie (MS), sodium 
dodecyl sulfate polyacrylamide Gel Elektrophorese (SDS-PAGE) and Circular Dichroismus (CD) 
analysiert.  
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Ebenfalls wird in dieser Arbeit die Synthese, Analytik und Charakterisierung von kleinen, 
Schwermetall-bindenden Peptiden dargestellt, die zur Familie der ATUCN Peptide gehören 
(Amino terminal Cu(II)- and Ni(II)- binding peptides). Die Integration dieser sensorischen 
Peptide in solide Nanoporen führt zum Design eines Sensors welcher in Zukunft zu einem 
diagnostisches Hilfsmittel ausarbeitet werden kann. Die generelle Struktur Xaa-Xbb-His bildet 
mit Cu(II) und Ni(II) ionen einen quadratisch planaren Komplex und setzt dafür Histidine in 
der dritten Position voraus. Wir haben vier Peptide synthetisiert, Ac-DAP-β-Ala-His-mPEG4 
(Peptid 1), welches das generelle ATCUN motif darstellt, Ac-DAP-β-Ala-Ala-mPEG4 (Peptid 2) 
and Ac-DAP-β-Ala-Asp-mPEG4 (Peptid 3), zwei ATCUN-Mutanten, die kein Histidine enthalten 
und (5/6)FAM-DAP-β-Ala-His-mPEG4 (Peptid 4), welches die Sequenz von Peptid 1, 
kombiniert mit einem Fluorophor, darstellt. Die Daten aus UV-VIS Spektroskopie Titrationen 
mit Cu(II) und Ni(II) werden genutzt, um Bindungskonstanten zu berechnen. 
Bindungskonstanten für die Cu(II)-Bindung von Peptiden 1-3 liegen in einem vergleichbaren 
Rahmen von K = 1.2 ×105 – 2.5 ×105 l × M-1. Die Bindung von Ni(II) durch die Mutanten 
bewegt sich im Bereich von K = 1.3 × 105 3.1 × 105 l × M-1 und die von Peptid 1 
K = 2.5 × 107 l × M-1. Wir konnten für alle Peptide, Peptide 1-3, einen quadratisch planaren 
Komplex evaluieren, auch für die Mutanten, die kein Histidin in ihrer Sequenz beinhalten. 
Das Komplexierungsverhalten von Peptid 3 kann durch den Einsatz der Carboxy-Gruppe der 
Asp Einheit beschrieben werden, während Peptid 2 eine Amidgruppe von einer Peptidbindung 
zur Komplexierung nutzen muss. Durch Integration des Fluorophores in die Sequenz von 
Peptid 4, wird Fluoreszenztitrationen eingesetzt und Bindungskonstanten von 
K = 2.1 × 109 l × M-1 für die Bindung von Cu(II) und K = 6.1 × 1011 l × M-1 für Ni(II) 
berechnet. Weiterhin wird ein statischer Quenchingprozess aus den Berechnungen evaluiert, 
dieser besagt die Formation eines nicht-fluorezierenden Komplexes durch Bindung der 
Liganden Cu(II) oder Ni(II). Peptid 1 und Peptid 4 werden zur Generation des Sensors 
eingesetzt und mithilfe von pH Verschiebungen eine Selektivität für Cu(II) entwickelt. Ein pH 
Wert von 6.5 wird für dieses Vorhaben ermittelt. Bei diesem pH steht eine Cu(II) Bindung im 
Vordergrund, mit Bindungskonstanten Kpeptid 1 = 3.8 × 106 l × M-1, 
Kpeptid 4 = 6.3 × 106 l × M-1, während kaum Ni(II) Komplex gebildet wird 
(Kpeptide 1 = 5.8 × 102 l × M-1, Kpeptide 4 = 4.9 × 103 l × M-1). Das Detektionslimit von 13.5 nM 
Cu(II) unterstreicht die Sensitivität. Die Immobilisierung von Peptid 4 auf die Oberfläche der 
Nanoporen einer Polmerfolie, macht Strom/Spannungs Messungen möglich, sowie das Design 
eines Sensors (Polyethylenterephthalat, 12 µm Dicke, Poren mit 5 nm tip und 300 nm base 
Öffnung). Konzentrationen von Cu(II) ionen im Femtomolaren Bereich konnten mit diesem 
System gemessen werden. Das integrierte Fluorophor kann weiterhin für visuelle 
Untersuchungen genutzt werden. Mithilfe eines Fluoreszenzmikroskops, confocal laser 
scanning microscopy (CLSM), wird das Event der Kupferionen-Bindung visualisiert. Die 
Zugabe von Kupfer führt zum Quenching der Fluoreszenz, welche durch die Zugabe von 
Ethylendiamintetraessigsäure (EDTA) regeneriert werden kann. Dadurch konnte eine 
Wiederverwendbarkeit des Sensor-Systems gezeigt werden.  
Weiterhin wird die Fähigkeit dieser Peptide untersucht, dsDNA zu schneiden. Werden die 
Peptide mit Ascorbat und Cu(II) versetzt, so setzt eine Autooxidation von Ascorbat Cu(I) und 
Reaktive Sauerstoff Spezies (ROS) frei. Diese ist interessant bezüglich des Einsatzes in der 
Medizin. In der Chemotherapie werden heutzutage vor allem Metallo-verbindungen, wie 
Cisplatin, als Medikamente eingesetzt.11 Untersuchungen zur Linearisierung von dsDNA 
verschiedener Plasmide, pUC19, pASK-IBA3, pACYCT2, werden angestellt und mögliche 
strukturbedingte Präferenzen für Schnittstellen neben der bekannten Bindung in der kleinen 
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Furche von DNA12 erforscht. Alle vier Peptide linearisieren die drei aufgeführten Plasmide in 
Gegenwart von Cu(II) und Ascorbat. Im nächsten Schritt, werden diese in Bereiche 
segmentiert und diese auf die Mögliche Schnittstelle untersucht. Folgende Ergebnisse wurden 
gefunden: das Plasmid pUC19 wird von Peptid 1, 2 und 4 in einer präferierten Region 
geschnitten, ebenfalls schneiden die Peptide 2 – 4 das Plasmid pAKS-IBA3 in einem 
bestimmten Sequenzbereich. Für das Plasmid pACYCT2 konnte eine Region definiert werden, 
indem der DNA Strand nicht geschnitten wird und intakt bleibt. Die präferierten Bereiche 
könnten weiterhin genutzt werden, um ein straight-forward drugdesign zu implementieren. 
Der zuvor vorgestellte Sensor, bestehend aus dem in Nanoporen immobilisieren Peptid, kann 
weiterhin genutzt werden, um Plasmid DNA zu schneiden und anschließend eine 
Translokation ausschließlich der linearisierten DNA durch die Nanoporen durchzuführen. 
Diese Translokation ruft in den I/V Messungen ein Signal hervor, welches zum Sequenzieren 
von DNA genutzt werden könnte. 
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3. Introduction 
Nanopores are holes exhibiting a diameter in the nanometer range within a membrane or 
other material and can be classified into two large groups. (a) Biological nanopores and (b) 
solid state nanopores with both areas under great scientific development. Interest in these 
structures arose in the 1990ies because of their extraordinary sensing abilities that go as far as 
single molecule sensing.13 The basic principle behind this concept is the translocation of ions, 
molecules, drugs and other small structures across a membrane and through a pore. Within 
the cells of organisms, this process is omnipresent and vital.  
Biological nanopores are ubiquitous in living systems. From ion channels to other pore-
forming structures, the variety is immense. While with the investigation of ion channels 
medicinal aims regarding e.g. pain treatment14 and fundamental functional research are 
focused, other pore-forming structures are used for the determination of DNA15, hairpin 
DNA16 and RNA17 as sequencing units. 
Solid state nanopores were designed after vivid research done with the biological, α-HL, a 
transmembrane protein from Staphylococcus aureus.18. With the vision to overcome 
disadvantages that biological structures usually exhibit, such as instability with regard to pH, 
buffer or temperature changes and their defined size, research was done on the fabrication of 
nanopores within solid state material. In the early 21st century the first solid state nanopores 
were created using a silica membrane (SiN) as the scaffold.19,20  
Combining a nanopore membrane made from solid-state material and inserting a biological 
nanopore or naturally occurring peptide/protein with key-lock behavior towards a target one 
obtains a so called hybrid nanopore. These systems are excellent scaffolds from which 
sensoring devices can be fabricated with stability against thermal, mechanical and electrical 
stress while exhibiting an ultra-sensitive, selective and reliable sensing unit. 
 
3.1. Membrane proteins 
As mentioned before, biological nanopores are ubiquitous and essential for living systems. 
Cell membranes surround and define their inside, functioning as a semipermeable barrier. 
One of the important equilibriums that cell membranes control, is the asymmetry of ion 
concentrations extra- and intercellular. The potassium cation [K+] is found in concentrations 
of 5 mM extracellular, 150 mM inside the cell, while [Na+] is present with 150 mM outside of 
the cell whereas within the cell it is found in concentrations of 10 mM. Complex protein 
structures, channel-forming proteins, control passage of cations as well as other organic 
structures, e.g. sugars while retaining macromolecules.21 Ion transport is performed in two 
different manners: through ion channels, ions can diffuse passively by an electrochemical 
gradient or through an active transport. Ion movement through ion pumps is an active 
transport that needs energy supplied by hydrolysis of adenosine triphosphate, ATP.22 For these 
structures to embed into the lipid bilayer they possess hydrophobic regions that span through 
or interact with the membrane (Figure 1). The transmembrane proteins (TM proteins) feature 
a scaffold that is based on α-helices spanning the membrane while single pass α-helical TM 
proteins are the most abundant, seven-pass α-helical proteins being subsequent.9 Additional 
regions around the central channel contribute to a wide variety within this protein family, e.g. 
controlling access to the pore. Membrane proteins, G-protein-coupled receptors, receptor 
 
  - 7 - 
tyrosine kinases, ion channels and transporters, such as the sodium/glucose cotransporter, 
realize vitally important processes.23  
 
Figure 1. Structure of the cell membrane 
The illustration of the cell membrane shows structures embedded (integral membrane proteins) or anchored to the 
phospholipid bilayer (peripheral membrane proteins). Illustration adapted from Achalkumar et al.24 
Membrane proteins make up 20 – 30% of all proteins within the eukaryotic and prokaryotic 
proteome25 and represent around 60% of drug targets. Therefore, FDA-approved drugs are 
mostly membrane proteins.26 Examples for approved drugs targeting membrane proteins are 
the subscribed β1-adrenceptor blocking agents targeting a G-protein coupled receptor. The 
serotonin transporter, SERT, displays 12 α-helices and is targeted by serotonin reuptake 
inhibitors, SRIs, which are frequently prescribed antidepressants. The last example is the 
blockage of a sodium-dependent glucose transporter (SGLT) by SGLT-2-blockers used by 
patients with type 2 diabetes.27,28 But not only the design of new drugs is of great interest, the 
development of bio-inspired sensors based on TM proteins is demanded because of their 
unique features involving high ion flux, tremendous selectivity and immense precision. 
Usually, ion channels are complex, large structures with diameters of 5 – 7 nm at a length of 
around 10 – 15 nm with a selectivity filter only being 1 – 1.5 nm.22 The diameter of ions they 
transport, is around 0.2 – 0.3 nm and they discriminate and transport these structures 
reliably.22 Despite their significance, very little is known about their structures, characteristics, 
biophysical and chemical properties because they are not readily available. Neither expression 
nor chemical synthesis of these structures is trivial and up until 2003 only around 60 high-
resolution structures of membrane proteins were available at databases.29 Expression using 
microorganisms is challenging since recombinant expression strategies for hydrophilic 
proteins are not applicable for hydrophobic structures, over-expression of especially ion-
channels often results in cell toxicity and overall handling in regard to extraction and 
purification is a great issue.30 Trying to overcome these problems, chemical synthesis using 
SPPS is the method of choice laying foundations for cross-border cooperation between 
chemistry and biology.  
Unfortunately, SPPS encounters limits as well. Poor handling in regard to aggregation and 
hydrophobicity of the amino acid sequences of TM proteins are problems that need to be 
addressed. The challenge lies not only in the synthesis, but in the purification, ligation and 
refolding of membrane proteins.23  
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3.2. Potassium Channels 
Investigation of potassium channels was triggered with the work published by MacKinnon in 
1998 that engaged the determination of the x-ray crystalline structure of KcsA (23-119), the 
integral potassium channel from Streptomyces lividans.1 Even though this ion channel is 
derived from prokaryotic gram positive bacteria, a prokaryote, it shows structural similarities 
to eukaryotic potassium channels. The pore region (P-region) of various potassium channels 
was extensively studied in the 1990ies and led to the conclusion that a certain sequential 
arrangement is omnipotent and invariant in these types of channels (Figure 2).31,32 This 
extremely homologous sequence in the P-region is characterized by eight amino acids 
TXXTXGYG (X being a variable amino acid).33 Not only is this selectivity filter extremely 
small, it is also able to discriminate between the two similar cations Na+ and K+ by over a 
thousand fold even though their atomic radii only differ by 0.38 Å.34,35 Potassium channels 
play an inevitable role due to their physiological function: homeostasis and the repolarization 
the action potential in excitable.36 Since x-ray data from the first experiments were not 
sufficient in understanding the exact structure, especially of the pore region, intensive studies 
were carried out later. Doyle et al. investigated the conduction and selectivity of KcsA (25-
119).1 The proposed37 and further proven tetrameric structure exhibits a symmetry around 
the central pore, one monomer built from an inward facing transmembrane α-helix connected 
to a further α-helix that faces the membrane with a selectivity filter only 12 Å long.1  
Cation K+ Rb+ Cs+ Li+ Na+ 
Å 1.33 1.48 1.69 0.6 0.95 
Table 1. Sizes of cations 
Cations in bold (Li+ and Na+) are not transported across the channel 
Table 1 shows sizes of various cations that are interesting in regard to being transported 
through potassium channels. The cations Li+ and Na+ are excluded and thus not transported 
across potassium channels whereas for Rb+ and Cs+ permeation is possible 
Additionally, conduction of most potassium channels is exceptionally fast with a flux of 108 
ions per second.34 Hodgkin et al. investigated the movement of potassium ions across axons in 
the 1950ies, already observing and proposing that more than one potassium ion has to be 
present within one channel.38 The lab around MacKinnon analyzed this hypothesis further, 
coming to the conclusion that two K+ ions are usually present within the selectivity filter and 
are separated by a water molecule (Figure 2). This phenomenon is explained in more detail in 
chapter 3.2. 
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Figure 2. Structure, design and ion flux of 
potassium channels 
(a) shows symmetry of the tetramer around 
the central pore (b) the pore region with 
corresponding potassium ions in the 
selectivity filter as a magnification of the 
complete channel, seen in (c)  
Images from the RCSB PDB (rcsb.org) of PDB 
ID 1BL8 (Doyle, D.A., Cabral, J.M., Pfuetzner, 
R.A., Kuo, A., Gulbis, J.M., Cohen, S.L., Chait, 
B.T., Mackinnon, R., (1998) Science 280: 69-
77 DOI: 10.2210/pdb1BL8/pdb) 
 
Regarding the behavior of K+ ions when entering the pore, four carbonyl oxygen open the 
selectivity filter towards the extracellular compartment making the hydrated K+ to shed its 
hydration shell to enter the pore (Figure 2c). Eight oxygen atoms (shown in red) build a cage-
like structure simulating water molecules and thus stabilizing the potassium cation.39,40 This 
unique feature of the way K+ enters the pore is the reason of the distinct discrimination 
between K+ and Na+. 
Due to structural accordance of all potassium channels, especially of the conserved sequence 
of the P-region, the flow of ions is supposed to be universally applicable. Ion flux of all 
potassium channels is as mentioned above, presumed to be similar due to the conserved P-
region. The structure, though, vary greatly. Table 2 coarsely classifies the different structural 
set-ups of various potassium channels introduced by Kuang et al41 excluding the class of two 
pore domains and eight transmembrane helices.42 
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 2TM/P 6TM/P K2P 
Format 
- two transmembrane 
helices 
- one P-loop 
- six transmembrane 
helices 
- one P-loop 
- four transmembrane helices 
- two P-loops 
- dimers (mostly two linked 
Kir-like sequences) 
Examples 
Inward-rectifier family 
-KirBac1.143, IRK144 
Channels of the Kcv 
family 
-KcvATCV-145 
Voltage gated KV46 
- human ether-a-go-go- 
related gene hERG 
K+47 
Ligand gated Kligand 
- Kch48 
Four different groups: weak 
inward rectifiers, acid 
stimulated, stretch-activated 
potassium channels, and K+ 
channels build with 
polyunsaturated fatty acids49 
Table 2. Classification of potassium channels 
 
 
Figure 3. Diverse structures of potassium channels 
In (a) the 2TM/P channels are shown, (b) illustrates the K2P channels and (c) the 6TM/P potassium channels. The 
phospholipid bilayer is shown with blue, hydrophilic heads and two red, hydrophobic tails and the helices of the 
illustrated potassium channels as purple barrels embedded into the membrane. The orange cylinder represents the 
pore helix while the green barrel strands for the selectivity filter. The Graphic was adapted from the illustration 
from Thiel et al.50  
 
3.3. Kcv – Potassium channels 
The family of Kcv channels belongs to the 2TM/P class of potassium channels and are 
encoded by a Chlorovirus that infects symbiotic chlorella-like green algae. The distinctiveness 
of these viruses is the presence of an internal lipid membrane which has a crucial role during 
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the process of early infection.36 These specific K+ channels show the signature sequence 
within the pore-forming helix. They are fully functional and sensitive to K+ blockers but their 
size represents to their unique feature.50 Some of the families’ members belong to the smallest 
known potassium channels. KcvATCV-1 (K+ channel chlorella virus Acanthocystis turfacea 
chlorella virus-1), KcvS (K+ channel chlorella virus smith) and KcvNTS (K+ channel chlorella 
virus next to smith) possess potassium channels containing only 82 amino acids.51,52 All three 
display the same, conserved sequence within the filter region, namely: THTTVGYGDL. 
 
 
Figure 4. Scheme of Kcv 
The figure shows a simulation of a Kcv channel with (a) two opposing monomer units and two potassium ions 
illustrated in red and the tetrameric form is shown in (b). There are no crystal structures of Kcv channels available, 
this simulation is only to demonstrate the function and composition 
Because of their size, they are almost fully embedded into the cell membrane, thus making 
them perfect candidates for functional studies with patch-clamp and lipid bilayer methods.51 
Single channel recordings using the patch-clamp method give information on the conductance 
and kinetics of the investigated ion channel. Therefore, a patch of the membrane of the 
investigated cell is isolated electrically through light suction into a fire-polished glass 
pipette.53 Various difficulties arise when the desired proteins are not sufficiently accessible to 
patch clamp methods. Proteins from bacterial membranes, for example, display difficulties but 
are readily measured using the lipid bilayer method.54,55 Lipid membranes introduced in 1962 
by Mueller et al.,56 are still used today to record single-ion channel current measurements at a 
constant applied voltage.57 For that, the planar lipid bilayer methods display many 
advantages. The composition of lipids, the buffers and the protein can be controlled.54 In 
Figure 5 a simulation of the tetrameric KcvNTS is shown as well as a section from planar lipid 
bilayer experiments by Braun et al.51 The current traces show a high single-channel open-
probability which is further calculated to be over 50% and a high conductance of 80 pS. Since 
function and structure of potassium channels are an exciting research field, the Kcv channels 
represent attractive models for studies because of their minimal size but functional 
robustness. 
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(a) (b) 
 
 
Figure 5. KcvNTS channel and lipid bilayer recordings 
KcvNTS is shown as a simulation in (a) and current traces from planar lipid bilayer experiments conducted with the 
native KcvNTS with O – open and C – closed states of the channel. The current trace was kindly provided by Tobias 
Winterstein from the Thiel lab (TU Darmstadt). There are no crystal structures of KcvNTS available, this simulation is 
only to demonstrate the function and composition 
 
3.4. Peptides/proteins as sensors 
Signal transduction of e.g. ion channels within biological cell membranes is one example of 
the extremely sensitive and selective behavior of proteins. For example, G-protein coupled 
receptors (GPCR) get triggered by external molecules, ligands and through a conformal 
change, a signaling cascade is implemented. Hundreds to thousands of second messengers 
may be activated only by one GPCR.58 A selected example of a vital sensor system in the 
human body are the various pH sensors located in the kidney. An adequate pH is essential for 
normal functioning of cellular enzymes and biochemical reaction. If a pH change is registered, 
the electrogenic, proton pumping vacuolar-ATPase (V-ATPase) translocates to the surface of 
the cell for regulation of HCO3-.59 Other pH sensing and modulating biological structures are 
various GPCR and H+ ion-sensing channels.60  
Coming back to the aforementioned potassium channels, ultra-sensitive sensing towards K+ 
and the discrimination between Na+ and K+ was already introduced. But, not only the 
conductance is of interest. Blockage of potassium channels, especially those of the Kcv family, 
is performed e.g. by extermal Ba+61, by amantadine62, an anti-viral drug, and TEA 
(Tetraethylammonium). Just recently, the importance of intrahelical H-bonds was 
investigated in regard to gating. Rauh et al. determined an open probability of 90% for KcvNTS 
and 40% for KcvS but an amino acid sequence identity of 90% (8 amino acids) coming to the 
conclusion that a Ser-mediated intrahelical H-bond results in longer closed states.52 These 
findings demonstrate the extreme structure-function relationship where only one amino acid 
within the sequence has a fundamental impact on the open probability of the channel.  
The ability to act as sensors is not only restricted to membrane proteins. Numerous protein 
structures are able to coordinate metals, e.g. the coordination of iron through the porphyrin 
ring of hemoglobin.63 A very abundant and essential transition metal in living organisms is 
zinc. Zinc homeostasis is mediated through monitoring of changes in the free zinc pool by 
sensing proteins. The MTF1 sensor displays a Kd below 90 µM thus again accentuating the 
ultra-sensitive sensing behavior of biological structures.64 
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3.4.1. Solid-state nanopores as sensors 
Leaving the biological environment, sensing can be performed through channels within solid-
state materials. Nanopores in solid state materials are enclosed channels of a certain length, 
diameter and shape. These attributes can be tuned to the desired shape. The easiest forms of 
nanopores are of bare structure and can be used for size-selective filtration. By coating the 
surface with substances of choice, enhanced separation processes are generated that are 
dependent on the object and substances used.65  
Different methods for fabrication, tuning and functionalization are summarized in Table 3. 
Method 
Shape of 
nanopores 
Smallest size 
of nanopores 
Solid-state 
material 
Follow-up 
protocols 
Ref. 
Ion-beam 
sculption 
bowel-shaped 
nanopores 
around 2 nm 
Si3N4, SiO2, 
SiN 
Atomic layer 
deposition 
(ALD) for fine 
tuning of pore 
size 
20,66,67 
Track-
etching 
various 
geometries 
(conical, 
cylindrical, 
hourglass, 
bowel-
shaped)  
5 nm (after 
gold 
plating68) 
Polycarbonate, 
Polyimide, 
Poly(ethylene 
terephthalate), 
Polycarbonate 
Layer-by-
layer, ALD 
69-71 
Transmission 
electron 
microscope 
drilling 
cylindrical, 
hourglass, 
cylindrical 
around 2 nm SiN, TiN ALD 72,73 
Electrical 
pulse 
*cylindrical 0.5 ± 0.3 nm Graphene 
enlarging of 
pore in steps 
of 0.1 ± 
0.3 nm/pulse 
74,75 
Table 3. Different types of nanopore fabrication 
*thinnest possible membrane, no variations in shape possible 
The multitudinousness of applications emerging from solid state nanopores is distinctively 
presented by Lee et al.76 The group investigated the selectivity of small molecule transport 
through gold nanotubules, which can be formed by deposition of gold into polycarbonate 
track-etched nanopores. By controlling the gold plating time, the diameter of the tubules is 
tunable, making clean and selective separation of small molecules possible (diameter < 1 
nm).76 Further studies focused on the differentiation between hydrophobic and hydrophilic 
molecules through chemisorbing either hydrophobic or hydrophilic thiols to the gold 
nanotubules.77 Furthermore, charging the membrane with excess positive or negative charge 
introduces ion selection by rejection of ions of same the charge whereas transport of ions 
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exposing the opposite charge is possible.78 Again, Lee et al. used the gold nanotubules and 
introduced a new pH-selective property by chemisorptions of cysteine.76  
 
 
Figure 6. Electron micrograph of a conical nanopore 
The image was kindly provided by Mubarak Ali, GSI Darmstadt 
Figure 6 shows a conical nanopore 
within PET foils (12 µm thickness). The 
advantages of this symmetry of pore is 
the possibility to mimic biological ion 
channels through rectification. They 
display a high selectivity because of the 
focusing of the electric field at the small 
tip opening.79,80 A resistive-pulse 
technique is used where the single 
nanopore is installed between two 
chambers filled with electrolyte solution, 
usually containing KCl. While potential 
is applied an ion current is generated. If 
an analyte is present in the solution and 
is driven through the nanopore, a block 
in the ion current is induced, effecting a 
change in current. 
The magnitude or duration of the current block can be attributed to the concentration of the 
analyte.81,82 Figure 7 represents the schematic set-up of resistive-pulse measurement set-up 
with a two-chamber system. 
 
Figure 7. Setting of ion current measurements 
The schematic setting was adapted from Zhang et al.83 
With the greater aim of designing sensors that can be used for biomedical or environmental 
applications, some kind of selective sensing towards a certain analyte is essential. Ligand 
binding to a receptor is an extremely selective and sensitive procedure and thus presents an 
optimal scaffold. Two designs of sensor systems are feasible. Using the first method, no 
attachment of the molecular-recognition agent (MRA) is needed. Differences in current when 
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using only the analyte or the analyte/MRA complex will give information on concentrations of 
the analyte. This concept is introduced by Sexton et al. using BSA and the corresponding 
binding antibody.84 Second, generation of a hybrid nanopore: with the attachment of a 
receptor into the solid state nanopores, binding of the ligand can be determined and 
evaluated through changes in ion current. To generate such a hybrid system out of solid state 
nanopores the integration of some kind of biologically active substance is mandatory. Siwy et 
al investigated attachment of MRAs to conically shaped nanopores (gold-coated). With their 
work they manifested applicability of sensor systems using the biotin/streptavidin, protein-
G/immunoglobulin IgG and an antibody to ricin MRA systems. Detection of the analyte (the 
latter listed structure) was done by the drop in the steady-state ion current when applying a 
constant transmembrane potential.85  
Especially the conically shaped nanopores exhibit competences for future applications. Their 
benefits introduced in 3.4.1 in regard to comparability to membrane proteins and focusing of 
the current on the tip resulting in high signal output, make them interesting scaffolds for 
sensor design.82 Furthermore, high stability of the solid state material (e.g. PET, PC) make 
them ideal candidates for the design of sensor devices. Possible applications comparable to 
e.g. glucose sensors are future goals. 
 
3.4.2. The ATCUN motif 
Coming back to peptides and proteins that can act as sensors, metal-binding peptides like 
hemoglobin were introduced earlier in 3.4. Besides iron, there are numerous other trace 
elements of vital importance for the human body such as copper.86 There are multitudinous 
enzymes involved in copper transportation and homeostasis, making copper essential for the 
normal function of the body, brain development and infant growth.87,88 Due to its importance, 
defects in the copper homeostasis can lead to diseases such as Wilson’s and Menke’s disease 
with the latter being linked to a lethal Cu2+ hyper-accumulation.87 Copper is calculated to be 
required in amounts of 1.2 – 2.0 mg/d with a dietary recommendation being 1.5 – 3.0 
mg/d.89 Usually, chronic as well as acute copper toxicity due to excess amounts of copper are 
relatively rare but when they occur, liver cirrhosis, damage of renal tubes and brain structures 
is possible.90 Due to the known risks as well as the need of copper the WHO limited copper 
concentrations in drinking water to be ≤ 2 mg/l.91 Through environmental pollution, heavy 
metals such as Nickel end up accumulating in the human body through inhalation, soil or 
drinking water leading to problems ranging from skin irritation and allergic reactions to an 
elevated risk of cancer.92 In this context, the WHO also included a limit of nickel in drinking-
water to be ≤ 0.07 mg/l.93  
In the human blood plasma, around 10 – 12% of copper ions are bound to albumin, the most 
abundant protein.94 In 1960 Peters et al described binding of Cu(II) to bovine serum albumin 
(BSA) and triggered an avalanche of research concerning this topic.95,96 Nowadays this 
structure is known as the Amino terminal Cu(II)- and Ni(II)-binding motif (ATCUN motif) 
occurring not only in BSA but also in human and rat serum albumin (HSA, RSA), neuromedin 
C and K, human sperm protamine P2a and histatins.12,97 One of the first experiments to 
determine the molecular structure of the ATCUN motif was done by Camerman et al. in 1975 
and is still valid today. They designed the simplest known ATCUN motif Gly-Gly-His and 
detected a square planar 1:1 binding stoichiometry. The copper is chelated through the 
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terminal nitrogen of the amino group, the two peptide 1ackbone nitrogens and the nitrogen of 
the imidazole ring of the histidine moiety.98  
(a) (b) 
 
Structure Sequence 
RSA Glu-Ala-His 
HSA Asp-Ala-His 
BSA (bovine serum albumin) Asp-Thr-His 
P2a Arg-Thr-His 
Histatin 3 Asp-Ser-His 
Neuromedin C Gly-Asn-His 
Neuromedin K Asp-Met-His 
 
Figure 8. Structure and sequence examples  
(a) Complex of the simplest ATCUN motif GGH with Cu2+ (b) various ATCUN motifs in natural occurring structures. 
The lack of the ATCUN motif in e.g. dog and pig serum albumin results in decrease of affinity to Cu(II) and Ni(II) 
Making use of the coordination of nickel and copper, theses motifs are interesting sensing 
units when integrating fluorescent groups that get quenched upon complex formation.99 The 
extent of quenching can further be used for the determination of metal-binding efficiency and 
thus displays characteristics of a fluorescent chemosensor.100 Making use of the green 
fluorescent protein (GFP) and attaching an ATCUN motif, Choi et al. were able to detect and 
visualize dynamic copper fluctuations on living cell surfaces.101 The vision behind this 
experiment is the Cu2+ imaging in neuronal cells, especially the synaptic cleft. ATCUN motifs 
can also be used as electrocatalysts for water oxidation making detection of DNA possible.102 
Looking further into DNA interactions, cleavage of DNA was investigated and will be 
introduced in the following section. 
 
3.4.3. DNA scission ability of ATCUN motifs 
Besides the intensively studied complexation behavior, these motifs are also interesting in 
regard to linearization of dsDNA. In nature restriction enzymes fulfill the task. These 
endonucleases can cleave dsDNA at defined sequences through disruption of the 
phosphodiester bond of both DNA strands being a protective mechanism towards foreign 
DNA.103 Using this defense mechanism in addition with e.g. a specific recognition unit, 
numerous medicinal applications are possible. 
Scission of the ATCUN motif was first described by S. H. Chiou using the tripeptide GGH.104 
He illustrated cleaving activity of a mixture of peptide, Cu(II)-ions and ascorbate on DNA 
from a bacteriophage and viral DNA. The process of DNA cleavage is provoked by the 
generation of hydroxyl radicals following this proposed mechanism by Harford et al. seen in 
Equation 1 - Equation 3.12 
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𝑎𝑠𝑐𝑜𝑟𝑏𝑎𝑡𝑒 + 2 𝐶𝑢 → 𝑑𝑒ℎ𝑦𝑑𝑟𝑜𝑥𝑦𝑎𝑠𝑐𝑜𝑟𝑏𝑎𝑡𝑒 + 2𝐶𝑢 + 2𝐻  Equation 1 
𝑎𝑠𝑐𝑜𝑟𝑏𝑎𝑡𝑒 + 𝑂 𝐶𝑢
→
𝑑𝑒ℎ𝑦𝑑𝑟𝑜𝑥𝑦𝑎𝑠𝑐𝑜𝑟𝑏𝑎𝑡𝑒 +  𝐻 𝑂  Equation 2 
𝐻 𝑂 +  𝐶𝑢  →  𝐶𝑢 + 𝑂𝐻 + 𝑂𝐻°(ℎ𝑖𝑔ℎ𝑙𝑦 𝑟𝑒𝑎𝑐𝑡𝑖𝑣𝑒) Equation 3 
The released hydroxyl radicals from Equation 3 are further able to cleave the DNA strand. 
This is initiated by the abstraction of a hydrogen atom from the desoxyribose backbone.105 
While the hydroxyl radical is able to abstract any hydrogen, it was already in the 1980ies that 
researchers determined the radicals of Cu2+ complexes to abstract certain hydrogens.106 
Studies of peptide-DNA and peptide-drug-DNA interactions led to a rising interest in this 
research field. Intensive studies came to the conclusion that the stereochemical orientation of 
the square-planar ATCUN-metal complexes is crucial for DNA cleavage.107 A preference for 
A/T-rich regions in dsDNA was evaluated with the binding to the minor groove. Huang et al. 
stated a minor groove binding through the N3 imidazole hydrogen to the N3 of adenine or the 
O2 of thymine.108 
 
Figure 9. Interactions of the ATCUN motif with dsDNA 
Images inspired by simulation studies from Fang et al. to illustrate the proposed binding and interactions of the 
ATCUN motif l-Arg-Gly-His with d(CGCGAATTCGCG)2.
107 (a) shows hydrogen bonding and (b) the relative 
orientation of the ATCUN motif in the space-filled DNA model (Proteine Data base 1CW9) 
Image from the RCSB PDB (rcsb.org) of PDB ID 1CW9 (van Aalten, D.M., Erlanson, D.A., Verdine, G.L., Joshua-Tor,L. 
(1999) Proc.Natl.Acad.Sci.USA 96: 11809-11814 DOI 10.2210/pdb1CW9/pdb) 
In the past, small metallopeptides were used as scaffolds for the development of low 
molecular drugs. In 1966 Umezawa et al discovered the antibiotic competence of the 
bleomycin family, a glycoprotein isolated by Streptomyces verticillus.109 Nowadays these 
structures are commonly used as antitumor agents in the combinational treatment of 
lymphomas, types of gem-cell cancers and certain head and neck cancers.110 These 
glycoproteins bind transition metals, such as Fe(II) and Cu(I) and cleave ssDNA as well as 
dsDNA through formation of lesions within the strands.111 Probably one of the most known 
anticancer drugs is Cisplatin, a metallopeptide that cross-links to DNA.112 Since this behavior 
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can also be found in ATCUN motifs, these structures are of great interest in the evolvement of 
new medications.  
In regard to cancer treatment, DNA sequencing of the tumor genome, will enhance treatment 
and identify mechanisms of drug resistance.113 
3.4.4. DNA translocation and sequencing through solid-state nanopores 
DNA sequencing makes “reading” of a DNA strand possible. Therefore, it is a fundamental for 
biological research making decoding of genomes possible. Over the last fifty years, sequencing 
of short oligonucleotides was enhanced to read millions of bases.114 Nanopores, biological and 
of solid state material, display interesting candidates in regard to fast and efficient DNA 
sequencing. With the translocation of a nucleotide unit within the DNA sequence, a current 
block is generated that is dependent on the base travelling through. The idea of nanopore 
DNA sequencing was proposed by Deamer and Akeson in 2000115 based on their findings from 
1996, where the biological pore α-Haemolysine, α-HL was successfully used to translocate 
ssDNA.15 The α-HL pore displays a pore opening of 2.6 nm with a stem of 2.2 nm and a 
limiting aperture of 1.5 nm.116 It passes a steady ionic current of 100 pA with voltages of 100 
mV applied through the pore that remains open at neutral pH values.115 
 
Figure 10. DNA sequencing through a alpha hemolysine 
nanopore with phi29DNA polymerase attached 
Figure showing the translocation of ssDNA through a α-HL 
nanopore (blue) with phi29 attached (green) inspired from 
Schneider et al.117  
 
Unfortunately, the speed of translocation is 
extremely high, making signal read-out 
challenging. Many strategies are proposed 
slow down the translocation time to make 
base identification possible and reliable. 
The Akeson lab designed a blocking 
oligomer used with phi29 DNAP 
(bacteriophage phi29 DNA polymerase) 
atop of a α-HL pore for controlled 
sequential movement of ssDNA strands.118 
To overcome limitations in translocation of 
only ssDNA, other pore forming structures 
were sceened. A pore from Mycobacterim 
smegmatis (MspA)119 evolved to be an 
interesting candidate towards DNA 
sequencing. Combined with the phi29 DNA 
Polymerase120 it was investigated towards 
sequencing of double stranded DNA 
(dsDNA) adding a Phi29.121 Still, a high 
error rate for both systems leaves room for 
improvement. 
Therefore, solid-state nanopores emerged to be possible structures applicable for DNA 
sequencing. The results from biological nanopores indicated a need for a unit to slow or 
interfere with the translocation rate. Therefore, functionalization of solid-state nanopores 
using a DNA-hairpin molecule, also for the transport of the desired sequence, emerged to be a 
promising approach.122,123 Solid-state materials from polymers are usually characterized by a 
great thickness, which is linked to major challenge towards DNA sequencing. A thickness of 
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only 30 nm corresponds to around 60 bases of an ssDNA molecule, exemplifying these 
problematics.117 Recently, graphene-based nanopores were introduced displaying a thickness 
of a singe carbon atom and could therefore circumvent the introduced difficulties. Successful 
translocation of dsDNA displays a fundament from which further experiments can be 
developed.124 
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4. Aim 
This thesis focuses on two ways on creating hybrid nanopores. The first approach is based on 
an example from nature and transport over a membrane in form of ion channels. The idea 
behind this is the combination of a naturally occurring ion channel and the embedding of this 
structure into artificial solid/lipid support. A second approach focuses on the usage of solid 
state/artificial nanopores and the immobilization of functional peptides aiming for a certain 
selectivity. For that purpose, this thesis addresses both aspects as followed: 
(1) The development of a chemical synthesis route for the viral potassium channel KcvNTS as 
the first step towards the design of bio-inspired nanopores. 
(2) The fabrication of a hybrid material that based on heavy-metal ion coordination through 
immobilization of the corresponding ion sensitive peptide into track-etched nanopores.  
 
In order to fulfill the first aim, the generation of sufficient quantities of KcvNTS, to facilitate 
structural studie, is addressed. Therefore, a robust synthetic route is needed that further 
allows for future integration of isotopically-labeled amino acids for NMR studies or for 
straight-forward mutations and additions to the native sequence prior to development of a 
bio-inspired material. The 82-mer displays a strong hydrophobicity especially within the 
alpha-helical transmembrane regions. With increasing hydrophobicity the chemical synthesis 
becomes more challenging. That is why a synthesis of the complete sequence within one step 
would fail. Therefore, the sequence needs to be divided in a way that ensures the native 
sequence after ligating the evaluated fragments through native chemical ligation (NCL). In 
this thesis several approaches are addressed including the correct conditions for the NCL 
reaction. Additionaly, synthesis of the fragments is challenging as well as purification after 
solid phase peptide synthesis with the need to address the available possibilities towards 
fragment generation. Finally, the correct folding and behavior of the product, the synthetic 
KcvNTS, needs to be investigated. The difficulties for analytical methods towards such 
hydrophobic structures are addressed as well. 
 
Approaching the second aim, a small sensing peptide needs to be evaluated that can be 
integrated into solid-state nanopores for the generation of a sensing device. To exploit the 
advantages of the hybrid system, the sensor needs to display a robustness, selectivity, 
sensitivity as well as re-usability. To fulfill the approach, peptides and mutants of the ATCUN 
family are designed and studied in regard to metal ion selectivity. A selectivity towards only 
one target is needed to generate a selective sensor. Therefore, binding studies are conducted. 
Addressing the sensitivity and re-usability several analytical approaches are presented using 
the selective system. Finally, the applicability of the sensor is discussed. To evaluate the need 
of the referred mandatory histidine moiety in the ATCUN motif, mutants are investigated 
towards heavy metal binding. Solid-state nanopores and biological nanopores are interesting 
regarding DNA sequencing. Aiming towards a sequencing device, first steps are presented 
making use of the scission ability of the ATCUN peptides. An approach is presented targeting 
the examination of a scission preference towards several dsDNA plasmids. Furhter studies 
regarding the scission ability of the designed ATCUN peptides and mutants, when 
immobilized to the solid-state nanopores, are addressed to use the outcomes for a possible 
device generation.    
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5. Methods 
5.1. Synthesis and analytics of voltage-gated potassium channels 
Synthesis of the 82 amino acid long Kcv protein is performed by division of the sequence into 
three fragments (Figure 30). All fragments are synthesized on a CEM liberty automated 
peptide synthesizer using the standard Fmoc-based solid phase peptide synthesis (SPPS) 
protocol. AmphiSpheres RAM (rink amide resin) (loading 0.38 mmol/g) is used for all 
synthesis protocols, respectively. Prior to synthesis, the resin is swollen using 
Dichloromethane (DCM) for 20 minutes under shaking and washed using N,N-
Dimethylformamide (DMF). Double coupling is performed for each amino acid at 50 °C and 
using microwave treatment (35 W). As coupling reagents, 1-[Bis(dimethylamino)methylene]-
1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU) (3.9 equ., 0.2 M) in 
DMF and N-ethyl-N-(propan-2-yl)propan-2-amin (DIEA) (8 equ., 0.4 M) in N-Methyl-2-
pyrrolidone (NMP) and are used with the concording amino acid (4 equ., 0.2 M). 
Deprotection of the 9-fluorenylmethoxycarbonyl (Fmoc)-group is performed in 20% 
piperidine/DMF (v/v) and controlled through the integrated UV-monitor of the peptide 
synthesizer for each deprotection step. The final deprotection step is done manually to control 
the remaining loading of the resin. Final cleavage from the resin is performed using a mixture 
of trifluoroacetic acid, TFA/triisopropylsilane, TIPS/anisole (90:2.5:2.5% v/v) for 3.5 h at 
room temperature. The crude peptide is precipitated in ice-cold diethyl ether, centrifuged, and 
washed with diethyl ether. The obtained crude product is dissolved in acetonitrile, ACN/water 
mixture and freeze dried (Christ Alpha 1-2 LDplus). All peptides are stored at -30 °C. 
Complete synthesis of fragment 1 and fragment A is done by automated SPPS according to the 
described procedure. Synthesis specifications for fragment 2 and 3 are reported in the next 
paragraph. 
Fragment 2 contains the oxo-ester group 2-hydroxy-3-thio-propanic acid (hmp) which is 
coupled with the two consecutive amino acids manually prior to automated peptide synthesis. 
For coupling of hmp, hmp(Trt) (4 equ., 0.2 M, 364.06 g/mol) is coupled by double coupling 
(2 × 1 h) using the standard reaction conditions described above with addition of 1-Hydroxy-
7-azabenzotriazole HOAt (4 equ., 0.2 M, 136.11 g/mol). After washing the resin with DCM, 
dry tetrahydrofurane, THF, is used to prepare the resin for the Mitsunobu reaction. Using this 
method, the next amino acid, Fmoc-Ser(tBu)-OH (5 equ., 0.2 M, 383.44 g/mol) is coupled 
using douple coupling (2 × 2 h) with triphenylphosphine, PPh3 (5 equ., 0.2 M, 262.29 g/mol) 
and diethylazodicarboxylate, DEAD (5 equ., 40 wt% in toluene, 174.15 g/mol). After Fmoc 
deprotection, the next amino acid Fmoc-Phe-OH (4 equ., 0.2 M, 387.43 g/mol) is coupled 
using the standard coupling protocol. No deprotection takes place, the resin is freeze dried for 
further automated SPPS. 
Fragment 3 also contains the oxo-ester group hmp. Manual coupling is analogous to fragment 
2 using Fmoc-Thr(tBu)-OH (5 equ. 0.2 M, 397.46 g/mol) for the Mitsunobu reaction. The 
next amino acid, Fmoc-Phe-OH, is coupled according to fragment 2. Fragment B is 
synthesized accordingly, with the consecutive amino acids seen in Table 5. 
Fragment 3.2 contains a solubility tag attached before hmp coupling. The solubility tag NH2-
Gly-Gly-Gly-Gly-Ser-Lys-Lys-Lys-CONH2 is coupled using the peptide synthesizer following the 
standard protocol. Coupling of the hmp unit and the following two amino acids is equal to the 
protocol described for fragment 3.  
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Sequence Fragment 
Molecular 
formula 
Resin scale (mmol) 
KcvNTS(36-82) 
Fragment A 
 
C239H360N54O63S2 
AmphiSpheres 
RAM 
 
0.1 
loading of resin 
(mmol/g) 
Mresin (mg) 
Calculated 
peptide mass 
(mg) 
Mresin end (mg)  
loading end 
(mmol/g) 
0.37 270 506 827.7 0.0667 
Table 4. Synthesis conditions for fragment A 
 
No. synthesis 1 2 3 
AA pos. 36 D36 D36E D36E 
Special features of 
synthesis 
2-methylpiperidine, 
Pseudoprolines 
2-methylpiperidine 
2-methylpiperidine, 
Pseudoprolines 
Resin weight (g) 0.556 0.600 0.5802 
Resulting resin 
weight (g) 
0.635 0.6336 0.5905 
Scale (mmol) 0.1 
Resin TentaGel® 0.18 mmol/g 
Crude product (mg) 80 25 28 
Calculated product 
(mg) 
407 439 426 
Synthesis yield (%) 19.7 8.0  6.6 
Table 5. Synthesis conditions for fragment B 
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Sequence Fragment 
Molecular 
formula 
Resin scale (mmol) 
KcvNTS(41-82) 
Fragment 1 
 
C209H322N50O55S2 
AmphiSpheres 
RAM 
 
0.25 
loading of resin 
(mmol/g) 
Mresin (mg) 
Calculated 
peptide mass 
(mg) 
Mresin end (mg)  
loading end 
(mmol/g) 
0.38 1400 1130 669.77 0.22 
Table 6. Synthesis conditions for fragment 1 
 
Molecular 
formula 
Calculated 
[M+H+]+ 
Calculated 
[M+3H+]3+ 
Measured 
[M+3H+]3+ 
Calculated 
[M+4H+]4+ 
Measured 
[M+4H+]4+ 
C209H322N50O55S2 4480.22 1493.79 1493.80 1120.59 1120.60 
Table 7. Measured and calculated masses during LC-MS measurements of fragment 1 
 
 
Sequence Fragment 
Molecular 
formula 
Resin 
scale 
(mmol) 
KcvNTS(16-
40) 
Fragment 2 
 
C139H199N29O40S5 
AmphiSpheres RAM 
 
0.25 
loading of 
resin 
(mmol/g) 
Mresin (mg) 
Calculated 
peptide mass 
(mg) 
Mresin end (mg)  
loading end 
(mmol/g) 
0.18 1400 775 225.87 0.08 
Table 8. Synthesis conditions for fragment 2 
 
Molecular 
formula 
Calculated 
[M+H+]+ 
Calculated [M-
H2O+2H+]2+ 
Measured [M-
H2O+2H+]2+ 
C139H200N30O39S5 3075.57 1529.65 1529.66 
Table 9. Measured and calculated masses during LC-MS measurements of fragment 2 
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Sequence Fragment 
Molecular 
formula 
Resin scale (mmol) 
KcvNTS(1-15) 
Fragment 3 
 
C89H152N28O29S5 
TentaGel 
 
0.25 
loading of resin 
(mmol/g) 
Mresin (mg) 
Calculated 
peptide mass 
(mg) 
Mresin end (mg)  
loading end 
(mmol/g) 
0.18 560 226 46.6 0.1 
Table 10. Synthesis and conditions for fragment 3 
 
 
Sequence Fragment 
Molecular 
formula 
Resin scale (mmol) 
KcvNTS(1-15) 
+solubility 
Fragment 3.2 
 
C118H205N29O28S2 
AmphiSpheres 
 
0.25 
loading of resin 
(mmol/g) 
Mresin (mg) 
Calculated 
peptide mass 
(mg) 
Mresin end (mg)  
loading end 
(mmol/g) 
0.38 1354 1353 n.a.* 0.04 
Table 11. Synthesis and conditions for fragment 3.2 
*Determination of the exact mass of the crude product was not possible due to gel-like structure of the product 
sticking to the walls of the falcon 
 
Molecular 
formula 
Calculated 
[M+H+]+ 
Calculated 
[M+2H+]2+ 
Measured 
[M+2H+]2+ 
Calculated 
[M+3H+]3+ 
Measured 
[M+3H+]3+ 
C118H205N29O28S2 2543.20 1271.76 1271.75 847.17 848.16 
Table 12. Measured and calculated masses during LC-MS measurements of fragment 3.2 
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5.1.1. Terminology of KcvNTS fragments 
Fragment Sequence 
Fragment 1 KcvNTS(41-82) 
Fragment 2 KcvNTS(16-40) 
Fragment 3 KcvNTS(1-15) 
Fragment 3.2 KcvNTS(1-15)+solubility tag 
Ligation product 1 KcvNTS(16-82) 
Ligation product 1.2 KcvNTS(16-82), after thioproline conversion 
Ligation product 2 KcvNTS(1-82) 
Fragment A KcvNTS(36-82) 
Fragment B KcvNTS(1-35) 
Table 13. Terminology of fragments 
 
5.1.2. RP-HPLC of KcvNTS fragments 
Dissolution of the fragments for preparative purification is illustrated in Table 14. 
Fragment Protocol 
Fragment 1 
15 mg of crude product are weighed into a 15 ml falcon. A droplet of 
concentrated TFA is added to the crude product dissolving around 70% of 
the crude peptide. 600 µl of ACN are added and vortexed. Around 300 µl 
of water are added and the falcon centrifuged and the clear solution 
injected  
Fragment 2 
25 mg of crude product are dissolved in 1.0 ml of ACN (0.1% TFA)/water 
(0.1% TFA) solution 1:1 v/v, vortexed and injected 
Fragment 3.2 
To a falcon of crude product (~ 10 mg) 500 µl of ACN (0.1% TFA)/water 
(0.1% TFA) solution 1:1 v/v are added and the solution vortexed. Another 
500 µl of water (0.1% TFA) are added and vortexed, respectively. The clear 
solution is injected into the RP-HPLC 
Table 14. Dissolution of the Kcv fragments 
RP-HPLC methods are described in Table 15. Eluent and HPLC system: 
Eluent A: water (0.1% TFA)  
Eluent B: ACN (0.1% TFA)  
Analytical RP-HPLC instrument: Waters 2695 alliance equipped with a Waters 2998 
photodiode array detector.  
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Preparative RP-HPLC instrument: Waters 600 equipped with a Waters 2996 photodiode array 
detector.  
Analytical RP-HPLC 
Fragment Method Column 
Fragment 1 Linear gradient of 20% - 95% eluent B over 
30 minutes, flow: 1 ml/min, column 30 °C, 
UV Vis: 214 nm 
MultoKrom High 
BIO 300-3 C4; 
3 µm particle size, 
300 Å pore diameter 
125 mm × 4 mm 
CS Chromatography 
Service GmbH 
Fragment 2 Linear gradient from 20% - 65% eluent B over 
20 minutes, flow: 1 ml/min, column 30 °C, 
UV Vis: 214 nm 
Fragment 3.2 5 minutes isocratic at 5% eluent B followed by a 
linear gradient of 5% - 70% eluent B over 20 minutes 
total, flow: 1 ml/min, column 30 °C, UV Vis: 214 nm 
Preparative RP-HPLC 
Fragment Method Column 
Fragment 1 Linear gradient from 40% - 95% eluent B over 
75 minutes, flow: 10 ml/min, UV Vis: 214 nm 
MultoKrom High 
BIO 300-5 C4;  
5 µm particle size, 
300 Å pore 
diameter, 
250 mm × 20 mm  
CS Chromatography 
Service GmbH 
Fragment 2 Linear gradient of 20% - 45% eluent B over 
45 minutes, flow: 10 ml/min, UV Vis: 214 nm 
Fragment 3.2 15 minutes isocratic at 5% eluent B followed by a 
linear gradient of 5% - 70% eluent B within 
60 minutes total, flow: 8 ml/min, UV Vis: 214 nm 
Table 15. RP-HPLC methods for Kcv fragments 
 
5.1.3. Native chemical ligation of KcvNTS fragments 
5.1.3.1. Ligation using ligation buffer A 
Native chemical ligation, NCL experiments were performed in ligation buffer A (flushed with 
argon) containing HFIP as the organic solvent. The following ratio is used 1:1.5 n/n fragment 
2 (1.0 mM) : fragment 1 (1.5 mM). Using NaOH (10 M, flushed with argon) the pH is 
adjusted to ~7.5 and the ligation reaction initiated. Under nitrogen atmosphere, the reaction 
is carried out for 24 h. 
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5.1.3.2. Ligation using ligation buffer B 
Ligation experiments are conducted according to 5.1.3.1 using ligation buffer B (flushed with 
argon containing TFE as the organic solvent. 
 
5.1.3.3. Ligation using ligation buffer C  
The 1,3-thiazolidine-4-carboxo, thioproline (Thz) conversion experiments are conducted in 
ligation buffer C. The ligation solution from NCL in buffer A is centrifuged to yield only the 
protein pellet. The supernatant is disposed and the resulting solid dissolved in the ligation 
buffer D. With the addition of methoxyamine (200 mM) and lowering the pH to 4.0 ligation 
buffer C is obtained. The reaction is carried out for 8 h until the loss of -12 Da is detected by 
MALDI-TOF MS.  
The ligation buffer C can further be used to perform the second NCL in a one-pot strategy. In 
concordance to 5.1.3.1, the ratio of 1:1.5 n/n thioester-forming peptide, fragment 3 (1 mM) 
to product from the first NCL, ligation product 1 (1.5 mM) is used and the NCL initiated with 
increasing the pH ~7.5. 
 
5.1.3.4. Ligation using ligation buffer D 
Ligation experiments are conducted according to 5.1.3.1 using ligation buffer B (flushed with 
argon) containing TFE as the organic solvent. 
 
Fragment and 
molecular 
formula 
Calculated 
[M+H+]+ 
Measured TFE 
ligation 
solution 
[M+H+]+ 
Measured TFE 
ligation 
sediment 
[M+H+]+ 
Measured HFIP 
ligation 
sediment 
[M+H+]+ 
Fragment 1 
C209H322N50O55S2 
4480.22 4480.69 4481.40 4484.82 
Fragment 2, 
hydrolyzed (see 
6.6) 
C136H1950N29O38S4 
2973.44 - - 2971.31 
Ligation 
product 1 
C345H512N78O92S6 
7417.60 7418.28 
Elevation 
within the area 
of product with 
intensitymax at 
7426.2 
7416.62 
Table 16. Molecular masses for MS analysis during ligation 1 
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5.1.4. Purification using Vivaspin® 
The purification protocol using Vivaspin® is conducted after the second ligation and, if no 
one-pot stategy is pursued, after the first ligation to evaluate its success using MALID TOF MS. 
Flipping of the Vivaspin® unit is illustrated in Figure 11. It is important to not touch the filter 
membrane with the pipette tip. 
No Step 
× g  
(fixed bucket) 
Time 
(minutes) 
1 
Convert into filter of Vivaspin® and fill up to 
1.0 ml using 1:3 v/v TFE/water (0.1% TFA) 
8000 30  
2 Add 500 µl of solvent from step 1 8000 30  
3 Add 200 µl of water and vortex throughoutly   
4 Flip Vivaspin® 5000 5  
5 Collect remains from the filter washed with water   
6 Add 200 µl of TFE and vortex throughoutly   
7 Flip Vivaspin® 5000 5  
8 
Collect the remains from the filter washed with 
TFE 
  
Table 17. Vivaspin centrifugation 
 
 
Cap, 
remove to 
add liquid 
 
Filter-
membrane 
(red) with 
5 kDa cut-
off 
Collection 
of Filtrate 
< 5 kDa 
 
 
Filter 
membrane 
(red)  
 
 
 
Cap as 
collection 
unit for 
> 5 kDa 
Figure 11. Vivaspin purification 
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5.1.5. Mass Spectrometry of KcvNTS fragments 
Both LC-MS (liquid chromatography mass spectrometry) using an ESI (electron spray 
ionization) ion source and MALDI-TOF MS (matrix assisted laser desorption ionization – time 
of flight mass spectrometry) are applied to characterize and investigate fragments 1 – 4 and 
ligation products 1 and 2.  
LC-MS measurements of fragments 1 – 4 are recorded on Brucker Impact II (Bruker Daltonik 
GmbH) combined with the RP-HPLC instrument Agilent 1200 using the MultoKrom High BIO 
300 C4 column at a flow rate of 0.2 ml/min. The eluent system is composed of 
eluent A = water (0.1% formic acid, FA) and eluent B = ACN (0.1% FA). The following 
gradient system is used: equilibration at 25% eluent B for 0.5 minutes followed by a linear 
gradient 25% - 95% eluent B over 30 minutes. A purging step at 99% eluent B for 10 minutes 
is added to the method. The applied MS method is the following: MS ESI 800 m/z – 
5000 m/z.  
LC-MS methods for the KcvNTS(1-35) and KcvNTS(36-82) can be found in the following table: 
Sample 
HPLC 
Method 
Solvents RP Column Flow MS method 
KcvNTS 
(36-82) 
Equilibration 
at 30% 
eluent D for 
0.5 minutes 
followed by a 
linear 
gradient to 
70% eluent D 
in 20 minutes 
Eluent C: 
H2O + 
0.1% TFA  
Eluent D: 
ACN (0.1% 
TFA) 
 
Vydac219TP 
diphenyl 
0.2 ml/min 
MS ESI 800 
m/z – 5000 
m/z 
KcvNTS  
(1-35) 
Table 18. LC-MS methods for KcvNTS fragments 
The standard procedure used for MALDI-TOF MS analysis is based on usage of the 2,5-DHAP 
(2,5-Dihydroxyacetophenone) matrix. For that, to a 2,5-DHAP solution in ethanol (133 mM), 
diammonium hydrogen citrate (125 µl, 80 mM) are added. The peptide (~0.3 mM, solvent: 
1:3 v/v TFE/water (0.1% TFA)) is dissolved 1:1 v/v in water (0.2% TFA). To that mixture, 
the matrix solution is added 1:1 v/v and pipetted up and down until crystallization takes 
place. The suspension (0.5 µl) is pipetted on the ground steel target and the MS spectra 
recorded in linear mode. 
For measurement of ligation product 2, the ultrathin layer method, introduced by Cadene et 
al.
125 was used and modified to fit our need.  
Sample matrix: 
x Saturated α-cyano-4-hydroxycinnamic acid (4-HCCA) in 3:2:1 formic 
acid/water/isopropanol v/v/v 
x Sample (0.3 mM) in octylglucoside, OG (1 mM in water (0.1% TFA)) or in methanol, 
is dissolved in matrix solution 1:15 or 1:5 
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Matrix for thin layer 
x Saturated 4-HCCA in 1:2 water/acetonitrile v/v 
x Dilute 4 times with isopropanol 
The matrix for thin layer is spotted on the target (0.8 µl) whereas the sample matrix is spotted 
onto the ultra-thin yellowish layer (0.5 µl) resulting in a crystalline film.  
The third sample preparation technique used is the threelayer method adopted from Keller et 
al.126 Layer 1 contains 4-HCCA (106 mM) in a methanol/acetone (40:60 v/v) solution. 
Layer 2 is composed of a saturated 4-HCCA solution in methanol/acetone (40:60 v/v) and 
layer 3 contains the peptide (~0.3 mM, solvent: 1mM OG in water (0.1% TFA) or methanol) 
Finally, three layers were plated onto the target as a sandwich from layer 1 to layer 3 in the 
ratio 3.3:1.3:1. 
 
5.1.6. SDS Page 
Sample preparation from ligation buffers B, C and D: 7 µl of the ligation solution are pipetted 
into 5 µl of TFE/water (0.1% TFA) 30:70 v/v. 10 µl of reducing sample buffer are added if 
reducing conditions are applied. For native SDS PAGE, 10 µl of non-reducing sample buffer 
are added. If samples are spiked with K+, 2.5 µl KCl (1 mM) in water are added to 7.5 µl 
reducing or non-reducing sample buffer. To ligation product 2 samples 1 µl of OG (1 mM) in 
water (0.1% TFA) are added. The samples are incubated at 37 °C for 15 minutes and 15 µl of 
sample added to the wells of the pre-cast gels (Mini-PROTEAN TGXTM, 4 – 20% precast gel). 
The gel is run at 90 V for 45 minutes.  
Freeze dried samples are dissolved in 10 µl TFE/water (0.1% TFA) 30:70 v/v. The following 
staining protocols are adapted from the protocol by Schägger.127 
 
5.1.6.1. Coomassie staining 
The gel is incubated in the fixing solution for 30 minutes and afterwards stained using the 
0.023% Coomassie dye solution for at least 60 minutes. Destaining of the gel is accomplished 
using 10% acetic acid solution. The gel can further be stored in water or used for additional 
silver staining. 
 
5.1.6.2. Silver staining 
The gel is incubated in the fixing solution for 30 minutes and washed with water twice for at 
least 60 minutes. The gel is sensitized using the 0.005% sodium thiosulfate solution for 
30 minutes and thereafter stained with a 0.1% silver nitrate solution. After washing with 
water, the silver bands are developed using 2% sodium carbonate and adding 0.036% 
formaldehyde directly before using the solution. The development can be stopped using a 
50 mM EDTA solution 
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5.1.7. Circular dichroism (CD) 
CD measurements are performed on a Jasco J-710 spectropolarimeter under nitrogen 
atmosphere using the following measurement set-up: UV area from 190 – 260 nm, cuvette 
path-length of 0.1 cm, data pitch 0.2 mm, scanning speed 100 nm/min and 10 accumulations. 
All measurements were performed at 21 °C. The peptide (~0.3 Mm) is dissolved in TFE and 
measured directly. 
For CD measurements using the extrusion method with 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) lipids, 15 equ. of POPC and 1 equ. of peptide 4re dissolved in TFE 
and freeze dried. The residue is suspended in degassed 10 mM Na2HPO4 buffer (pH 7.5) and 
shaken at room temperature or 2 h. Using freeze/thaw cycles the sample is prepared for 
extrusion through a 1 µm polycarbonate membrane using a mini-extruder. 
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5.2. Synthesis and analytics of ATCUN-like peptides 
Ac-DAP-β-Ala-His-mPEG4, (Peptide 1) Ac-DAP-β-Ala-Ala-mPEG4 (Peptide 2) Ac-DAP-
β-Ala-Asp-mPEG4 (Peptide 3) and (5/6)FAM-DAP-β-Ala-His-mPEG4 (Peptide 4), were 
synthesized following the standard Fmoc-SPPS using a chlorotrityl chloride resin, Cl-Trt 
(0.966 mmol/g). The loading of the dried resin with the Fmoc-NH-PEG(4)-COOH residue 
(2 equ., 0.2 M, 487.54 g/mol) is performed using DIEA (4 equ., 0.4 M, 129.24 g/mol, 
p = 0.742 g/mol) in DMF. The resin is capped using DCM/methanol/DIEA 16:2:1 v/v and 
deprotected using 20% piperidine/DMF v/v and coupling efficiency monitored via UV-Vis 
spectrometry at 301 nm. The following amino acids Fmoc-His(Trt)-OH (4 equ., 0.2 M, 
619.71 g/mol), for peptide 1 and 4, Fmoc-Ala-OH (4 equ., 0.2 M, 311.33 g/mol) for peptide 2 
and Fmoc-Asp(Ot-Bu) (4 equ., 0.2 M, 411.45 g/mol) for peptide 3 are coupled using the 
standard Fmoc-based SPPS protocol and with activators HATU (4 equ. 0.2 M, 380.11 g/mol) 
and 8 equivalents of DIEA (8 equ., 0.4 M, 129.24 g/mol, p = 0.742 g/ml) in DMF. To all 
peptides, Fmoc-β-Ala-OH (4 equ., 0.2 M, 311.33 g/mol) and Fmoc-Dap(Boc) (4 equ., 0.2 M, 
426.46 g/mol) are coupled accordingly. Acetylation of the deprotected peptides 1 – 3 is 
performed using DMF/Ac2O/DIEA 5:1:2 v/v/v. To peptide 4 (5/6)-Carboxyfluorescein, 5/6-
Fam (4 equ., 0.2 M, 473.39 g/mol) is coupled using an incubated (12 minutes) mixture of 
Tetramethylfluoroformamidinium hexafluorophosphate, TFFH (4 equ., 0.2 M, 262.29 g/mol) 
and DIEA (8 equ. 0.4 M, 129.24 g/mol, p = 0.742 g/mol). The in diethyl ether precipitated 
peptides are washed and the crude product dissolved in ACN (0.1% TFA)/water (0.1% TFA) 
1:1 v/v, freeze dried and stored at -30 °C. 
 
Name Sequence 
Peptide 1 Ac-DAP-β-Ala-His-mPEG4 
Peptide 2 Ac-DAP-β-Ala-Ala-mPEG4 
Peptide 3 Ac-DAP-β-Ala-Asp-mPEG4 
Peptide 4 (5/6)FAM-DAP-β-Ala-His-mPEG4 
Table 19. Overview of ATCUN-like peptides 
 
Amino Acid 
Peptide 1 
(mmol/g) 
Peptide 2 
(mmol/g) 
Peptide 3 
(mmol/g) 
Peptide 4 
(mmol/g) 
mPEG4 1.25 1.05 1.05 1.310 
Fmoc-His(Trt)-OH (1,2)/ 
Fmoc-Ala-OH (3)/ Fmoc-
Asp(Ot-Bu) (4) 
0.956 0.877 0.887 1.100 
Fmoc-β-Ala-OH 0.717 0.727 0.559 1.200 
Fmoc-Dap(Boc) n.d. 0.587 0.539 1.200 
Table 20. Resin loading throughout synthesis 
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5.2.1. RP-HPLC 
Eluent A: water (0.1% TFA) 
Eluent B: ACN (0.1% TFA) 
Analytical RP-HPLC instrument: Waters 2695 alliance equipped with a Waters 2998 
photodiode array detector.  
Preparative RP-HPLC instrument: Waters 600 equipped with a Waters 2996 photodiode array 
detector.  
 
Analytical RP-HPLC 
Fragment Method Column 
Peptides 1 - 3 Isocratic method at 0% eluent B over 4 
minutes followed by a linear gradient from 
0% - 30% over 20 minutes total, flow: 
1 ml/min, UV Vis: 214 nm 
 
MultoKrom C 18 100-5 
5 µm particle size, 100 Å pore 
diameter 125 mm × 4 mm 
CS Chromatography Service 
GmbH 
Peptide 4 Linear gradient of 5% - 40% eluent B over 
20 minutes, flow: 1 ml/min, column 30 °C, 
UV Vis: 214 nm, 494 nm 
Preparative RP-HPLC 
Fragment Method Column 
Peptide 1 -3 Isocratic method at 0% eluent B over 12 
minutes followed by a linear gradient from 
0% - 30% over 60 minutes total, flow: 
8 ml/min, UV Vis: 214 nm 
MultoKrom C18 100-5  
5 µm particle size, 100 Å pore 
diameter, 250 mm × 20 mm  
CS Chromatography Service 
GmbH 
Peptide 4 Linear gradient from 5% - 40% eluent B 
over 60 minutes, flow: 10 ml/min, UV Vis: 
214 nm, 494 nm 
Table 21. RP-HPLC methods for ATCUN-like peptides 
The purified peptide 4 in Figure 55 is measured on a waters SymmetryTM C18 3.9 × 150 mm 
columns with a flow of 1 ml/min at 30 °C. 
 
5.2.2. Mass spectrometry of ATCUN-like peptides 
To evaluate the complex formation via MS measurements, CuSO4 or NiSO4 (1 equ., in water) 
is added to the peptide solution (1 mM, phosphate buffer pH 7.4, peptides 1 - 4).  
Peptide 4 and 2 are measured using LC-MS on a Brucker Impact II (Bruker Daltonik GmbH) 
combined with the RP-HPLC instrument Agilent 1200 using the ReproSil gold 120 C18 
 
 - 34 - 
column (3 µm, 100 mm × 2 mm). The eluent system for peptide-Cu measurements is 
composed of eluent A – water, eluent B – acetonitrile. with a gradient of 10% - 50% eluent B 
in 5 minutes. For peptide-Ni measurements, samples are diluted 1:1 v/v with phosphate 
buffer pH 7.4 and measured using the following gradient: equilibration at 0% eluent B for 5 
minutes followed by a linear gradient 0 – 50% eluent B in 10 minutes 
For MALDI-TOF MS measurements saturated 4-HCCA is used as the matrix system in water 
(0.1% TFA)/ACN (0.1% TFA) 1:1 v/v. Sample and matrix are mixed 1:1 v/v and spotted onto 
the ground steel target. Measurements are operated in reflectron positive (RP) mode. 
 
5.2.3. Amino Acid Analysis 
For determination of the content through amino acid analysis (AAA) of each amino acid, the 
peptide/protein sequence needs to be broken down into the building blocks using hydrolysis. 
6 M HCl is sufficient for total hydrolysis when heated to 100 °C for 24 h in a closed system. 
Pre-column erivatization with aminoquinolyl-N-hydroxysuccinimidyl carbamate, AQC, is 
performed using AccQ-Flour reagent kit (Waters). Primary and secondary amines react with 
AQC to form stable urea-derivates that absorb at 254 nm. The reaction is carried out in borate 
buffer. Using a mixture of amino acids as an external standard (amino acid standard, 
Thermoscientific) and performing derivatization accordingly, RP-HPLC of the standard and 
sample can then be compared and the content calculated. 
 
Figure 12. Amino acid analysis 
Reaction scheme of primary/secondary amine with ACQ to form UV active urea-derivate 
 
RP-HPLC runs are performed on the Waters 2695 alliance equipped with a Waters 2998 
photodiode array detector using the following conditions: 
 
Buffer E Buffer F Gradient flow Column 
50 mM NaAc, 
pH 5.75 
50 mM NaAc, pH 6.00 
in 70% acetonitrile 
linear gradient of 
2% - 20% buffer F over 
30 minutes 
1 
ml/min 
MultoKrom 
C18, 45 °C 
Table 22. RP-HPLC conditions for AAA 
 
Within the sequence of peptide 4, only one native amino acid is found: histidine. Thus, amino 
acid analysis can only be applied by comparing the peak area of histidine within the amino 
acid standard solution with the peak resulting from the ATCUN sample. To correctly identify 
the histidine peak, the sample solution is spiked resulting in the double amount of histidine in 
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the resulting chromatogram compared to the chromatogram of the sample. Furthermore, the 
amino acid standard and the sample solution are blended, resulting in the spectrum with 
increased peak areas where amino acids are duplicated.  
 
Figure 13. RP-HPLC chromatograms of the amino acid analysis.  
Method: linear gradient of 2% to 20% buffer B in 30 minutes using a flow of 1 ml/min and the MultoKrom C18 
column at 45 °C. 
The stacked chromatogram in Figure 13 shows the different injections. Peak 1 at 
12.2 minutes represents the non-reacted ACQ reagent, showing the highest peak at the 
histidine injection, being the sample with the least content of amino acid that ACQ can react 
with. Peak 2 at 17.8 minutes is generated by histidine and can be found in every injection. 
When comparing the peak area of 2 in the amino acid standard and the amino acid standard 
spiked with the sample the peak area almost doubles from an area of 1034759 to 1637255 
while the other peak areas stay in the same range. 
To evaluate the content, a sample containing only histidine is needed for AAA measurement. 
Injections of a dilution series result in increasing peak areas that are used for the development 
of a calibration curve (Figure 14).  
 
 
Figure 14. Determination of content using AAA 
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The following equation is used for the calculation of the content: 
𝑛  =  𝑛  ×  𝑉  ×  𝑉  × 𝑀 4 µ𝑙 × 𝑉  
Equation 4. Calculation of content determined through AAA 
 (Calculated) value 
𝑛  0.000269896 µmol 
𝑉  94 µl 
𝑉  516 µl 
𝑀  0.918 mg/µmol 
𝑉  µl 
Table 23. Values to calculate content. 
 
 
5.2.4. NMR for content determination 
NMR spectra were measured on an Avance HD spectrometer at 500 MHz at 298 K by Daniel 
Tietze. The signal from the protons within the acetyl-group of the external standard N-acetyl 
alanine were used as our standard signal. For peptides 1 – 3 comparison was done using the 
acetylated C-terminus. For comparison to peptide 4, protons from the aromatic imidazole 
moiety of the His-residue were taken. Measurements are done in H2O/D2O 9:1 v/v dissolving 
peptide 1 (2.56 mM), peptide 2 (3.11 mM), peptide 3 (3.03 mM) and peptide 4 (0.55 mM) in 
440 µl total volume. The HDO peak was set to a frequency of 4.7 ppm as a reference for the 
1H chemical shift. The exact solution from NMR measurements was diluted seven times and 
injected via RP-HPLC. A calibration curve is obtained from the peak area at different 
concentrations, making it possible to determine the concentration each time a new batch is 
purified. RP-HPLC methods used were in accordance to chapter 5.2.1. 
 
Figure 15. RP-HPLC calibration of peptide 1 after NMR spectroscopy 
RP-HPLC conditions isocratic flow of 5% over 5 minutes followed by a linear gradient 5%- 40% eluent B over 20 
minutes total with a flow of 1 ml/min, MultoHigh 100 RP 18 column at 30 °C with a retention time of 11.6 minutes. 
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Figure 16. RP-HPLC calibration of peptide 2 after NMR spectroscopy 
RP-HPLC conditions isocratic flow of 5% over 5 minutes followed by a linear gradient 5%- 40% eluent B over 20 
minutes total with a flow of 1 ml/min, MultoHigh 100 RP 18 column at 30 °C with a retention time of 12.4 minutes. 
 
 
 
Figure 17. RP-HPLC calibration of peptide 3 after NMR spectroscopy 
RP-HPLC conditions isocratic flow of 5% over 5 minutes followed by a linear gradient 5%- 40% eluent B over 20 
minutes total with a flow of 1 ml/min, MultoHigh 100 RP 18 column at 30 °C with a retention time of 12.0 minutes. 
 
 
 
Figure 18. RP-HPLC calibration of peptide 4 after NMR experiments 
RP-HPLC conditions: linear gradient of 5% - 40% eluent B over 20 minutes with a flow of 1 ml/min, MultoHigh 100 
RP 18 column at 30 °C. Retention times of 11.5 and 11.9 minutes are attributed to the mixed isomers, new 
retention times to a different column used.  
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5.2.5. UV VIS titrations 
All UV VIS titrations were prepared and executed on Tidas MCS UV/NIR and evaluated using 
Panorama® program 3.1 (LabCognition). 
 
5.2.5.1. pH titration studies 
Evaluation of the optimal pH values for further titration studies is designed as follwod. 
To the solution of peptide 1 (1mM, in water) one molar equivalent of CuSO4 (160 mM, in 
water) or of NiSO4 (160 mM, in water) is added. The pH is lowered with HCl (100 mM, in 
water) until pH 3. Using NaOH (100 mM, in water) the pH is increased to pH 11 and spectra 
recorded for each pH step. 
To the solution of peptide 2 and 3 (2 mM, in water) one molar equivalent of CuSO4 (320 mM, 
in water) or of NiSO4 (320 mM, in water) is added. The subsequent steps are according to the 
experiment set-up of peptide 1.  
 
5.2.5.2. Cu(II) and Ni(II) titration studies 
The in Table 24 summarized experiment set-ups are used to evaluate binding constants. To 
the corresponding peptide solution in the selected buffer system, heavy metal is added in 
0.1 molar equivalents to a final of 1.4 equivalents. After each 0.1 equivalent step, a spectrum 
is recorded. 
Peptide pH Buffer Heavy metal 
Peptide 1,  
1 mM in 
corresponding 
buffer 
6.5 MES, 100 mM CuSO4 and NiSO4, both 16 mM in water 
6.5 MES, 100 mM ZnSO4, 16 mM in water 
8.0 TRIS, 100 mM CuSO4, 16 mM in water 
10.55 TRIS, 100 mM NiSO4, 16 mM in water 
Peptide 2,  
2 mM in 
corresponding 
buffer 
10.55 TRIS, 100 mM CuSO4, 32 mM in water 
10.55 TRIS, 100 mM NiSO4, 32 mM in water 
Peptide 3,  
2 mM in 
corresponding 
buffer 
8.0 TRIS, 100 mM CuSO4, 32 mM in water 
10.55 TRIS, 100 mM NiSO4, 32 mM in water 
Table 24. Buffer systems and set-up for titration studies 
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5.2.6. Benesi-Hildebrand plot 
The Benesi-Hildebrand plot was introduced in 1949128 and is up to date a widely used method 
to determine binding constants of complexes displaying a 1:1 and 1:2 stoichiometry. In the 
following, calculation using this plot will be introduced. For that, our ligand, the heavy metal, 
will correspond to M while out ATCUN-like peptide represents the molecule, A. 
.
𝑀 + 𝐴 
𝑘
⇌ 
.
𝑀𝐴 
Equation 5. 
1:1 complex 
formation 
Furthermore, the Lamber-Beer law is needed, which is expressed in the following equation: 
𝐴 =  𝜀 × 𝐶 
A – Absorbance 
ɛ - extinction coefficient l × mol-1 × cm-1 
C – concentration (mol/l) 
Equation 6. 
Lamber Beer 
law 
 
Inserting the Lamber-Beer law into Equation 5 leads to: 
𝐶
∆𝐴
 =  1 [𝐶  × 𝐾 (𝜀 − 𝜀 )] + 1 (𝜀 − 𝜀 )⁄⁄  
𝑪𝑨𝟎 & 𝑪𝑴𝟎  - initial concentrations 
of M and A 
∆A – change of absorbance 
during complexation 
ɛMA & ɛA – absorption 
coefficients of MA and A 
Equation 7. 
Benesi-
Hildebrand 
Plot 
 
When plotting 
∆
 versus  a linear relationship is obtained from where the binding constant 
K can be calculated from the intercept and the slope.129 
 
5.2.7. Fluorescence titration studies 
All fluorescence titration studies were executed on a FP-6200 Jasco making use of the 
quenching of 5/6-FAM upon addition of heavy metals. 
To the solution of peptide 4 (1 µM, in 100 mM MES buffer pH 6.5), CuSO4 (1 mM, in water) 
is added from 0 – 20 molar equivalents. For Ni(II) studies, NiSO4 (100 mM, in water) is added 
from 0 – 1400 equivalents. For Zn(II) studies, ZnSO4 (100 mM, in water) is added in 
concentrations of 0.13 – 2.7 mM. 
For calculation of binding constants a peptide solution (0.01 µM, in phosphate buffer pH 8.0) 
is used and CuSO4 (0.32 µM, in water) added in steps of 0.1 molar equivalent until 1.5 
equivalents are reached. To investigate Ni(II) binding, NiSO4 (0.32 mM, in water) is added in 
0.1 molar equivalent steps until 1.5 equivalents are reached to a peptide solution (0.01 µM, in 
CAPS buffer pH 10.55) 
 
5.2.8.  Stern-Volmer Plot 
The Stern-Volmer Plot was introduced in 1919130 and up until today it is used to describe and 
calculate various constants involved in a quenching process. In the following the 
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determination of the Stern-Volmer constant KSV, the Quenching rate constant Kq and the 
binding constant K are described. 
𝐹
𝐹
= 1 + 𝐾 [𝑄] 
F0 – fluorescence intensity with no 
quencher present 
F – fluorescence after quencher 
added 
[Q] – concentration of quencher 
Equation 8. 
Determination of Stern-
Volmer constant 
 
To further calculate the biomolecular quenching rate constant Kq this equation is used: 
𝐾 =  
𝐾
𝜏
 
Kq – quenching rate constant (M-1s-1) 
τ0 – fluorescence lifetime s-1 (approx. 
10-8 s-1 for most protein molecules)131 
Equation 9. Calculation 
of the biomolecular 
quenching rate 
This quenching rate can be used to calculate the quenching process. The quenching rate of 
diffusion collision for diverse quenchers is defined to be < 2 × 1010 M-1s-1. Values above this 
quenching rate indicate a static quenching process.  
Furthermore, calculation of the binding constant K is done by plotting log([F0-F]/F) vs log(Q) 
following this equation: 
log
𝐹 − 𝐹
𝐹
=  𝑙𝑜𝑔𝐾 + 𝑛𝑙𝑜𝑔(𝑄) 
K – binding constant 
n – number of binding sites 
Equation 10. 
Calculation of the 
binding constant using 
the Stern-Volmer plot 
 
5.2.9. Determination of the limit of detection (LOD) 
For the six-fold blank measurement, 1 µl of blank solution (100 mM MES buffer, pH 6.5) is 
pipetted to the peptide solution (1 µM in 100 mM MES buffer pH 6.5). From the change of 
absorbance at λem 518, the standard deviation, σ is determined. 
In a second titration, CuSO4 (1 µM, in water) is added from 0.7 – 60 nM and NiSO4 (10 µM, 
in water) from 7 – 722 nM to a new peptide 4 solution. To evaluate the LOD, the slope of this 
titration experiment is needed. 
The slope of ∆fluorescence intensity vs. concentration Cu(II)/Ni(II) from SI Figure 38 and 
standard deviation, σ from the blank titration are inserted into Equation 11 and the LOD is 
calculated as followed using the equation from the International Conference on 
Harmonization (ICH)132: 
𝐿𝑂𝐷 =  
3.3 × 𝜎
𝑆
 
σ – standard deviation  
S – slope  
Equation 11. Calculation of the LOD 
 
5.3. Immobilization to solid support 
5.3.1. Fabrication of nanopores 
PET foils (12 µm thickness) are bombarded with heavy ions (Ag, Pb or U) at the Universal 
linear accelerator, UNILAC and track-etched using a NaOH solution (9 M). To generate 
 
  - 41 - 
conically shaped nanopores, etching solution is filled only in one compartment (see Figure 7 
for schematic set-up of the two compartments). The resulting free carboxygroups are 
transformed to primary amines using 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimid, EDC 
(100 mM in ethanol), pentafluorophenol., PFP (200 mM in ethanol) and diethylamin, EDA 
(100 mM in ethanol) (Figure 19). Etching and modification of PET foils was done by Ivana 
Duznovic from RG Prof. Ensinger, Material Science, TU Darmstadt. 
 
Figure 19. Fabrication of nanopores 
Two different geometries were used in the presented studies: conically shaped (a) and 
cylindrical nanopores (b) illustrated in Figure 20. For evaluation of the pore geometry, High-
Resolution Field-Emission Scanning Electron Microscopy is used cutting a representative piece 
out of the foil. The piece is plated with a thin gold layer using a sputter coater (Q300TD 
Sample Preparation System, Wuorum Technologies Ltd) with a gold target (99.9% purity) 
and argon-plasma (100 s, 3 mA). To obtain a cross section the membrane has to be irradiated 
by UV-light at 312 nm for 90 hours.  
 
 
Figure 20. Geometry of nanopores used 
Drawings are not to scale. 
Nanopores are usually fabricated perpendicular to the plane of the substate while 
nanochannels are in-plane structures. Nanochannels are frequently fabricated in polymer 
material.133 For better reading, nanochannels in PET foils will be referred to as nanopores in 
the following.  
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5.3.2. Immobilization of peptides to nanopores 
For immobilization of the peptides, two methods were applied. First, coupling using EDC/sulf-
NHS and second, using the standard protocol of SPPS amino acid coupling. 
To the peptide 4 solution (0.5 mM, in ethanol/water 1:3 v/v), EDC (2 mM final 
concentration) and sulfo-NHS (5 mM final concentration) are added. The reaction solution is 
protected from light for 15 – 30 minutes and added to the compartmens surrounding the PET 
foil. The reaction is carried out overnight. 
(a) 
 
(b) 
 
(c)  
 
Figure 21. Coupling to solid support using EDC/NHS 
Addition of EDC to peptide shown in (a) will result in the formation of an unstable intermediate, the O-acylisourea 
ester that would undergo hydrolyses rapidly. Adding sulfo-NHS to the reaction solution, a semi-stable amine 
reactive NHS-ester is formed (b) that slowly reacts with primary amines under amid bond formation (c).134,135  
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For immobilization following the standard Fmoc SPPS protocol, peptide 4 (4 equ., 0.5 mM) is 
dissolved with HATU (4 equ., 0.5 mM) and DIEA (8 equ., 1 mM) in DMF and the reaction 
solution filled into the chambers surrounding the PET foil. The reaction carried out overnight 
and after 16 h, HATU (4 equ., 0.5 mM) and DIEA (8 equ., 1 mM) added again for a reaction 
time of 2 h. 
 
5.3.3. Characterization of immobilized nanopores 
In order to characterize the immobilized nanopores, several methods were applied, namely 
I/V measuremtns and confocal laser scanning microscopy, CLSM. 
 
5.3.3.1. I/V measurements 
I/V measurements were performed using a picoammeter/voltage source (Keithley 6487, 
Keithley instruments) by Ivana Duznovic from the research group of Prof. Ensinger 
(Department of Material Science, TU Darmstadt). The foil containing a single nanopore 
modified with peptide 4 coupled is fixed between two compartments filled with MES buffer 
pH 6.5 (100 mM, with 100 mM KCl electrode solution). On the base of the conically shaped 
nanopores, the ground electrode is placed and on the tip side the working electrode (Ag/AgCl 
electrodes) (Figure 7). The recording of I/V curves is done using a scanning triangle voltage 
signal from -1 to +1 V.  
 
5.3.3.2. Confocal laser scanning microscopy  
CLMS measurements were conducted on the Leica TCS SP8 with using the red laser at 488 
nm excitation and 515 – 530 nm emission with Wadim Weber from the research group of 
Prof. Stein (Protein engineering, TU Darmstadt). The foil is fixated on the object holder using 
hot agarose solution (1% in TAE buffer). For conically shaped nanopores, the tip opening 
faces the object holder. The following modified PET foils were used for on/off characteristics 
and titration experiments: 12 µm thickness, conically shaped, fluence 107 pores/cm2. Foils 
used to visualize successful coupling using the EDC/NHS method: cylindrical nanopores with 
200 nm diameter in the 12 µm thick PET foil with a fluence of 107 pores/cm2. 
 
5.3.3.3. CLSM study of turn on/off characteristics 
To investigate re-usability of the hybrid system, CuSO4 (100 µM, in 100 mM MES buffer 
pH 6.5) solution is pipetted onto the fixated foil and let to diffuse for 5 mintues. An image is 
taken (sum of 20 stacks travelling vertically through the foil). For reconstitution of the 
fluorescence, CuSO4 is removed and EDTA solution (1 mM, in water) added and left to 
coordinate Cu(II) for 5 minutes. The foil is washed and the steps repeated.  
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5.3.3.4. CLSM study of ion selectivity 
To evaluate the sensitivity towards the heavy metals Cu(II), Ni(II) and Zn(II) titration studies 
were carried out. CuSO4 solution (in 100 mM MES pH 6.5) is added ranging from 10 µM - 
100 µM. NiSO4 solution (in 100 mM MES pH 6.5) is added in ranges 10 µM - 1000 µM. For 
Zn(II) investigations solutions of ZnSO4 (in 100 mM MES pH 6.5) in the range of 1 - 3 mM 
were used. 
 
5.4. DNA studies of ATCUN-like peptides  
In order to perform DNA scission experiments with peptides 1 – 4, DNA plasmids were 
prepared according to the following procedure. Plasmids pUC19, pASK-IBA3 and pACYCT2 
were kindly provided by Wadim Weber from the research group of Prof. Stein and 
transformed into DH10β competent cells and amplified. The plasmids were isolated and 
purified using the NucleoSpin® Plasmid DNA purification kit by Macherey-Nagel.136 The 
cultivated cells are centrifuged and the cell pellet used for further cell lysis using 250 µl of 
buffer A1. Additionally, 250 µl of buffer A2 are added to the homogenous suspension and 
incubated for 5 minutes at room temperature. With the addition of 300 µl of A3 the blue 
sample turns colorless/white. After centrifugation (11 000 × g, 5 minutes), the supernatant is 
transferred to NucleoSpin® Plasmid column and centrifuged (11 000 × g, 60 s). The liquid is 
discarded and the column washed with 500 µl buffer AW (centrifugation at 11 000 × g, 60 s) 
and 600 µl buffer A4. The silica membrane of the NucleoSpin® Plasmid column is dried (11 
000 × g, 2 minutes) and the DNA eluted using 50 µl AE buffer (11 000 × g, 60 s). The 
concentration of the DNA is determined using a nanodrop ND-1000 Spectrophotometer 
(pequLab). 
 
5.5. DNA scission experiments 
For general DNA scission experiments, the following concentrations are used in volumes of 
75 µl total (Table 25). As the solvent, TRIS HCl is used (25 mM, autoclaved) 
Solution Concentration (µM) 
Peptide 1 – 4 100  
CuCl2 90 
NiCl2 90 
Sodium ascorbate 100 
EDTA Saturated 
TRIS HCl buffer pH 7.4 25 mM 
Table 25. DNA scission experiments 
A solution of peptide (100 µM in 25 mM Tris pH 7.4), heavy metal (90 µM in 25 mM Tris 
pH 7.4), sodium ascorbate (100 µM in 25 mM Tris) is created and DNA added to yield a final 
concentration of 0.5 µg. The reaction is carried out for 4 h with sample drawing times of 0 h, 
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0.5 h, 2 h and 4 h. 25 µl sample are added to 5 µl EDTA and 5 µl purple loading dye. For 
further DNA extraction from Agarose gels, the reaction conditions are doubled and the DNA 
concentration increased to 2 µg. For concentration dependent studies (Figure 78), the 
concentration of peptide is increased to 125 µM or 150 µM with an increase of the 
concentrations of ascorbate and Cu(II) accordingly. 
 
5.5.1.  Agarose gels 
After DNA scission experiments, scission activity is visualized and determiend using agarose 
gels. The samples are loaded to pockets of agarose gels. To cast the gels, hot agarose (1% in 
TAE buffer), containing 0.02% HD green or Midori green, is added to the casts and let to 
solidify while cooling down. Samples are loaded to the wells and the gel run at 100 V using a 
pequlab casting and BIO-RAD system. 
To extract DNA from the agarose gel, the band of desired DNA fragment is cut out using a 
clean scalpel and transferred into an eppendorf tube. Purification is accomplished using the 
NucleoSpin® PCR clean-up, gel extraction kit from Macherey-Nagel explained in the 
following.137  
To 100 mg cut-out gel, 200 µl of the NTI buffer are added and the components heated to 
50 °C for 5 – 10 mintues. The clear solution is transferred to the provided clean-up columns 
and centrifuged (11 000 × g, 60 s). The supernatant is disposed and the column washed with 
NT3 buffer two times (600 µl, 11 000 × g, 60 s and 300 µl 11 000 × g, 60 s) . The column is 
dried (11000 × g for 2 minutes) and the DNA eluted using 25 µl of NE buffer (11 000 × g, 60 
s). Concentration of the DNA is determined using the nanodrop ND-1000 Spectrophotometer 
(pequLab). 
 
5.5.2. Polymerase chain reaction 
 (a) (b) 
Component Volume (µl) Volume (µl) 
Sample 1  1  
Primer, forward 2.5 2.5 
Primer, reverse 2.5 2.5 
dNTPs 1  1  
Buffer (Phusion® 5 x) 10  10  
Water  33 33 
Phusion 0.4 0.4 
DMSO  1 
Table 26. PCR pipetting scheme  
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The PCR is run using a SensoQuest Labcycler using the following time schedueles 
 (a)   (b)   
Step Temp (°C) Time Cycles Temp (°C) Time Cycles 
Initial denaturation 98 2 min 1 × 98 2 min 1 × 
Denaturation of template 98 20 s 35 × 98 20 s 35 × 
Annealing of primers 54 20 s 35 × 56 20 s 35 × 
Extension 72 40 s 35 × 72 90 s 35 × 
Final extension 72 3 min 1 × 72 3 min 1 × 
Table 27. PCR conditions 
The PCR conditions of (a) are applied to pUC19 and pASK-IBA3 primer and (b) for pACYCT2 
Amplified DNA samples produced by PCR were purified using the NucleoSpin® PCR clean-up, 
gel extraction kit from Macherey-Nagel. 5.4 describes the protocol in detail. Instead of cutting 
out a band from an agarose gel, the NTI buffer is pipetted directly into the PCR solution. To 
50 µl of PCR components, 100 µl NTI are intended. From this step on the protocol is 
analogous to the gel extraction.  
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6. Results and Discussion: Synthesis and characterization of KcvNTS 
6.1. KcvNTS Synthesis strategy 
As mentioned in the aims, one of the goals is to pave the way for the development of 
bioinspired nanopores based on biological ion channels. The most intensively studied and best 
known example in literature is the α-hemolysine (α-HL) pore, a toxin from Staphylococcus 
aureus. It is a mushroom-shaped homo-oligomeric heptamer (of 33.2 kD monomers) with a 
β-barrel structure transversing the membrane.116 It is widely used for translocation of various 
analytes, like metal ions138 and small organic molecules,139 through the 1.4 nm pore.140 Using 
click chemistry, namely Cu(I)-catalyzed azide-alkyne [3 + 2] cycloadditions (CuAAC) 
diversification of the pore-structure is shown to be possible.141 Furthermore, NCL strategies 
gained attention in semisynthetic modification of α-HL to create so-called nanoreactors.142 
These methods often target orthogonal modifications or modifications at the termini, while 
the protein’s core sequence remains untouched. To fill this gap, we went the first steps 
towards using membrane proteins as scaffolds for bioinspired nanopores. Our approach 
focuses on the chemical synthesis of ion channels exploiting the benefit of being able to easily 
modify the sequence, especially the core sequence. The incorporation of novel functionalities, 
the possibility to tune selectivity towards ions and the integration of isotopically labeled 
amino acids for NMR measurements, are some of the advantages of our approach. 
For our aim we selected the minimal viral voltage-gated potassium channel KcvNTS because of 
its small size (82 amino acids) but full functionality (for detail see 3.3).51 The first step 
towards our goal, a successful and robust synthesis strategy has to be developed. As a 
transmembrane protein that incorporates itself autonomously into the lipid bilayer, KcvNTS 
exhibits an extreme hydrophobicity especially within the sequence for the two transmembrane 
helices. To overcome problems in chemical synthesis, the sequence has to be divided into two 
or more fragments and fused together to result in the final sequence. Recently, our lab 
developed a strategy for the synthesis of hydrophobic proteins which uses an oxo-ester, 
namely the thioester-forming Hmp-group, in combination with a solubilizing tags, aiding NCL 
reactions.143 Solubilizing tags are favorable additions of hydrophilic amino acids integrated to 
hydrophobic sequences. They facilitating SPPS, purification and NCL with especially arginine-
based solubilizing units widely used in present and past.144-147 The following scheme 
illustrates the NCL reaction using the oxo-ester unit an a solubilizing tag. 
 
 - 48 - 
 
The reaction scheme of 
the oxo ester based NCL is 
shown in Figure 22, for 
which the C-terminal oxo-
ester is required at one 
fragment, while the other 
fragment exhibits a N-
terminal cysteine moiety. 
Within the amino acid 
sequence of KcvNTS, there 
is a naturally occurring 
Cys36 being the perfect 
starting point for the 
hmp-based ligation 
strategy. The first attempt 
was to synthesize KcvNTS 
applying a two-fragment 
strategy. The following 
scheme shows the amino 
acid sequence and 
segmentation used for the 
two-fragment approach. 
Figure 23 also shows 
structural components 
(green – selectivity filter 
region, yellow – pore 
region, violet – 
transmembrane helices) 
and highlights the ligation 
site at Cys36 in red.  
Figure 22. NCL scheme using Hmp 
At a pH of > 7 the C-terminal oxo-ester undergoes a SÆO acyl shift to generate the thioester from (a) to (b). The 
generation of the activated thioester from reaction of the MPAA with the N-terminal hmp moiety of the peptide 
fragment is seen in (c) with the detaching of the solubilizing tag. The thiol-group of the peptide fragment 
exhibiting the N-terminal cysteine moiety attacks the activated C-terminal thioester (c). An intermediate thioester is 
formed (d) which readily rearranges through a S Æ N-acyl shift which leads to an amide bond formation resulting 
in the native peptide/protein sequence shown in (e). 
 
 
Figure 23. Synthesis strategy using two fragments 
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Upon the first reaction attempt, pseudoprolines were incorporated into the sequence, for 
backbone stabilization at positions F39S40 (Fmoc-L-Phe-L-Ser[PSI(Me,Me)Pro]-OH) and at 
F14T15 (Fmoc-L-Phe-L-Thr[PSI(Me,Me)Pro]-OH). General procedure for the incorporation of 
psedoprolines into a peptide sequence was first introduced by Mutter’s lab and is nowadays 
one of the most effective methods to increase yields during chemical synthesis of “difficult 
sequences”.148-150 
Proline-like structures are able to disrupt 
conformations that leads to aggregation 
through a so-called “kink” within the 
backbone of the sequence.150 Ser, Thr and Cys 
can be used as scaffolds for mimicking the 
Pro structure (through oxazolidine for Thr 
and Ser and thiazolidine for Cys). Cleavage 
under normal Fmoc-conditions will result in 
the native peptide sequence (Figure 24).151  
 
 
Figure 24. Pseudoprolines 
 
Both fragments, fragment A and B were synthesized according to protocols described in 5.1 
with synthesis conditions summarized for fragment A in Table 4 and fragment B in Table 5. A 
RP-HPLC of the fragment A is represented in Figure 25a. Inspite of usage of pseudoprolines 
outcome of the synthesis is obviously not as desired. Multiple peaks at the retention time (Rf) 
range from 3 – 9 minutes indicate terminated shorter sequences of the peptide. However, 
LC-MS analysis of the peak at Rf 16.2 minutes indicates the right molecular mass of the 
peptide [M+4H+]4+ with calculated 1274.6611 m/z and found 1274.6623 m/z with a 
corresponding isotopic pattern (Figure 25b). 
 
Figure 25. Synthesis out of two fragments. Fragment A 
RP-HPLC of the crude product in (a) and insert showing purified fragment, gradient of 25% - 95% eluent B over 30 
minutes with a flow of 1 ml/min, column temp 30 °C using the MultoHigh BIO 300 column and (b) ESI-MS 
chromatogram of the purified fragment A with Rf 16.8 minutes with insert showing [M+4H
+]4+ simulation and 
sample  
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Several attemps were undertaken to synthesize fragment B successfully indicated in Table 5. 
According to literature data, the effect of the neighbouring amino acid to Hmp displays a 
great effect on coupling efficiency. When this amino acid was aspartic acid, researchers 
obtained a yield < 5% yield compared to e.g. a 69% yield when using valine.152 That might be 
the reason, the first attempt to synthesize fragment B was not successful.  
As the next step, a mutation was introduced into the sequence. We expected an increased 
yield with synthesis of KcvNTS D35E. This mutation does not have an effect on the function of 
the ion channel (from unpublished results). The synthesis was performed without usage of 
pseudoprolines. In the final crude product, the desired product could not be found using 
RP-HPLC and LC-MS analysis. 
As the next step, pseudoprolines were incorporated at F14T15 and the mutation D35E was 
introduced. The RP-HPLC of the crude peptide (Figure 26a) does not show any significant 
peak. Moreover, LC-MS analysis did not indicate the right molecular mass of the desired 
product. However, the MS spectra of the desired fragment in the crude product was found 
within the washing step of the column with [M+2H+]2+ calculated 2034.5727 m/z and 
measured 2034.5765 m/z (Figure 26b) at 35.9 – 40.0 minutes. It is possible that due to the 
highly hydrophobic character of fragment B, which is indicated by the Leu, Ile and Val rich 
sequence at the region 1-12 of the peptide, the product is precipitated during the elution 
gradient on the RP-HPLC column. For an overview of MS-Spectra at different time points 
during the run, see SI Figure 1. 
 
Figure 26. Synthesis out of two fragments. Fragment B 
(a) RP-HPLC of the crude product measured with a linear gradient of 25% - 95% eluent B over 30 minutes, at a flow 
of 1 ml/min, column temp 30 °C using the MultoHigh BIO 300 column (b) ESI-MS of the crude fragment B showing 
the 3 times charged [M+3H+]3+ simulation and sample measurement 35.9 – 40.0 minutes 
Facing the difficulties during the synthesis of the Hmp-peptides, we decided to alter the two-
fragment synthesis strategy. The idea was to synthesize shorter fragments and introduce 
alternative ligation sites since cysteine is not an abundant amino acid with quantities of only 
2.25% in protein sequences of mammals.153 We incorporated the following mutations: A16C 
and A41C. The newly generated cysteine residues can be readily converted to alanine through 
the desulfurization process.154,155  
The following scheme shows the amino acid sequence and segmentation used for this the 
three-fragment approach. Figure 23 also shows structural components introduced in Figure 3 
(green – filter region, yellow – pore region, violet – transmembrane helices) and highlights 
the ligation site at A16C and A41C in red.  
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Figure 27. Synthesis strategy using three fragments 
Besides the mutations from Ala Æ Cys, Cys16 
hat to be masked in order to selectively 
connect fragment 1 with fragment 2 and in the 
next step connect ligation product 1 with 
fragment 3. One promising residue to mask Cys 
is the 1,3-thiazolidine-4-carboxo-group, Thz, 
thioproline group which is commercially 
avalabile and regularly used for multiple-step 
and one-pot ligation strategies.156-158 
 
Figure 28. Thioproline moiety 
This Thz group is stable throughout the first ligation and can be converted to a cysteine 
moiety in a simple step which can be performed in the ligation buffer.159 Moreover, the 
naturally occuring Cysteine moiety, C36, needs to be protected throughout the synthesis and 
desulfurizations conditions in order to avoid intermolecular side-reactions and to guarantee 
for the native sequence.  
 
Figure 29. Acm protection group 
For that, an orthogonally protection via the 
acetamidomethyl group (Acm) is the method of 
choice.160,161 The originally proposed method for 
Acm removal involved usage of 
mercury(II)acetate161, whereas a few years later the 
practice of using silver salts became more 
popular.162 A recent approach focuses on the 
application of the well-established scavenger, TIPS 
for both, cleavage to obtain the free thiol as well as 
the generation of disulfide bridges.163 
Both, synthesis and NCL of fragment 1 and fragment 2 were possible with efficient thioproline 
conversion while fragment 3 could not be purified using the implemented RP-HPLC 
techniques. From the experience on our lab for the incorporationof solubilzing tags to oxo-
ester fragments,143 we decided to incorporate a spacer containing polyglycine residues due to 
presumed problems in NCL with the sterical hindrance of the rather big Lys units. Figure 30 
shows the third synthesis scheme with the self-removable solubilizing tag in blue.  
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Figure 30. Three fragment synthesis strategy with solubility tag 
The pursued synthesis strategy is visualized in Figure 31. 
(a)  
  
(b) 
 
Figure 31. Synthesis strategy for KcvNTS 
During NCL 1, fragment 1 and 2 are ligated to yield ligation product 1 which further reacts, after unmasking of the 
N-terminal cysteine, with fragment 3.2 to ligation product 2 (a). Four monomers assemble to the functional, 
tetrameric state of KcvNTS 
  
+ 
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6.2. Chemical synthesis of KcvNTS(1-82) 
Synthesis and analytics of fragment 1 
Following the standard Fmoc SPPS procedure introduced in 5.1 with synthesis conditions seen 
in Table 6, fragment 1 is synthesized. The impurities within the crude product, seen in Figure 
32a, indicate challenges in purification of the 41 amino acid long sequence. LC-MS analysis of 
the peak at Rf 17 minutes (Figure 32d) indicate the right expected molecular mass of the 
fragment at [M+3H+]3+ with calculated 1493.79 m/z and found 1493.80 m/z (Figure 32b,e) 
and [M+4H+]4+ with calculated 1120.59 m/z and found 1120.60 m/z (Figure 32c,f) and 
corresponding isotopic patterns. All measured and calculated masses are summarized in Table 
7 in the “methods” section. The peak displaying the expected molecular mass, is insignificant 
in the RP-HPLC chromatogram of the crude product indicating the high amount of impurities. 
Difficulties in purification are demonstrated by the yield of purified product: from 53.02 mg 
crude product, only 3.0 mg purified product are obtained (5.7%). Furthermore, dissolution of 
the sample was only obtained with the addition of neat TFA to the freeze-dried product 
(Table 14).  
 
Figure 32. RP-HPLC chromatogram and MS spectra of fragment 1 
RP-HPLC chromatogram of the crude product (a) with insert showing purified fragment, gradient: 20% - 95% over 
30 minutes eluent B with a flow of 1 ml/min measured on the MultoHigh BIO 300 column at 30 °C. LC-MS showing 
spectra of the purified product in (b) with the insert showing sample and simulated pattern with [M+3H+]3+ and 
[M+4H+]4+ from LC-MS with a retention time of LC-MS between 23.1 - 26.5 minutes. 
 
Synthesis and analytics of the fragment 2 
Synthesis of the fragment 2 is pursued using manual and automated peptide synthesis 
according to the fmoc SPPS method introduced in 5.1. with synthesis conditions summarized 
in Table 8. No decrease in the original loading from 0.18 mmol/g after the Mitsunobu 
reaction using Phe as the subsequent amino acid was evaluated, illustrating sufficient 
coupling. The crude product (Figure 33a) indicates a successful synthesis with a low rate of 
impurities that is confirmed by LC-MS and the expected molecular mass in the peak at Rf 10.6 
minutes (Figure 33b). Molecular masses of [M+2H+]2+ with calculated 1529.65 m/z and 
found 1529.660 m/z were determined within the significant peak (Figure 33c). Table 9 
summarizes measured and calculated masses for LC-MS spectra. Purification of 71.26 mg 
crude product resulted in 17.05 mg pure product, representing an oval yield of 24%. 
Comparing both fragments 1 and 2, this outcome is expected. Fragment 1 displays the 
transmembrane helix region and thus is the more challenging fragment for SPPS. 
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Figure 33. RP-HPLC chromatogram and MS spectra of fragment 2 
RP-HPLC of (a) crude product with the insert showin the purified product, gradient: 20 - 65% eluent B over 20 
minutes, flow: 1 ml/min on the MultoHigh BIO 300 column at 30 °C. Illustration (b) shows MALDI-TOF MS (HCCA 
matrix) of the purified fragment with Rf – 10.6 minutes and the LC-MS sample measurement with simulated 
patterns of [M+2H+]2+ with a retention time of LC-MS between 16.5 – 18.7 minutes. 
 
Synthesis and analytics of the fragment 3 
This section highlights synthesis and analytics of fragment 3 that is further modified to exhibit 
a solubilizing tag (fragment 3.2). Fmoc-SPPS is performed similar to fragment 2 using manual 
and automated synthesis (5.1). The RP-HPLC chromatogram seen in Figure 34a illustrates 
elution of this fragment, prior dissolved in a mixture of 0.3 mM N-dodecyl-beta-maltoside, 
DDM, in ACN (0.1% TFA), water (0.1% TFA) (17:3 v/v) as a solvent due to being insoluble in 
100% ACN (0.1% TFA). Non-ionic detergents, such as OG and DDM, can be used to aid 
solubilization of membrane proteins because they are considered to be non-denaturing.164. 
Above their critical micelle concentration, CMC, they self-assemble to micelles which embed 
the ion channel. The literature value for the CMC of OG is 20 – 25 mM165 and for DDM 
0.17 mM.166 Another RP-HPLC chromatogram, with addition of 30 mM octylglucoside, OG can 
be seen in SI Figure 2. However, even optimization of dissolution led to a chromatogram not 
displaying any significant peaks. The molecular mass of the peptide was found within the 
purging step of the LC-MS method and cannot be appointed to any peak within the gradient. 
That means that even here, as already described for fragment B, the stationary phase of the 
MultoHigh BIO 300 C4 column, strongly interacts with the peptide which does not elute 
sufficiently. Molecular masses of [M+H+]+ with calculated 1843.1025 m/z and found 
1843.1012 m/z and [M+2H+]2+ with calculated 922.0549 m/z and found 922.0530 m/z 
were detectable within the purging step (Figure 34b,c). Purification using RP-HPLC was not 
possible and thus, does not seems to be an appropriate method. 
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Figure 34. RP-HPLC and ESI MS of fragment 3 
RP-HPLC of (a) crude product gradient: 60% - 99% eluent B over 30 minutes with a flow of 1 ml/min on the 
MultoHigh BIO 300 column at 30 °C. Illustration of (b) shows the MALDI-TOF MS (HCCA matrix) of the crude 
product with the insert showing LC-MS sample measurement of sample and simulated pattern of the fragment as 
[M+H+]+ and [M+2H+]2+ form a retention time of LC-MS between 26.5 – 28.8 minutes 
 
Synthesis and analytics of fragment 3.2 
Following a three-step synthesis protocol, the solubilizing tag is synthesized automatically, 
followed by manual coupling of the oxo-ester unit and finished with automated peptide 
synthesis introduced in 5.1 Due to failed attempts, usage of TentaGel® resin was re-evaluated 
and compared to AmphiSpheres RAM. Table 28 summarizes outcomes of trial synthesis 
protocols (0.1 mmol scale) with AmphiSpheres being superior to TentaGel.  
Resin AmphiSpheres RAM  TentaGel 
Initial loading 0.380 mmol/g 0.18 mmol/g 
Loading after solubilizing 
tag 
0.095 mmol/g* 0.095 mmol/g 
Loading after Mitsunobu 0.075 mmol/g 0.021 mmol/g 
Loading at end 0.031 mmol/g 
Aborted after Mitsunobu due to 
low loading 
Table 28. Comparison of two resin types for synthesis of fragment 3.2 
*loading after the solubility tag corresponds to TentaGel loading. This led to the conclusion that the loading on the 
label of the AmphiSpheres RAM® does not correspond to the true loading. 
Synthesis conditions are summarized in Table 11 and illustrate a decrease in loading of 
0.38 mmol/g to only 0.04 mmol/g (89.5% initial loading) while using AmphiSpheres RAM 
resin. This emphesizes the challenges still connected to the synthesis of the last fragment 
albeit optimization of resin choice and the integration of a solubilizing tag took place. Many 
impurities emboss the appearance of the chromatogram of the crude product, again 
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illustrating the great challenge the synthesis exhibits (Figure 35a). The corresponding mass of 
the product was found within the peak at 5.9 minutes of the LC-MS method (5.1.5) with 
[M+2H+]2+, calculated 1271.76 m/z and found 1271.75 m/z and [M+3H+]3+, calculated 
847.17 m/z and found 848.16 m/ (Figure 35b-f). The product peak in the corresponding RP-
HPLC chromatogram at 16 minutes cannot be assigned to an explicit peak in the 
chromatogram of the crude product. Table 12 summarizes measured and calculated masses 
for LC-MS measurements. 
 
Figure 35. RP-HPLC and MS spectra of fragment 3.2 
RP-HPLC chromatograms of the crude product (a) and the purified fragment (d), gradient: 5% eluent B for 5 
minutes followed by a linear gradient 5% - 70% eluent B over 20 minutes with a flow of 1 ml/min on the MultoHigh 
BIO 300 column at 30 °C. LC-MS of peak at Rf 15.9 minutes with insert showing [M+2H
2]2+ and [M+3H2]3+ sample 
and the corresponding simulated patterns with a retention time during LC-MS of 17.2 minutes 
 
6.3. Native chemical ligation 1 
The solution, in which the ligation is carried out, is an aqueous buffer solution containing 
either guanidinium hydrochloride, Gdn·HCl or urea and Na2HPO4. Albeit solubility tags are 
used for better solubilization, it is rather uncommon that the fragments will dissolve totally. 
To enhance solubility, the addition of organic solvents is crucial. In literature the partial 
adding of TFE,143,167 HFIP143 and DMF168,169 is described. Urea or Gdn·HCl are added for 
denaturation, meaning the unfolding of the amino acid sequence to bypass non-wanted 
aggregation.170 Other detergents, such as sodium dodecyl sulfate, SDS were also investigated 
to enhance solubility in the ligation solution.171 When looking at the natural environment of 
membrane proteins, it makes sense to investigate the addition of lipids to the solution. Hunter 
et al. investigated a lipid bilayer system, a cubic lipidic phase matrix, to perform NCL of a 
hydrophobic polypeptide172 whereas Clayton et al. utilized dodecylphosphocholine (DPC) as 
well as TFE.173 
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To optimize ligation conditions, HFIP 
(ligation buffer A, 5.1.3.1) and TFE 
(ligation buffer B, 5.1.3.2) are 
investigated as organic solvents for 
ligation using organic solvent/water 
1:3 v/v. Ligation conditions are 
according to 5.1.3.1 for HFIP and 
5.1.3.2 for TFE. During both conditions, 
a sediment is formed after 4 h of 
reaction time. Figure 36b shows 
sediment formation after 24 h of 
ligation 1 using ligation buffer A with 
(Figure 36a) showing clear solution at 
the starting point. Evaluation of the 
results form ligation experiments is 
done applying MALDI-TOF MS 
measurements according to 5.1.5.  
 
Figure 36. Sediment formation during HFIP ligation 
For evaluation of the ligation outcome, crucial masses of educts and the product are 
summarized in Table 16. Using MALDI-TOF MS, the sediment as well as ligation solutions of 
both NCL preparations (ligation 1 using buffer A or buffer B) are investigated in regard to 
product formation. Figure 37a shows MALDI-TOF MS spectra from the solution using buffer 
B, (b) sediment from buffer B and (c) sediment from buffer A. 
(a)         (b) 
sediment 
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Figure 37. Comparison of ligation using buffer A and buffer B 
All MALDI-TOF MS spectra are recorded using the LP mode and DHAP as the 
matrix system. Samples from sediment are dissolved in TFE/water (0.1% 
TFA) 1:3 v/v 
Both NCL methods using 
ligation buffer A with HFIP 
and ligation buffer B with 
TFE are applicable due to 
product formation using 
both. However, using the 
strategy with buffer B, the 
product can be found in 
both, the solution and the 
sediment making this 
method inferior to usage of 
buffer A. This is because a 
further needed step in 
merging both product 
fractions for unmasking of 
the thioproline group would 
be needed. The sediment 
from the ligation in buffer A 
can easily be separated from 
the remaining solution by 
centrifugation and used for 
further thioproline 
conversion in buffer C.  
Additionally, we can extract 
further information from this 
experiment. HFIP will not be 
a suitable solvent for further 
experiments due to 
precipitation of the product 
while TFE seems to be 
employable. Using 1:2 v/v of 
TFE leads to partial 
precipitation but is also able 
to dissolve the product. We 
hypothesized that increasing 
the portion of TFE could lead 
to complete dissolving of the 
product and prosperous 
thioproline conversion. 
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6.4. Unmasking of the N-terminal thioproline group 
The product within the sediment of the HFIP ligation in buffer A is re-dissolved in the ligation 
buffer C (Table 45) yielding a clear solution. Addition of methoxyamine·HCl and a lowering of 
the pH to 4 results in the ring-opening of the Thz moiety and conversion to the cysteine 
fragment indicated by a loss of 12 Da (see Figure 38). 
 
 
Figure 38. Conversion of the N-terminal thioproline moiety from ligation 1 to N-terminal cysteine 
The first step shows the NCL using a thioester and a cysteine (a). A amide bond is generated between both 
fragments, the sequence now exhibits the N-terminal thioproline moiety (b). Using methoxyamine·HCl and 
lowering the pH to 4 the thioproline is unmasked and converted to a N-terminal cysteine (c). 
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Figure 39. Unmasking of the thioproline unit after ligation 1 
To monitor the loss of 12 Da, MALDI-
TOF MS is performed (for the used DHAP 
protocol see 5.1.5.). The drawn samples 
are directly put on dry-ice to stop further 
conversion and further measured. Figure 
39 shows the conversion of the 
thioproline moiety over the time course 
of 8 hours. The simulated patterns of the 
ligation product 1 [M+H+]+ as well as 
the ligation product 1.2 are shown with a 
loss of a C atom (-12 Da) in the 
molecular formula from C345H512N78O92S6 
to C344H512N78O92S6.  
At the time point 0 h, only presence of 
ligation product 1 (Figure 39) can be 
evaluated whereas over 2 h two peaks 
are visible which can be appointed to 
ligation prouct 1 and ligation 
product 1.2.  
After a time course of 2 – 4 h, and 
increase in the peak intensity of ligation 
product 1 can be investigated with 
increasing intensities of the peak 
representing ligation product 1.2. At 2 h 
conversion time, around half of the educt 
(ligation product 1) is converted to the 
N-terminal cysteine fragment (ligation 
fragment 1.2) while after 4 h this 
proportion of 
ligation product 1.2 : ligation product 1 is 
3:1 respectively. The full conversion of 
the thiopoline moiety to the N-terminal 
cysteine can be observed after 8 h. 
 
MALDI-TOF MS showing the simulated pattern of the educt, ligation product 1 and product, ligation product 1.2 
indicated by a loss of 12 Da over the time course of 8 h. All spectra are recorded in an linear positive (LP) mode 
with DHAP as the matrix 
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6.5. Vivaspin® purification 
For purification of the hydrophobic ligation product 1.2 from fragment 1 and fragment 2, 
Vivaspin® concentrators (polysulfone, PES membrane, cut-off 5 kDa) were used as a mass-
filtration unit. The cut-off of 5 kDa may not be enough to separate the ligation product 1.2 
(9.1 kDa) from fragment 1 (4.5 kDa) but should be sufficient to separate the hydrolyzed 
fragment 2 (3.0 kDa). The protocol used is described in 5.1.4. The success of the filtration is 
evaluated by MALDI-TOF MS using the DHAP matrix (5.1.5). The MS-spectrum of the filtrate 
(solution filtrated through the membrane) does not reveal any of the above mentioned 
fragments, only a peak of m/z 2941 which cannot be assigned to any fragment (Figure 40a). 
Additionaly, the remaining solution above the filter membrane is analyzed. Since no fragment 
is found in the filtrate, all other components, fragment 1, fragment 2 and ligation product 1 
should be determined in this fraction. As seen in the insert of Figure 40a, none of the 
fragments are found within that fraction leading to the conclusion that the fragments, due to 
the great hydrophobicity, remain and interact with the PES membrane. After washing the 
membrane with water, an aliquot is taken, diluted using 1:3 TFE/water (0.1% TFA) v/v and 
MALDI-TOF MS applied. With a mass peak of [M+H+]+ at m/z 4478.94 fragment 1 is 
identified supporting the hypothesis of interaction with the membrane (Figure 40b). 
However, a washing step using water can be used to separate parts of fragment 1 from the 
ligation solution. Employing a second washing step using 1:3 TFE/water (0.1% TFA) v/v the 
ligation product 1.2 with [M+H+]+ at 7404.33 m/z is found aside from hydrolyzed 
fragment 2 with [M+H+]+ at 2978.28 m/z and fragment 1 with [M+H+]+ at 4478.94 m/z 
(Figure 40c). Flipping the filter and applying centifugational forces lead to an increased 
elution of of the ligation product 1.2, KcvNTS(16-81) (Figure 40d) as well as an increased 
intensity of fragment 1. These results lead to the conclusion that due to hydrophobicity of all 
fragments, fragment 1, fragment 2 and ligation product 1.2, stick to the filter membrane and 
are only realeased after several washing steps and the addition of organic solvent. Vivaspin® 
filtration can thus be used to reduce the amounts of fragment 1 because is released also by 
washing with water, and to concentrate the ligation product 1.2 as well as separating the 
added salts within the ligation buffer system. 
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Figure 40. Vivaspin® filtration/purification 
Different stages of the Vivaspin® filtration are shown. (a) shows MS spectra of the residual solution while the insert 
shows spectra of the filtrate at the bottom. (b) Illustrates the spectra after the washing step using water, (c) using 
TFE in water. Lastly, (d) shows spectrum of the flipped membrane that was washed with TFE. All spectra were 
recorded using DHAP as the matrix in the LP mode. 
 
6.6. Hydrolysis of the fragment 2 
The ligation reaction can only take place 
as long as both fragments, the C-
terminal thioester and the N-terminal 
cysteine, are present in the solution. 
While fragment 1 is added in excess, 
fragment 2 represents the crucial factor. 
Not only is it deficient in concentration, 
it can also be inactivated through 
hydrolysis of the oxo-ester unit which 
leads to inactivation of this fragment.  
 
 
 
Figure 41. Hydrolysis of oxo-ester 
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Figure 42. Hydrolysis of fragment 2 
To monitor the hydrolysis process, at 
different time points of the ligation 
reaction samples are drawn and 
investigated using MALDI-TOF MS. 
A scheme of the hydrolysis is illustrated 
in Figure 41 with Figure 42 showing 
hydrolysis (simulated patterns in red) of 
fragment 2 (intact fragment with 
simulated patterns in blue) over a time 
course of 24 h.  
With the start of the ligation 1 using 
ligation buffer B, illustrated in Figure 42 
bottom, fragment 2 is still intact with no 
change in peak intensities seen until 
30 minutes. After 1 h, the peak 
appointed to the hydrolysis product, 
increases and reaches intensities 
comparable to the intact product. Until 
4 hours of reaction the portion between 
inact and hydrolyzed fragment 2 does 
not change. From 8 h on until 24 h no 
intact fragment 2 can be visualized 
using MALDI-TOF MS which leads to 
the conclusion that a further addition of 
fragment 2 after 8 h of reaction time is 
beneficial to keep the ligation reaction 
going. After 8 h the NCL is aborted since 
no oxo ester of fragment 2 is available 
for reaction with the N-terminal 
cysteine moiety of fragment 1.  
 
 
 
 
 
 
 
Hydrolysis of the C-terminal hmp-oxo ester of 
fragment 2 over the course of 24 h. All spectra 
were recorded using DHAP as the matrix and the 
LP mode. 
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6.7. Native chemical ligation 2  
The successional ligation, NCL 2 of ligation product 1.2 with fragment 3.2, is performed in 
ligation buffer D (5.1.3.4). Figure 43 illustrates the change in the MS spectra from the first (a) 
to the second ligation (b) and (c). Again, a sediment is formed within the 24 h of ligation 
reaction (Figure 44). Both fractions, the solution and the sediment were used for further 
MALDI-TOF analysis.  
 
 
Figure 43. MALDI TOF results of the second ligation 
Illustration of MALDI-TOF MS spectra from the first ligation after 
Thz conversion (a) and the second ligation solution (b). 
Measured using DHAP matrix and LP mode. (c) showing a 
spectra of the sediment measured using the Thinlayer method 
with MeOH as the solvent 
The ligation solution is acidified using 
1:3 TFA/water (0.1% TFA) v/v and 
the spot on the MALDI target washed 
with water (0.1% TFA) to suppress 
interfering salts from the ligation 
buffer D. 
Figure 43a shows a spectra of the first 
ligation reaction in ligation buffer C 
after unmasking of the thioproline 
unit and serves for comparison to 
Figure 43b. A significant decrease of 
the peak representing the ligation 
product 1.2 with [M+H+]+ at 
7404.96 m/z gets visible. 
Furthermore, fragment 2 is still visible 
because it could not be separated 
using the VivaSpin® centrifugation 
methods (6.5). Since it displays a N-
terminal Cys moiety, there is a 
possibility of fragment 1 to react with 
fragment 3.2. This would result in a 
peak of [M+H+]+ (C295H469N67O73S3) 
with a mass of 6218.44 m/z. This 
peak cannot be found within the 
spectra of the solution (Figure 43b) 
nor the sediment of the second 
ligation (Figure 43c). Neither is the 
ligation product 2 found within those 
two fractions. The product would be 
represented by a peak with [M+H+]+ 
at 9144.84 m/z. To investigate the 
sediment, it is dissolved in 
1:3 TFA/water (0.1 % TFA) v/v. 
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For investigation of the sediment, the DHAP method 
did not show a sufficient spectra. Therefore, 
additional methods for MALDI-TOF MS of 
hydrophobic membrane proteins were applied and 
tested (5.1.5). First, Sinapinic acis, which is often 
used as a matrix for high molecular weight samples 
for measurements in LP positive mode174, (SI Figure 
3) did not show any superiority. Second, the 
comparison of sandwhich methods led to the 
conclusion that the thinlayer method using methanol 
as a solvent is the method of choice, generating the 
most intensive peaks (SI Figure 4). To illustrate this 
superiosity, the DHAP spectra is compared to the 
thinlayer method in SI Figure 5. Unfortunaltely, even 
though optimization of the matrix system and sample 
preparation led to a better MS spectra, the product 
cannot be determined. 
 
Figure 44. Sediment generation during the 
second ligation 
(a) start of ligation reaction (b) after 24 h 
As seen in 6.5, applying a purification step using the Vivaspin® ultracentrifugation units, does 
not efficiently remove fragments such as fragment 1 with a molecular weight of around 
4.5 kDa. These findings suggested a one-pot ligation strategy using the ligation buffer C. 
However, Vivaspin® purification if beneficial to prepare the samples for MALDI-TOF MS due 
to separation of salts from the buffer system. Figure 45 shows MALDI-TOF MS of the acidified 
ligation solution form ligation 2 in 1:3 TFE/water (0.1% TFA) v/v using the DHAP matrix and 
LP mode. Both, Figure 45a and b represent the exact same spot on the target plate while (b) 
has been washed twice using 1 µl of water (0.1% TFA). The results are discussed in 6.7, this 
illustration shows that washing the spot, to avoid interferences of salt such as urea on the 
ionization, on the target is crucial for the generation of significant spectra.  
 
 
Figure 45. One-pot ligations strategy 
(a) One-pot ligation solution in DHAP matrix (b) same spot from (a) washed 2 x with water (0.1% TFA) 
  
(a)   (b) 
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6.8.  Characterization of the final product KcvNTS(1-82) 
Detection of the correct size of KcvNTS using SDS PAGE 
Looking at the MS results it can be seen that ionization is strongly dependent on the matrix 
used as well as the sample preparation. It is possible that the product is present but not 
ionized and thus not detectable in the methods applied. Only the appliance of different 
analytical methods will give information on product formation. A further method used to 
identify product formation is SDS PAGE, sodium dodecyl sulfate polyacrylamide gel 
electrophoresis. With the addition of SDS to the sample buffer, proteins denaturate and bind 
SDS non-covalently resulting in a negative charge that is constant due to micellar effects with 
an overall similar charge-to-mass ratio. The sample then migrates through the gel from the 
cathode (-) to the anode (+) according to its size when applying an electric field.175,176 Two 
types of staining procedures were performed, Coomassie stain and silver stain. While 
Coomassie binds to basic and hydrophobic proteins, making them visible through a blue color, 
the sensitivity is rather low with a value of around 25 ng/band. Thus, a further staining is 
used to visualize also difficult and small amounts of protein. Silver staining can be sensitive 
towards 0.5 ng protein/band.177 Usually, samples are boiled at 95 °C with the SDS-containing 
sample buffer, following Schägger’s recommendation, incubation at 37 °C for 15 minutes is 
sufficient for membrane proteins.127  
First, Coomassie stain is applied resulting in the gel found in the supporting information (SI 
Figure 6). Silver staining is performed to make further bands visible or to intensify already 
visible bands (Figure 46). For the used protocol, see 5.1.6. 
(a) (b) 
 
Figure 46. SDS PAGE of second ligation 
(a) and (b) showing silver stain of the same gel with (b) an extract 
 
 
Besides the significant band at 10 kDa, which coincides with the mass of the product 
(9.1 kDa), two more bands are visible. In the extract (b) two red arrows indicate the other 
visible bands, i at around 20 kDa and ii at 30 kDa. Since they represent the mass of the 
product multiplied by 2 × for i and 3 × for ii, those bands match the masses for oligomeric 
formations, the dimer and trimer of the product. This behavior of forming oligomeric 
structures with denaturing SDS PAGE conditions is very common. While e.g. Kcv showed 
formation of the monomeric and tetrameric structure with the addition of K+ ions to the 
sample solution178 investigated by Pagliuca et al., SDS PAGE of BM2 (1-51) showed formation 
of all oligomeric states, the monomer, di-, tri- and tetramer.179 Looking at the starting point of 
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the NCL 2, the significant band at around 10 kDa is visible and comparable to the bands of the 
NCL 0.5 h – 24 h while no oligomeric forms at 20 kDa and 30 kDa are detected. This sample 
though, represents the starting point of the NCL 2 which, at 0 h, should not contain the 
product. Since membrane proteins usually do not run strictly according to their size due to 
aggregation and their hydrophobic nature it could be possible to not see a significant 
difference in height of the band of the ligation product 1.2 at 7.5 kDa and the product of NCL 
2 at 9.1 kDa. Further information from this SDS PAGE is the non-existence of additional 
bands within the sediment sample which leads to the conclusion that the product of the 
second ligation can only be found within the ligation solution, not the sediment.  
With the addition of DTT to the loading buffer, formation of disulfide bridges is disrupted. A 
further SDS PAGE Gel is run using the 24 h samples of NCL 2 and denaturing, reducing (red.) 
and native conditions. 
 
Figure 47. SDS PAGE using denaturing and native conditions 
 
Looking at the second gel (Figure 47), a forth band indicated by the red arrow iv is visible in 
the samples dissolved in the reducing sample buffer. This forth band can be arranged between 
42 kDa and 100 kDa and represents the tetrameric form of the product, KcvNTS. It becomes 
visible, that the addition of K+ does not influence formation of potential oligomeric forms 
when taking the samples directly from the ligation solution containing salts and buffers. 
Looking at the native conditions from the same initial solution, formation of only a second 
band in the range of 20 kDa can be found, visualized with a red arrow v. Dismissing DTT from 
the sample buffer, disulfide bridges can be formed. The synthesized sequence exhibits two 
potential cysteine residues for disulfide bridge formation which would result in around 20 
kDa. Also, these conditions will not lead to oligomeric behavior which is represented in this 
gel. 
To evaluate bands i, ii, iii and vi to really be oligomeric forms of our product, a positive 
sample is needed. Native KcvNTS samples were gratefully provided by Tobias Winterstein from 
the Thiel lab. Both samples represent KcvNTS in different lipid environment.180 Coomassie stain 
of the gel can be found in the supporting information (SI Figure 7). 
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Looking at the sample ligation product 2 solution in the agarose gel (Figure 48) we can see 
a similar image compared to Figure 46. Only three oligomeric forms are visible indicated by 
the red arrow pointing at i (monomer), ii (dimer) and iii (trimer). A possible tetrameric form 
as seen in Figure 47 is not visible, again emphasizing the difficulties attached to analytics of 
membrane proteins. Furthermore, ligation product 2 Vivaspin represents the same solution 
discussed afore but purified using the Vivaspin® protocol after TFE washing and flipping of 
the membrane. Since no further bands are visible but the significant band at 10 kDa, using 
Vivaspin® for purification of the NCL 2 is not recommended. Also, ligation product 2, 
4 weeks does not show any significant peaks indicating that the product may not be stable 
stored in the ligation solution at -30 °C for more that 4 weeks. In accordance to Figure 46, the 
sediment (ligation product 2 sediment) does not show oligomeric behavior. Ligation 
product 1.2 represents the ligation solution of the first ligation showing two bands. Since the 
first product displays one transmembrane region, formation of oligomeric states could be 
possible. Furthermore, the obtained bands from ligation 1 and ligation 2 are not similar 
indicating a product formation after NCL 2. Coming to the positive samples, native KcvNTS we 
can see that there are multiple bands visible. The channel is synthesized using expression and 
further integrated into nanodiscs or lipids, no further purification step is applied. Thus, 
multiple bands are visible which do not match completely. Bands iv, v and vi can be attributed 
to iii, ii and i while band vi runs similar to i in Figure 47. These results indicate a successful 
synthesis and the presence of the synthesized KcvNTS. 
 
Figure 48. SDS PAGE with Kcv positive samples 
 
Determination of the predominant overall fold of KcvNTS(1-82) with circular dichroism 
spectroscopy 
Circular dichroism is a powerful and useful tool to investigate not only the folding properties 
of proteins but it can also be applied in investigating conformational changes over time or in 
dependency on temperature to obtain data on kinetics.181,182 Three decisive bands characterize 
the existence of α-helical structures: two negative bands at 222 nm and 208 nm as well as a 
positive band at 193 nm.183 In Figure 49 the CD spectra of ligation preparations are shown as 
well as the positive KcvNTS sample from Figure 48 (KcvNTS native nanodiscs). Also, a blank 
measurement in shown in (a) indicated by a blue color. Unfortunately do all samples show 
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very little absorption. Additionally, the positive sample does not show a clearly defined 
α-helical structure which could be appointed to the nanodiscs within the solution having an 
interfering absorption behavior. Only the ligation in orange shows a spectra that can be 
evaluated and meets the requirements of α-helical proteins. The spectra displays a minimum 
around 208 nm and a further on at 222 nm. Looking at the wavelengths range of 190 – 
200 nm we can see a “zick-zack” behavior which can be translated to insufficient 
concentration but a tendency for a positive CD value can be carefully evaluated. Since 
dissolving of the product is needed to obtain evaluable spectra, another method is used that 
has been successfully applied in literature.184 To generate an environment similar to a cell 
membrane, lipids can be used, e.g. POPC to preserve the native state of the membrane 
protein.185 To generate a narrow size distribution of POPC vesicles, they are extruded through 
a 1 µm polycarbonate membrane and measured directly. Unfortunately, no usable spectra 
could be recorded (see SI Figure 8). Again, this investigation suggests successful synthesis and 
existence of KcvNTS but again shows the difficulties in analyzing membrane proteins. 
 
 
Figure 49. CD spectra of product from second ligation 
All spectra are recorded at 21 °C with samples dissolved 
in TFE. In (a) the blank value, results of the NCL 2 and the 
positive sample KcvNTS are shown while (b) only shows 
the positive sample using a better scaling. In (c) the 
spectra of ligation product 2 can be seen. In (b) and (c) 
the important wavelengths of 193 nm, 208 nm and 
222 nm are illustrated with red dashed lines 
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7. Conclusion and outlook: KcvNTS 
Successful synthesis, purification and characterization of membrane proteins face numerous 
challenges. A major component contributing to the difficulties is the sequence itself, usually 
exhibiting hydrophobic amino acids especially in the transmembrane regions, predominantly 
build up from α-helices penetrating the membrane. Two of the major problems related to 
these hydrophobic amino acids during SPPS are (1) incomplete amino acid coupling reactions 
and the tendency to (2) aggregate on-resin. According to the results presented in section 6 the 
synthese of KcvNTS faced challenges in regard to synthesis, purification and analytics.  
Synthesis. Incomplete coupling can be targeted by the careful evaluation of coupling reactants 
and conditions. HATU was chosen as the coupling reagent because of its superiority and high 
coupling efficiency with quick coupling times leading to high yields during SPPS.186,187 HATU 
displays an excellent stability in DMF (>99% in closed vial over 48 h) and can thus be applied 
for automated peptide synthesis.188 Furhtermore, inter- and intramolecular aggregation can be 
reduced with elevated temperatures.189 Microwave irradiation during automated SPPS is 
employed during synthesis of the KcvNTS fragments leading to precise and controlled elevation 
of the temperature (see 5.1). The problem of aggregation on resin can be approached by the 
incorporation of structures stabilizing the backbone, namely pseudoprolines. According to our 
results (Table 5) and evaluating the yield of the product outcome (fragment B) from 8.0% to 
6.6% while using pseudopolines for fragment B, we do not see a positive development in 
synthesis yield with the addition of pseudoprolines. For difficult sequences, resins with proper 
swelling characteristics, little cross-linking and low-loadings are recommended.190,191 For 
fragment 3.2, we evaluated AmphiSpheres 40 RAM resin to be superior to TentaGel R RAM 
resin (see Table 28). Albeit the AmphiSpheres 40 RAM resin holds a higher loading capacity 
then the TentaGel R RAM resin (0.38 mmol/g compared to 0.18 mmol/g), this resin shows a 
high content of long PEG units which enhance synthesis if difficults peptide sequences.192  
Other employable alternatives for minimization of aggregation are usage of Hmb-amino 
acids193 and depsidipeptide units (O-acyl isopeptides) for backbone modification and 
stabilization through disruption of amide bond patterns.194,195 Additionally, the choice of the 
SPPS protocol could target these difficulties and be applied in further synthesis optimization 
steps.30,196,197  
Purification. The purification step is essential for sufficient analytics and efficient native 
chemical ligation reactions. For extremely hydrophobic fragments, such as fragment B, 
fragment 3 and fragment 3.2, RP-HPLC reaches its limits, although optimization of the 
stationary phase of the column took place. We used a wide pore silica of 300 Å, which allows 
for larger peptides and proteins to better interact with the surface and a butyl phase (C4) that 
is suitable for proteins and larger, hydrophobic peptides.198 For efficient purification, complete 
dissolution is required. To guarantee this state, fragment 2 was dissolved adding droplets of 
concentrated TFA first (Table 14) and fragment 3 was only soluble with addition of 
detergents such as OG and DDM. Ultimately, usage of detergents did not lead to sufficient 
purification of fragment 3 which resulted in the incorporation of a solubilizing unit. While we 
integrated a hydrophilic tail at the C-terminal hmp oxo-ester unit, there are various 
alternatives possible from side-chain solubilizing units to N-terminal tags199. For our need, the 
C-terminal solubilizing tag displays the best method since it is readily detached during the 
NCL reaction with no additional cleavage step needed.  
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Additionaly, larger fragments from the herein presented ligation experiments, ligation product 
1, 1.2 and 2, could not be purified using optimized RP-HPLC or dissolution protocols. 
Therefore, the purification using Vivaspin® concentrators was established. As presented in 
6.5, fragment 1 was partially separated from the ligation solution with ligation product 1.2 
being concentrated due to release of the fragments during different washing steps.  
This purification method holds great potential with optimization needed. As presented, 
washing and flipping of the membrane is needed and only with the addition of TFE (1:3 
TFE/water (0.1% TFA) v/v), ligation product 1.2 is released. Applying a gradient of the 
TFE/water mixture will lead to more sufficient separation and better concentration of the 
product. The increasing amounts of TFE are to be evaluated carefully in regard to the stability 
of the membrane. 
Analytics. An optimized purification method facilitates analytics such as MALDI-TOP MS, 
LC-MS and SDS. Using the Vivaspin® filtration units prior to MALDI-TOF MS measurements, 
samples from ligation solutions, that contain high amounts of interfering salts, are ionized 
more efficiently.200 Also, washing of spots on the MALDI target, using water (0.1% TFA), that 
are taken directly form reaction solutions, e.g. during Thz conversion, will lead to optimized 
and better sprectra (Figure 45). There are various protocols published targeting membrane 
proteins. Presented in this work is the thinlayer and threelayer methods (5.1.5) that led to 
more precise spectra compared to the mainly used 2,5-DHAP method (Figure 43 and SI Figure 
5). Still, ionization of the ligation product 2 was not possible leaving room for optimization of 
MALDI-TOF MS methods.  
Ionization of membrane proteins displays an enormous challenge. To circumvent ionization of 
these large structures, a digestion, generating multiple fragments with lower masses, is a 
method that is applicable. Therefore, the method of peptide mass fingerprinting (PMF) is an 
interesting and important analytical tool.201 
Native Chemical ligation, NCL. The hmp peptides were successfully synthesized presented in 
6.2. Therefore, NCL using this mehod is very reliable for the KcvNTS sequence and has been 
successfully used at our lab. The choice of solubilizing tag, though, is of great interest since 
the herein used consists of eight amino acids possibly leading to sterical hinderance during 
NCL 2. Baumruck et al. from our lab investigated efficiency of different solubility tags on 
model peptides and a sequence of BM2 when using the hmp building block for NCL. 
Improvement of solubility was achieved with the addition of one ADO unit (8-amino) and a 
Lys5 tag.143 The inserted solubility tag used for the synthesis of KcvNTS consists of the soluble 
amino acids, Lys and a spacer consisting of Gly units and is self-cleavable during NCL. 
Consisting of eight amino acids this tag is rather big and could be decreased in size to prevent 
sterical hindrance during NCL. There are numerous examples for alternative solubility tags in 
literature. To point out one of a very recent idea to incorporate a solubility tag is the method 
introduced by Brailsford et al. making use of the orthogonal Acm protection group. With the 
addition of several arginine groups to its acetyl group, they generated a novel solubility tag, 
AcmR, that is only cleaved off, when mild reducing conditions are used in an additional 
step.202 This would make the solubility tag stable throughout NCL. 
Focusing on improving NCL conditions, we evaluated addition of two organic solvents, HFIP 
and TFE with the latter in two concentrations (1/3 TFE and 2/3 TFE). Recently, the 
replacement of solvents by ionic liquids has been studied by Baumruck et al. in our lab and 
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may represent an interesting new approach and alternative to the aforementioned organic 
solvents.203,204 Another interesting proposal to facilitate NCL emerged in recent years with the 
ever-growing corporation between chemistry and biology. Amide bond formation is performed 
by ligases in living systems, leading to the idea to make use of these enzymes to fuse several 
protein fragments to their native sequence. A recent summary by Schmidt et al. highlight the 
possibilities.205  
 
Figure 50. Optimized synthesis strategy 
Summary. Various optimization protocols were used during the challenging synthesis of the 
membrane channel KcvNTS. The first attempt in the fully chemical synthesis of the 82-mer 
transmembrane potassium channel protein KcvNTS followed a two-fragment strategy that, 
unfortunately, did not lead to the desired product. Through the high hydrophobicity of the 
peptide fragments, optimization various steps, from synthesis conditions to purification, 
analytics and NCL were needed. The final ligation, following a three-fragment approach, 
resulted in positive results with SDS Page gels showing oligomeric bands at the desired 
masses (see Figure 47 with bands at 10 kDa, 20 kDa, 30 kDa, 40 kDa) and CD spectroscopy 
shows the predminant formation of the alpha-helical structure. Figure 50 summarizes the 
herein presented optimizations of various steps towards successful synthesis of KcvNTS. 
Outlook. Due to the lack of final product material, electrophysiological studies were not 
possible. These will make comparison to behavior of the native KcvNTS possible. Up-scaling of 
the synthesis is needed to generate sufficient amounts of product. Furthermore, when a robust 
synthesis route is evaluated, the integration of isotopically labeled amino acids can make 
NMR experiments possible which will bring structural insights. Additionaly, further mutations 
can then be integrated for functional studies. 
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8. Results and Discussion: Development of a hybrid nanosensor 
8.1. Strategy towards the design of a hybrid nanosensor 
This section focuses on the incorporation of biologically relevant peptides into nanopores of 
solid state material for the generation of hybrid nanopores. These hybrid systems are 
favorable over just biological nanopores or only solid state nanopores because they combine 
the advantages of both systems into one. Biological nanopores show extreme sensitive and 
selective behavior towards targets with atomically precise structures and the possibility to 
synthetically modify the sequences while advantages of solid state nanopores are the 
robustness of the materials towards pH changes, thermal and mechanical stress as well as the 
control of size and shape.206 Combining both structures, unveils endless possibilities for 
extreme sensitive and selective sensing in a robust system that can futher be used for the 
generation of a sensor device. 
As a first example in these studies, a modified Amino-terminal Cu(II) and Ni(II) binding 
motif, ATCUN motif, was chosen as the basic biological structure for this hybrid system. The 
relevance of an applicability of the ATCUN motif as a sensor is presented in 3.4.2. The 
proposed Cu(II) and Ni(II) binding is interesting in regard to using this characteristic for 
development of a sensing hybrid material. 
For this development, the following steps have to be carefully taking into consideration: 
1. Screening for the available ATCUN motifs in literature 
2. Design of a peptide structure that can be covalently coupled to the solid-state material 
3. Synthesis and characterization of the ATCUN peptides 
4. Investigation of binding properties towards Cu(II), Ni(II) and Zn(II) 
5. Immobilization of the peptide to the solid support 
6. Characterization of the hybrid material 
 
Figure 51. Design towards the bio-inspired sensing peptide sensor 
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(1) The ATCUN motif consists of a minimum of three amino acids with histidine being 
mandatory in the third position while the first and second amino can be any arbitrary moiety. 
The simpliest structure generated from the general sequence Xaa-Yaa-His is Gly-Gly-His.207 
Numerous examples for variations of this ATCUN-motif sequences are described in literature. 
The integration of unnatural amino acids through SPPS makes various applications possible. 
Inserting isotopically labeled, 15N amino acids enable structural investigations in regard to 
complex formation.208 Moieties, such as β-amino acids facilitate the addition of e.g. 
fluorophores for visualization of a binding event. The 2,3-diaminopropionic acid, Dap, is 
widely used for addition of fluorophores.99,209,210 We evaluated 5/6-Carboxyfluoresceine, 
5/6-FAM, to be an interesting moiety to be integrated due to the straight-forward insertion 
into the sequence through SPPS. 
(2) For the generation of a hybrid device, both systems, the biological sensing peptide 4 and 
the solid state nanopores, need to be compatible in regard to the covalent coupling. The 
peptide has to be attached from either N-terminus, C-terminus or from integrated side-chains 
to the solid state material while the sensing ability has to be guaranteed after immobilization. 
Attachment from the C-terminus was evaluated to be optimal for our system due to primary 
amines from side chains that could interfere with coupling from the N-terminus. To guarantee 
full functionality of the sensing characteristics of the peptide, a spacer is needed to generate 
distance from the nanopore surface to the sensing unit of the peptide. Ganesh et al. 
investigated several spacer lengths (from O(CH2) 4 to O(CH2)8) on a glycosly acceptor coming 
to the conclusion that a longer spacer will increase reactivity and mimic solution-phase 
environments.211 While iterative amino acids, e.g several Gly-units, are possible spacers 
compatible with SPPS, we aimed for using the spacer to also enhance the characteristics of 
our peptide sequence. Torrado et al. used two serine units within their peptide sequence as a 
spacer and to improve water solubility. We evaluated a PEG unit (miniPEG4) to fulfill our 
requirements since it improves the overall hydrophilic nature.212  
(3) Having determined the sequence and important features of the sensing peptide, synthesis, 
purification and analytics are needed. Peptide synthesis following the fmoc-based SPPS 
protocol is employed. Therefore, the linker and fluorophore need to be evaluated to be 
compatible with fmoc-SPPS.  
(4) The binding characteristics towards Cu(II), Ni(II) and Zn(II) have to be determined and 
compared. Especially in regard to selectivity, it has to be carfully investigated and determined 
at which conditions Cu(II) or Ni(II) are favored over one another. Our sensor design is based 
on the work of Imperiali work and stated to be selective towards Cu(II) due to the integration 
of the β-amino acid, Dap.99 This statement has to be reviewed in experiments and proven as 
correct or incorrect. Furthermore, quenching of fluorescence with addition of Cu(II), Ni(II) 
and Zn(II) needs to be evaluated and characterized. 
(5) For the immobilization, various protocols are available. Cu-free click-chemsitry,213 cysteine 
to gold coupling214 and EDC/NHS immobilization215 are methods frequently used, just to 
name a few. With expertise in SPPS, we decided to try using HATU/DIEA for immobilization 
and to compare success over the EDC/NHS method, which was also applicable to our need. 
Therefore, a blank foil needs to be investigated in regard to stability towards DMF for 
HAUT/DIEA immobilization. 
(6) The characterization of the hybrid material comprises several analytical methods that are 
needed. First, the requirements of the system need to be defined. For us, the selectivity and 
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sensitivity towards Cu(II), the robustness of the system in regard to overall stability and 
storage time, as well as the re-usability of the system are of great importance. I-V 
measurements are a method applicable to investigate all of these requirements. To underline 
and verify results from I-V investigations, further analytical methods need to be performed. 
Due to the integration of a fluorescent moiety, fluorescence microscopy can be applied, 
especially in regard to show the re-usability and feasability of the system.  
A scheme of the immobilization of the sensing peptide and the function of the sensor is 
illustrated in Figure 52. 
(a) 
 
(b) 
 
Figure 52. Scheme and sensor idea 
The magnifying glass in (a) shows the cut-out of one nanopore within the PET foil that has already been prepared 
to exhibit a –NH2 group for coupling of the peptide. In (b) a heavy metal is added and the peptide 1 coordinates 
the heavy metal ion M2+ 
 
We synthesized four peptides, all exhibiting the miniPEG linker for immobilization. Peptide 4 
carries the fluorophore, 5/6-FAM for visualization of the binding event. The sequence of 
peptide 1 is similar to peptide 4 but lacks the fluorescent moiety.. To gain further insight into 
the coordination behavior emanating from the amine groups within our motif, we designed 
two mutants. Instead of the crucial histidine moiety in the third position, we inserted alanine, 
peptide 2 and aspartic acid, peptide 3, and evaluated the binding behavior in solution. 
 
8.2. Synthesis of ATCUN-like peptides 
The ATCUN-like peptides (1 – 4) were synthesized as described in 5.2. The general structure 
is shown in Figure 53 and varies in positions R and R2. Based on the described motif by 
Torrado et al. Xn-(Dns)-βAla-His-Ser-Ser-NH2 (with X1 = L-β-aminoalanine (Baa), X2 = L-(α,ɣ-
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diaminobutyric acid (Amb) or X3 = L-ornithine (Orn)99 we designed our peptide 4 
incorporation a linker and fluorescent moiety. We determined this motif to be ideal for our 
experiment since they were able to shift the binding behavior towards Cu(II) binding. Table 
29 gives an overview of the sequences and molecular formulas as well as molecular weights.  
 
Figure 53. Structures of peptides 1 - 4  
 
Name within 
text 
Rest 
Molecular 
formula 
Calculated 
[M+H+]+ 
Measured [M+ 
H+]+ 
Peptide 1 
R = His 
R2 = CH3 
C25H43N7O10 602.31 602.31 
Peptide 2 
R = Ala 
R2 = CH3 
C22H41N5O10 536.29 536.29 
Peptide 3 
R = Asp 
R2 = CH3 
C23H41N5O12 580.28 580.28 
Peptide 4 
R = His 
R2 = 5/6-
FAM 
C44H51N7O15 918.35 918.34 
Table 29. Overview of peptides 1 - 4 
During synthesis the efficiency of coupling is monitored with UV-Vis control of the 
deprotected Fmoc values (Table 20). While loading reaches 92% of the initial value for 
peptide 4 prior to coupling of the fluorophore, final loading of peptides 2-4 are within 
50 - 60% of the initial loading. The decrease of the coupling efficiency from peptide 4 to 
peptide 3 illustrates the loss in loading throughout storage of the Cl-Trt resin. 
After successful synthesis, the crude product is analyzed using RP-HPLC. The resulting peaks 
can be collected from the analytical RP-HPLC method, freeze dried and evaluated using 
ESI-MS.  
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Confirmation of the molecular masses of peptide 1 - 4 were given measuring the samples from 
RP-HPLC using ESI-MS (for detail see Table 29). 
 
Figure 54. RP-HPLC and ESI MS of peptide 1 and peptide 2 
(a) RP-HPLC of the crude product with insert showing purified peptide 1 at a retention time of 11.6 minutes and 
the respective ESI MS spectra (b) with isotopic pattern of sample and simulated pattern. RP-HPLC conditions: 
isocratic flow of 5% over 5 minutes followed by a linear gradient 5%- 40% eluent B over 20 minutes total with a 
flow of 1 ml/min, MultoHigh 100 RP 18 column at 30 °C. (c) RP-HPLC of the crude product with insert showing 
purified peptide 2 at a retention time of 12.2 minutes and the respective ESI MS spectra (d) with isotopic pattern of 
sample and simulated pattern. RP-HPLC conditions: isocratic flow of 5% over 5 minutes followed by a linear 
gradient 5%- 40% eluent B over 20 minutes total with a flow of 1 ml/min, MultoHigh 100 RP 18 column at 30 °C. 
*the peak at 8 minutes is generated through a change in pressure changing from the isocratic method to a linear 
gradient 
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Figure 55. RP-HPLC and ESI MS of peptide 3 and peptide 4 
(a) RP-HPLC of the crude product with insert showing purified peptide 3 at a retention time of 12.0 minutes and 
the respective ESI MS spectra (b) with isotopic pattern of sample and simulated pattern. RP-HPLC conditions: 
isocratic flow of 5% over 5 minutes followed by a linear gradient 5%- 40% eluent B over 20 minutes total with a 
flow of 1 ml/min, MultoHigh 100 RP 18 column at 30 °C. *the peak at 8 minutes is generated through a change in 
pressure changing from the isocratic method to a linear gradient. (c) RP-HPLC of the crude product with insert 
showing purified peptide 4 at a retention time of 12.1 minutes and the respective ESI MS spectra (d) with isotopic 
pattern of sample and simulated pattern. RP-HPLC conditions: linear gradient of 5% - 40% eluent B over 20 minutes 
with a flow of 1 ml/min, Waters® symmetryTM C18  
 
Through the integrated photo-diode array detector, PDA, the correct peak of peptide 4, 
exhibiting the fluorescent moiety, was readily identified using 214 nm for amide bond 
absorbance and 494 nm for 5/6-FAM absorbance. The correct mass was confirmed by ESI-MS. 
RP-HPLC and ESI MS are implemented and widely used analytical methods but give little 
information of the actual pureness of the compound. Impurities, especially salts, are usually 
not visible in both methods but are a major pollutant. It is relevant to determine the actual 
mass of the peptide for further characterization of the complexation towards heavy metal 
ions. NMR spectroscopy (see 5.2.4) and amino acid analysis (AAA, see 5.2.3), both coupled to 
RP-HPLC, were applied. 
To determine the content of the ATCUN-like peptides via NMR spectroscopy, a concentration-
dependent calibration of N-acetyl alanine was used as an external standard. Afterwards, 
concentration-dependent RP-HPLC chromatograms were recorded using the stock solution of 
each peptide. The content of peptide 1 was calculated to be 67.7%, peptide 2 to be 73.4% and 
peptide 3 to be 77.3%. Correct weighing of peptide 4 was not possible due to little product 
formation. Therefore, NMR spectroscopy measurements were performed without a calculated 
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concentration. The concentration determined from NMR spectrosocopy and calibration using 
RP-HPLC for peptide 4 was 0.55 mM for the established stock solution. For RP-HPLC 
chromatograms and calibrations see Figure 18 - Figure 17. 
 
Concentration 
calculated (mM) 
Concentration determined 
via NMR (mM) 
Content determined 
via NMR (%) 
Peptide 1 3.78 2.56 67.7  
Peptide 2 4.24 3.11 73.4 
Peptide 3 3.92 3.03 77.3 
Table 30. NMR spectroscopy for content determination 
The content of peptide 4 was evaluated using a further method, amino acid analysis with a 
known concentration of the peptide. The protocol described in 5.2.3 is applied resulting in a 
final content value of 67%. Interestingly, the evaluated content range between 67% and 77%, 
meaning that around 30% of the measured weight using an analytical scale, correspond to 
impurities, especially salts. 
 
8.3. Determination of binding affinity by UV-Vis and fluorescence spectroscopy 
8.3.1. pH-dependent binding of metal ions to peptide 1 
To determine the optimal pH value for the coordination of copper ions, peptide 1 was used in 
the following pH titration experiment, which lacks the fluorophore 5/6-FAM, due to the 
fluorophore absoption interfering with the absorption of the peptide-metal complex (see SI 
Figure 27). Formation of the complex with a dilavent metal ion, M2+, is illustrated in Figure 
56. 
 
Figure 56. Complex formation 
The addition of 1 equivalent of Cu(II) ions and Ni(II) ions to peptide 1 results in an 
absorption maximum at 550 nm for Cu(II) and 450 nm for Ni(II) seen in Figure 57a.  
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Figure 57. UV VIS spectra of peptide 1 with copper 
and nickel 
(a) shows absorption spectra at optimal pH values 
and with addition of 1 equivalent heavy metal, Cu(II) 
and Ni(II); green: addition of 1 equ. Cu(II) to 1 mM 
peptide 1 in water at pH 8; blue: addition of 1 equ. 
Ni(II) to 1 mM peptide 1 in water at pH 10.55.  
 
 
Throughout the titration the pH is steadily increased with the solution containing 
peptide-Cu(II) and peptide-Ni(II) in one molar equivalent, respectively. Efficient Cu2+ binding 
to peptide 1 occurrs at pH values greater pH 5 rising to a maximum of complex formation at 
pH 9 indicatd by a plateau (Figure 58a). Looking at the absorption maximum of the spectra at 
each pH value, we see a shift from λ 800 nm at low pH values, where no adequate 
coordination can be found, to a stable maximum around λ 550 nm from pH 5.5 on to pH 11 
(Figure 58b). A maximum at λ 800 nm and low pH values indicates the existence of an aqua 
complex.216 With raising the pH, peptide 1-Cu(II) complex formation enhances thus making a 
d-d transition band at λ 550 nm visible. This is expected giving that ATCUN peptides form a 
1:1 square-planar complex with the N4 donor atom set.216,217  
Next, pH-dependent Ni(II) binding to peptide 1 is investigated. Form the presented results 
(Figure 58a) the peptide 1-Ni(II) complex requires pH values to be above pH 7 to see 
absorption of the complex. Rising steadily, a pH value of > pH 10 is needed to give complete 
complexation. With an increasing pH the absorption maximum shifts to longer wavelengths 
(Figure 58b) with a presice turning point at pH 7 from λ 400 to λ 460. This shift is generated 
from the d-d transition band of the square planar peptide-nickel complex.216 
 
 
Figure 58. pH dependent Cu(II) and Ni(II) coordination to peptide 1 
SI Figure 28 shows the complete spectra of the extracted points presented in SI Figure 28. 
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Determination of peptide 1-Cu(II) and –Ni(II) binding behavior at 100% complex 
formation 
To further characterize the behavior of peptide 1 towards Cu(II) and Ni(II) ions, the binding 
constants towards these ions are determined from titration experiments at pH values where 
the complex is completely formed. They can be evaluated from Figure 58b for the λmax of 
around 550 nm for peptid 1-Cu(II) and 450 nm peptide 1-Ni(II) according to Neupane et al.216 
In Figure 58a these values for 100% complex formation are indicated with dashed lines (blue 
for Cu2+ and green for Ni2+). Due to the MES buffer system not being suitable for the basic 
conditions, Tris buffer was chosen. It is frequently used for UV-Vis titration experiments in 
biological sytems and displays a buffer capacity of pH 7.5 – 9.0.218  
The peptide 1-Cu(II) complex is completly formed at pH values > 8. Therefore, titration 
experiments were conducted according to 5.2.5.2. With the addition of Cu(II) ions, the 
absorption at λmax 561 nm rises (SI Figure 11a) and reaches molar extinction coefficients of 
around 80 mol-1 × cm-1. These findings are in good correlation to literature where Neupane et 
al. investigated the 1:1 stoichiometry of linear ATCUN motifs in the range of 530 – 545 nm216 
while Gajda et al. determined the square planar complex to be generated at λ 525 nm in the 
pH range of pH 5-10 for the peptide GGHA.217  
In Figure 58b, the dominant peptide 1-Ni(II) complex is appointed to wavelengths of around 
λ 440 nm – 460 nm starting from pH > 7 with complete complex formation at pH 
values > 10. Therefore, titration experiments were conducted according to 5.2.5.2. With this 
addition of Ni(II) ions, the absorption at λmax 458 nm rises (SI Figure 12a). Adding more than 
1 molar equivalent of Ni(II) ions to the peptide solution results in no further increase in the 
absoption an the molar extinction coefficient (SI Figure 12b). This behavior can be seen in 
complexes that are formed in a 1:1 fashion, like the ATCUN complexes are described in 
literature.216  
With UV-Vis titration experiments indicating the 1:1 binding behavior, we investigated 
solutions of peptide1-Cu(II) and –Ni(II) (in PBS buffer pH 7.4) in LC-MS experiments. SI 
Figure 20 shows peptide 1-Cu(II) binding and SI Figure 24 peptide 1-Ni(II) binding and 
therefore confirm results from UV-Vis experiments. 
 
Binding behavior of peptide 1 towards Cu(II)/Ni(II) and Zn(II) at pH 6.5 
Having in mind the design of a selective copper sensor within a complex system, the pH value 
can be adjusted to a selective predominant complexation of Cu(II) ions at pH 6.5. This pH is 
indicated with a black dashed line in Figure 58 and correlates to the pH50 value for peptide 
1-Cu(II) whereas binding to Ni(II) is insignificant. Therefore, a buffer within that range was 
selected. MES buffer is listed as a Good’s buffer thus displays advantageous characteristics for 
metal titration experiments. Given its structure, the tertiary amine is sterically hindered and 
thereby not able to coordinate metal ions (SI Figure 29).219 With a pKa of 6.15220 the buffer 
capacity at pH 6.5 is within a good range.  
With a λmax of 551 nm the peptide 1-Cu(II) complex is formed reaching a plateau at an 
extinction coefficient of 60 mol-1 × cm-1. The dominant species at 551 nm is present from 
pH 5.5 on (see Figure 58b) and can be attributed to the 1:1 square planar complex. Figure 
59b shows an approximation to the plateau area at a little over 0.6 equivalents of Cu(II) 
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added to the peptide 1 solution. With pH 6.5 being slightly over the pH50 range, >50 % of 
possible complexes are formed, verified by these findings.  
 
Figure 59. UV VIS titration of Cu(II) to peptide 1 in MES buffer at pH 6.5 
UV-VIS titration experiments of peptide 1 (1 mM peptide, in MES buffer pH 6.5). (a) Increase in absorption upon 
addition of 0.1 equivalents Cu(II) (CuSO4, in water), wavelengths of 450 - 800 nm. (b) Extinction coefficient of the 
peptide 1-Cu(II) complex vs. equivalents of Cu(II) added. 
According to Figure 58 insignificant binding of Ni(II) ions is observed at pH 6.5. Therefore, no 
saturation in Ni(II) binding can be reached conducting the titration experiment at pH 6.5 with 
λmax of only 393 nm (SI Figure 13). Adding 20 equivalents of Ni(II) ions to the peptide 
solution does not result in the ATCUN-like absorption maximum of λ 425 nm – 450 nm 
determined in literature.216,217  
Certifying selective Cu(II) binding to peptide 1 at pH 6.5, the binding towards Zn(II) ions was 
investigated using UV-Vis titration experiments. Figure 60 shows that there is no significant 
rising of the Amax upon addition of increasing Zn(II) concentrations. Figure 60b shows the  
negligible increase at λ 584. Comparing the rise in absorption values at the λ of complex 
coordination of peptide 1-Cu(II)/-Ni(II) and -Zn(II), it becomes visible that at pH 6.5 is 
extremely selective towards Cu(II) in comparison to Ni(II) and that there is no binding of 
Zn(II) (see Figure 60). 
 
 
Figure 60. UV-Vis titration of Zn(II) to peptide 1 
(a) Change in absorption at λ 584 of peptide 1 solution (1 mM, MES buffer pH 6.5) upon addition of Zn(II) (0.1 M 
ZnSO4, in water) with (b) comparison of the addition of 1 equivalent Cu(II), Ni(II) and Zn(II) to peptide 1 at pH 6.5  
To determine the binding behavior from UV-Vis experiments, binding constants are calculated 
using the Benesi Hildebrand plot according to Tietze et al.221  
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First, binding constants at pH 6.5 illustrate the insufficient binding towards Ni(II) with a 
logK(Ni) of 2.76. With the logK(Cu) being at 6.57, selective binding towards Cu(II) is verified 
and comparable to other ATCUN based Cu(II)-sensor systems.222 Kulprachakarn et al. 
investigated Cu(II) binding to Hepcidin (Asp-Thr-His) to be logK = 7.7 showing a similar 
result. 
Comparing the findings to the titration data at pH 6.5, we see a significant rise in binding 
constants for the peptide 1-Ni(II) complex from K = 5.8 × 102 l × mol-1 to 2.5 × 107 l × mol-1 at 
pH 8. Furthermore, the λmax 458 at pH 10.55 indicates the ATCUN-like complex formation. 
For peptide 1-Cu(II) binding, no improvement in binding was evaluated with binding 
constants being within the same range of 3.8 × 106 l × mol-1 at pH 6.5 and 9.8 × 105 l × mol-1 at 
pH 8. These findings indicate that the buffer system affects binding constants.223 Therfore, 
UV-Vis titration experiments for calculation of the binding constants for and characterization 
of peptide 2 and 3-Cu(II)/-Ni(II) complexes were conducted in Tris buffer.  
 
Species Heavy metal pH K (l × M-1) logK Ʌmax, buffer 
Peptide 1 
Cu(II) 6.5 3.8 × 106 6.57 551 
Ni(II) 6.5 5.8 × 102 2.76 393 
Peptide 1 
Cu(II) 8.0 9.8 × 105 5.99 561 
Ni(II) 10.55 2.5 × 107 7.39 458 
Peptide 2 
Cu(II) 10.55 1.7 × 105 5.23 501 
Ni(II) 10.55 3.1 × 105 5.50 436 
Peptide 3 
Cu(II) 8.0 1.2 × 105 5.08 584 
Ni(II) 10.55 1.3 × 105 5.12 441 
Table 31. Binding constants for peptide 1 – 4-Cu(II) and –Ni(II) complexes 
 
8.3.2. pH-dependent binding of metal ions to non-His containing peptides 2 and 3 
The presented binding constants of the non-His containing peptides 2 and 3, show that there 
is a efficient Cu(II) and Ni(II) binding that is comparable to the His-containing ATCUN motif 
peptide 1. The ATCUN motif is composed of the Xaa-Xbb-His sequence (Xaa and Xbb = 
variable amino acid) and, as stated in literature, His in the third position, is mandatory for the 
motif and the resulting 1:1 square planar complex formed with Cu(II) and Ni(II) ions.12 
Neupane et al. investigated the behavior of ATCUN mutants lacking this motif coming to the 
conclusion, that when converting His to Asp or when stabilizing the peptide structure through 
macrocyclizaiton, ATCUN-like complexes are formed even with His being absent.224  
pH-dependent binding of metal ions to peptide 2 and 4 
Figure 61 shows all obtained pH dependent titration experiment data, including peptide 1 for 
comparison of determined values. The addition of Cu(II) ions to peptide 2 and peptide 3 
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results in the generation of a λmax of 504 for peptide 2-Cu(II) with a pH value of pH > 10 for 
optimal complex formation and λmax of 563 for peptide 3-Cu(II) with a pH value of 8 for 
optimal complex formation. Comparing the values to peptide 1, the 1:1 square planar ATCUN-
like complex of peptide 1-Cu(II) is formed exhibiting a λmax of 537 with optimal complex 
formation at pH 8. Comparing titration curve progressions, peptide 3 and peptide 1 show 
comparable behavior towards complex formation at the corresponing pH values while 
peptide 2 shows different behavior displaying a very gradual formation of the complex (Figure 
61a).  
All three peptides display a shift from the Cu(II) aqua complex at 800 nm to the 
peptide-Cu(II) complex through a d-d transition. Peptide 2, again, shows a different behavior, 
exhibiting two absorption maxima at λmax of 625 from pH 5 – 7.5 and a shift to a λmax of 492 
with further increasing of the pH. While peptide 1, the original ATCUN motif, uses the 
imidazole moiety of the histidine as the side chain ligand, peptide 3 uses the carboxyl group, 
both resulting in the formation of the ATCUN-like complex.216 Peptide 2, exhibiting only an 
Alanine, must use an additional backbone amide to form the 1:1 square planar complex. The 
absorption maximum at λmax of 625, which represents a second absorption maximum of 
peptide 2 can, most likely, be appionted to a different protonation state (Figure 61b). 
 
Figure 61. UV-Vis pH studies of peptide 1 – 3-Cu(II) complexes 
Behavior of peptides 1 – 3 (1 mM peptide 1, 2 mM peptides 2 and 3) using 1 equ. of Cu(II) (CuSO4, in water) 
towards different pH values in regard to complex formation  
Towards Ni(II), all peptides show similar behavior with peptide –Ni(II) complex formation at 
pH values > 10 (Figure 62a). In regard to complex formation, similar λmax are determined 
from pH titration experiments. Peptide 1-Ni(II) shows λmax at 438 nm, peptide 2-Ni(II) an λmax 
at 455 nm and peptide 3-Ni(II) at λmax at 440. As stated in 8.3, a λ between 425 nm – 450 nm 
is determined for ATCUN-Ni(II) complexes in literature.216,217 Therefore, Ni(II)-coordination is 
most likely formed on basis of ATCUN-like complex formation for all three peptides, peptide 
1-3. Identical binding behavior was found by Neupane et al. describing a discrete, two-state 
transition form a Ni(II)-aqua complex to a species exhibiting d-d transition bands at 440 nm. 
Additionaly, they evaluated no evidence for multiple species at any investigated pH value for 
the ATCUN mutants GGCL and GGML.224 
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Figure 62 UV-Vis pH studies of peptides 1 – 3-Ni(II) complexes 
Behavior of peptides 1 – 3 (1 mM peptide 1, 2 mM peptides 2 and 3) using 1 equ. of Ni(II) (NiSO4, in water) 
towards different pH values in regard to complex formation  
In a comparative study, Appleton et al. investigated binding of Cu(II) to HSA and dog serum 
albumin, DSA. DSA does not exhibit the ATCUN motif with a N-terminal sequence of Glu-Ala-
Tyr and thus binds Cu(II) in a different manner. They evaluated the Cu(II) binding to the 
ATCUN motif in a 1:1 square planar fashion to be at around 525 nm from pH values of 6.5 
on.225 Looking at Figure 61b we can see that peptide 1 and peptide 3 fulfills these 
requirements showing a rapid blue shift from the aqua complex at λ 800 nm to λ 525 nm at 
pH values of around pH 6. Peptide 2 shows the blue shift at higher pH values around pH 9 
and thus can be compared to the finding of Appleton et al. with DSA, where a shift to around 
515 nm is only reached at pH values of pH 10 while below this pH the λmax oscillated around 
640 nm.225 
 
Determination of peptide 2 and 3-Cu(II) and –Ni(II) binding behavior at 100% complex 
formation 
To evaluate binding constants, UV-Vis titration experiments are performed according to 
peptide 1 using pH values which show efficient complex coordination identified from Figure 
61b for Cu(II) binding and Figure 62b for Ni(II) binding. 
The addition of Cu(II) to peptide 2 leads to an increase in the absorption at a λmax of 501 nm 
at pH 10.55 (SI Figure 16) and Ni(II) to an increase in the absorption at a λmax of 436 nm at 
pH 10.55 (SI Figure 18).  
Peptide 3-Cu(II) complex formation is indicated by the increase of the absorption at a λmax of 
584 nm (SI Figure 17) and binding towards Ni(II) is seen with an increase of the absorption 
at λmax of 441 nm (SI Figure 19). 
In addition, MALDI-TOF MS of the peptide 2 and 3-Cu(II) and –Ni(II) complexes was 
performed, to emphasize the findings from UV-Vis titration experiments. The 1:1 binding of 
peptide 2-Cu(II) and peptide 3-Cu(II) can be found in SI Figure 21, SI Figure 22. Ionization of 
the peptide 3-Ni(II) displayed a challenge. While Peptide 2-Ni(II) was found (SI Figure 25) 
with extreme low intensities, ionization of peptide 3-Ni(II) complex was challenging not 
resulting in a significant spectra. 
 
Binding constants were calculated using the Benesi-Hildebrand method and are summarized 
in Table 31. All non-His containing complexes, peptide 2-Cu(II) and –Ni(II) as well as peptide 
3-Cu(II) and Ni(II) show similar binding constants within the range of K = 1.2 × 105 – 3.1 × 
105  l × M-1. Comparing all binding constants of peptides 1-3 at the pH values for complete 
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complex formation, we can identify a preference towards Ni(II)-binding, especially 
pronounced for peptide 1-Ni(II) binding with a logK(Ni) of 7.39 compared to logK(Cu) 5.99. 
 
8.3.3. pH-dependent binding of metal ions to peptide 4 
To visualize the binding event, we integrated a fluorescent moiety into the structure of 
peptide 1. 5/6-FAM is coupled at the N-terminus, R2 (Figure 53) leading to synthesis of 
peptide 4. Torrado et al. were one of the first to integrate a fluorescent moiety, 
5-(dimethylamino)naphthalene-1-sulfonamide (Dns) into an ATCUN motif and determined 
fluorescence quenching of 93% for Cu(II) and 65% for Ni(II) ions.99 Fluoresence quenching is 
a process that decreases the fluorescence intensity of a fluorophore with addition of a 
quencher due to molecular interactions.226 Two types of quenching are possible: dynamic and 
static quenching. While dynamic quenching is caused by a molecular collision, static 
quenching results from the forming of a non-fluorescent complex with addition of the 
quencer.227 To observe formation of peptide 4-Cu(II) and peptide 4-Ni(II) complex, quenching 
of fluorescence of the 5/6-FAM unit through heavy-metal ion addition is monitored (see 
Figure 63). 
 
Figure 63.Quenching of fluorescence of peptide 4 
 
Literature data describes excitation of 5/6-FAM to be at λ 494 nm and emission at 519 nm.228 
We evaluated the optimal emission and excitation to be λex 494 and emission λem 518 nm 
(Figure 64) with no interference of the MES buffer system (SI Figure 30). 
 
Figure 64. Determination of excitation and emission wavelength 
(a) Peptide 4 (1 µM in MES buffer pH 6.5) fluorescence spectra showing emission resulting from different excitation 
wavelengths (490 – 498 nm) with insert showing magnification. (b) Emission and excitation at λEm 518 and 
λEx 494 nm.  
ON 
 
OFF 
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Additionaly, to ensure the non-binding behavior of the fluoresceine unit itself, it was 
subjected to titration experiments with Cu(II). As seen in SI Figure 31, even after addition of 
40 equivalents of Cu(II) ions to the 5/6-FAM solution, no difference in the spectrum can be 
determined. This titration confirmes no binding of Cu2+ to the fluorophore. After 
determination of the experiment set-up, fluorescence quenching of peptide 4-Cu(II) and 
peptide 4-Ni(II) complexes was investigated with fluorescence titration.  
 
Determination of binding behavior of peptide 4-Cu(II) and -Ni(II) at 100% complex 
formation 
Analogous to the UV-VIS studies, investigation of the optimal pH was conducted. Peptide 
4-Cu(II) binding is investigated at pH 8 in PBS buffer. Tris buffer was not feasible due to high 
absorption of the buffer itself during fluorescence titration experiments. The formation of the 
peptide 4-Cu(II) complex is indicated by decrease of fluorescence intensity of λmax 518 nm 
from 963 to 95 using 1.5 equivalents of Cu(II) ions (SI Figure 32). This represents a final 
quenching of 90%. Compared to findings from pH 6.5 (88% quenching with addition of 20 
equivalents Cu2+), pH 8 is superior due to less molar equivalents of Cu(II) needed to quench 
around 90% of fluorescence. 
The Good’s buffer CAPS was chosen for pH 10.55 measurements, displaying the least 
interference with the absorption spectra of buffers tested. Peptide 4-Ni(II) complex formation 
is indicated by the decrease of fluorescence intensity at λmax 518 nm from 997 to 261 with a 
final quenching of 76% (SI Figure 33). After addition of 0.9 equivalent of Ni(II) ions, a plateau is 
reached. This behavior was also evaluated during UV-Vis titration experiments at pH 10.55 
with peptide 1-Ni(II) and described with the formation of the 1:1 peptide-Ni(II) complex. 
 
Determination of binding behavior of peptide 4- Cu(II), -Zn(II) and Ni(II) at pH 6.5 
 
In correspondence to the investigation of peptide 1-Cu(II) and Ni(II) binding at pH 6.5 
experiments towards peptide 4 were undertaken at this pH regarding the sensor application. 
Upon addition of Cu(II) ions, quenching of fluorescence from fluorescence intensities of 920 
at λmax 518 nm to intensities of 114 after addition of 20 equivalents of Cu(II) is investigated. 
This represents a quenching of 88% in total. The change influorescence intensity ∆F (F0-F) 
comes to a plateau beginning at >10 equivalents Cu(II) added(Figure 65a-b). Furthermore, 
addition of more than 20 equivalents of Cu2+ does not result in a significant change of the 
fluorescence intensity. These findings can be compared to literature where Pearce et al. 
determined a 40% quenching caused by ten equivalents of Cu(II) to an ATCUN motif, 
Dap(LR)-Asp-His-Dap(DE)-Ser-Ser-CONH2 containing a rhodamine (LR) and coumarin (DE) 
fluorophores (in 50 mM HEPES buffer pH 7.0).209 
The behavior towards Ni(II) ions was investigated accordingly. The formation of the peptide 
4-Ni(II) complex results in quenching with an decrease of fluorescence intensities at 
λmax 518 nm from 894 to 509 after addition of 1360 equivalents of Ni(II) ions representing a 
total quenching of 43%. Futher addition of Ni2+ does not result in a significant decrease of 
fluorescence intensities (Figure 65c-d).  
Comparing these values to Cu(II) binding and the generation of peptide 4-Cu(II) complex, 
43% quenching is reached with addition of only 6 equivalents of Cu2+. These findings affirm 
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findings from titration studies. The pH value of 6.5 is not suited for Ni(II) coordination while 
Cu(II)-binding is selective and sensitive. 
Additionally, binding of another bivalent heavy metal was investigated. The addition of 73 
equivalents of Zn(II) to peptide 4 results in a decrease of fluorescence intensity of 4% and can 
therefore be neglected (Figure 65e-f). 
The negligible binding of Zn(II) to peptide 4 can be compared to peptide 1-Zn(II) binding 
(5.2.5.2). 
 
 
Figure 65. Fluorescence titration of Cu(II) to peptide 4 in MES buffer pH 6.5 
Fluorescence titration experiment of peptide 4 (1 µM, in MES buffer pH 6.5). (a) decrease of fluorescence intensity 
upon the addition of Cu(II) to the peptide solution (b) change in fluorescence intensity vs. Cu(II) equivalents added 
to the peptide solution (c) decrease in fluorescence intensity upon the addition of Ni(II) to the peptide solution (d) 
change in fluorescence intensity vs. Ni(II) equivalents added to the peptide solution. (e) insignificant decrease in 
fluorescence intensity upon addition of Zn(II) to the peptide solution (f) change in fluorescence intensity vs. Zn(II) 
equivalents added to the peptide solution. 
From obtained fluorescence quenching data the binding constants and quenching behavior are 
determined using the Stern-Volmer plot (see 5.2.8) according to to Li et al.229. In literature, 
the property of Cu(II) or Ni(II) ions to quench the fluorescence signal upon binding can be 
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described as a static quenching process due to formation of a non-fluorescent complex.226 SI 
Figure 34 shows plotting of peptide 4-Cu(II) and SI Figure 35 the Ni(II) data. 
To evaluate a 1:1 binding, LC-MS experiments were conducted, verifying this binding 
behavior (SI Figure 23 and SI Figure 26). 
Due to the demonstrated applicability of pH 6.5 to selectively bind Cu(II), the limit of 
detection (LOD) towards Cu(II) and Ni(II) was determined using fluorescence titration 
experiments. The limit of detection, LOD, is a value that gives information on the lowest point 
at which the used analytical approach is feasible while the limit of quantitation, LOQ 
describes a value at which the measurement works with high confidence.230 For our sensor 
system, both values, the LOD and LOQ, are determined to characterize the sensibility and 
selectivity. Therefore, mearusements are conducted in MES buffer pH 6.5 following the 
protocol described in 5.2.9. The LOD for peptide 4-Cu(II) is calculated to be 13.5 nM and for 
peptide 4-Ni(II) 0.23 µM. Changing the value 3.3 in Equation 11 to the value 10 will result in 
the calculation of the LOQ which is 40.91 nM for peptide 4-Cu(II) and 0.71 µM for peptide 
4-Ni(II). These values show extreme sensitivity towards Cu(II) with less sensitivity towards 
Ni(II).  
The Stern-Volmer plots were applied for determination of quenching rates and binding 
constants of peptide 4-Cu(II) and peptide 4-Ni(II) and can be found in the supporting 
information (SI Figure 36 and SI Figure 37). Table 32 displays the calculated values. 
Comparing values of peptide 4-Cu(II) and peptide 4-Cu(II) fluorescence titration experiments 
at pH 6.5 and pH 8.0 has to be done carefully due to different buffer systems used. It can be 
determined that there is a significant increase in the logK values towards Cu(II) as well as 
Ni(II) for peptide 4-Cu(II) at pH 6.5 from logK 6.8 to 9.3 and for peptide 4-Ni(II) from 
logK 3.26 to 11.79. Haas et al. investigated copper transport proteins (Ctr, ATCUN sequence 
Met-Asp-His) and mutants to exhibit binding constants towards Cu(II) of logK 11.0 +/- 0.3.231 
Studies of Neupane et al. reassure the determined binding constans. They evaluated binding 
constants to exhibit values of at least 108 M-1.224 
The calculated binding constant and logK for the coordination of peptide 4-Ni(II) at pH 6.5 
are in concordance to UV-Vis titration data of peptide 1-Ni(II). The pH is not suited for 
formation of the Ni-complex, therefore binding constants are extremely low with peptide 
4-Ni(II) logK 3.26 and peptide 1-Ni(II) logK 2.76. Looking at peptide 4-Cu(II) binding, a 
binding constant with the value of 6.27 × 106  l × M-1 is comparable to chemosensor 
presented by Zheng et al. They introduced a dansylated Gly-Gly-His-Gly ATCUN motif with a 
binding constant towards Cu(II) of K = 3.8 × 106 l × M-1 in phosphate buffer at pH 6.8.232 
Due to the pH dependency of heavy metal coordination, a pH of 6.5 can be used to guarantee 
only efficient Cu(II) binding with negligible Ni(II) binding which shows a successful 
implementation of the idea to generate a selective Cu(II) sensor. Furhtermore, the quenching 
constant of Kq of 1013 M-1s-1 indicates a static quenching process, as assumed (5.2.8). The 
quenching constants for static quenching are comparable to those reported by Crouse et al. 
with Kq for BSA-Ni(II) and BSA-Cu(II) complexes to be within the range of 1012 and 
1013 M-1 s-1.233 The maximum possible quenching behavior is investigated analogous to UV-Vis 
titration experiments increasing the pH to optimal complex formation.  
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 Cu(II) Ni(II) 
 Kq (M-1s-1) K (l × M-1) logK pH Kq (M-1s-1) K (l × M-1) logK pH 
Peptide 4 
2.75 × 1013 6.27 × 106 6.80 6.5 4.9 × 1010  1.8 × 103 3.26 6.5 
5.28 × 1016 2.06 × 109 9.3 8.0 1.19 × 1020 6.1 × 1011 11.79 10.55 
Table 32. Binding constants of peptide 4 towards Cu(II) and Ni(II) 
 
In general, Ni(II)-binding is determined to be more favorable when investigating optimal pH 
values for complex formation with logK(Ni) 7.40 > logK(Cu) 5.99 for peptide 1 and 
logK(Ni) 11.79 > logK(Cu) 9.3 for peptide 4 as well as for the non-His containing mutants. 
Torrado et al. explain preferred Cu(II) binding through modification of the peptide backbone 
with changing the sequence from Baa(Dns)-Gly-His-Ser-Ser to Baa(Dns)-β-Ala-His-Ser-Ser 
(Baa – L-β-aminoalanine)99 and describe this replacement to generate a highly selective 
chemosensor for Cu(II).209 Our sequence, (5/6)FAM-DAP-β-Ala-His-mPEG4 (peptide 4) and 
(5/6)FAM-DAP-β-Ala-His-mPEG4 (peptide 1) was inspired by their work due to the aim of the 
generation of a Cu(II) selective sensor. Looking at our results, the preference for Cu(II) can 
only be obtained from tuning the pH not from the sequence itself. All structures, peptides 1-4 
show preference for Ni(II) ions, not for Cu(II).   
 
8.4. Generation of hybrid nanopores 
After complete characterization of the fluorescently labelled peptide 4 towards Cu(II), Ni(II) 
and Zn(II) at different pH values and in regard to detection limits, immobilization of the 
peptide to the nanopore containing polymer foil are performed. Therefore, polyethylene 
terephthalate, PET, foils were track-etched to reveal conically shaped nanopores according to 
5.3.1. To control successful track-etching, high-resolution field-emission scanning electron 
Microscopy, HR-FT-SEM, is performed. Figure 66 shows images of a track-etched PET foil 
with a pore density of 107 pores / cm2 and a pore diameter of around 200 nm at the base from 
two different angles. While in Figure 66a and b, a top view shows different magnifications of 
the same pores, Figure 66c shows a cross section of the pore geometry. The protocol for 
generation of a cross section is described in 5.3.1.  
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(a) (b) (c) 
   
Figure 66. HR-FT-SEM images of conically shaped track-etched nanopores in PET foils 
(a) Top view of nanopores with a magnification of 20000 × (b) of 50000 × (c) shows a cross section of conically 
shaped nanopores. Fluence 107 pores per cm2. Images were kindly provided by Ivana Duznovic. 
 
In order to immobilize peptide 4, two methods of immobilization were tested. A widely used 
method, intensively described in literature, is the coupling using EDC/NHS herein performed 
according to 5.3.2. Additionaly, we tested an immobilization method using HATU and DIEA. 
For both methods the existence of a primary amine and a carboxylic group containing part is 
essential. The designed peptides, peptide 1 – 4, all exhibit a linker, the PEG-unit, that is 
integrated into the peptide sequence for the immobilization at the C-terminus of the peptide. 
The solid state material, in our case the PET foil, needs to display primary amines (see Figure 
21). No difference between the performance of hybrid foils generated by either method 
emerged. Therefore, the HATU/DIEA is chosen as the standard protocol since it does not 
require pre-activation that is needed for the EDC/NHS preparation. SI Figure 39 shows a PET 
foil with immobilized peptide 4 from the EDC/NHS protocol. 
 
Characterization of hybrid nanopores through Atomic Force Microscopy  
Atomic force microscopy can be applied for high resolution imaging within fractions of 
nanometers and was therefore chosen to investigate the hybrid nanopores. Amplitude 
modulation atomic force microscopy (AM-AFM) is also known as tapping-mode AFM. A stiff 
microlever is excited to (or near) the free resonance frequency and the oscillation amplitude 
used for measurement of topography or phase differences in the sample surface.234 Figure 67 
shows results from AFM measurements of a pore with immobilized peptide 4 (Figure 67c and 
d) and a track-etched blank pore (Figure 67a and b). Images of the topography (Figure 67a 
and c) of the hybrid and blank foil are comparable while images of phase difference (Figure 
67 b and d) show differing behavior. While the phase difference of the pore from the blank 
foil does not show a change of material, in Figure 67d a significant white circular structure 
characterizes the image. This circular region represents the pore opening as seen in the 
topography image (Figure 67c). The white color in the phase difference image illustrates 
areas of soft material and therefore represent the peptide that is bound to the nanopore. 
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Figure 67. AFM of peptide 4 immobilized to conically shaped nanopores 
The top pictures (a) and (b) represent a blank nanopore, no peptide 2oupled to the surface whereas (c) and (d) 
show a pore with peptide 4 coupled. (a) and (c) show the topography of the foils surface and (b) and (d) show the 
change in phase differences. Images generated by Dr. Christian Dietz (TU Darmstadt) 
 
 
8.4.1. Confocal laser scanning microscopy (CLSM) 
The integration of the fluorescent moiety enables visualization of the hybrid nanopores and 
the investigation of the behavior towards heavy metal ions. First, the success of covalent 
binding to the peptide to the nanopores was investigated using CLSM with Wadim Weber (RG 
Prof. Stein, TU Darmstadt) 
 
Figure 68. CLSM of etched area 
Figure 68 shows the brightlight 
and fluorescence image of the 
functionalized PET foil. Here, 
the functionalized part is 
indiacted by green fluorescent 
spots generated from peptide 4 
coupled to the nanopores, 
whereas the unfunctionalized 
zone does not show any 
fluorescence (Figure 68b) but 
pores (Figure 68a). 
This appearance is influenced by the so-called “etching zone”. Only within this area, etching 
with NaOH is conducted (5.3.1) thus only this area exhibits primary amine groups which are 
needed for immobilization of peptide 4. After multiple washing steps with water, no leaking 
of the material was detected, again, indicating covalent binding. 
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Overlaying the brightlight image (Figure 69a) with the fluorescence image (Figure 69b) and 
visualizing the fluorescent areas with green results in Figure 69c. This image shows the 
successful immobilization with the green spots indicating peptide 4 coupled to pores of the 
PET foil. 
 
Figure 69. Brightlight, fluorescence and overlay 
PET foil with conically shaped nanopores with an opening of 300 nm and a tip size of 5 nm under CLSM with an 
emission at 488 nm and excitation between 515 – 530 nm 
The quenching of the fluorescence from immobilized peptide 4 with the addition of Cu(II) is 
investigated. Therefore, a CuSO4 solution is added to the fixated hybrid foil leading to a 
visible decrease in fluorescence intensity. With the addition of EDTA, the fluorescence is 
restored. After washing, the cycle can be repeated. Seven on/off circles are presented in 
Figure 70. Fluorescence intensities are displayed in the bar chart showing the decrease and 
increase of signal from the pore according to Cu(II) or EDTA addition in comparison to a 
reference point that is not influenced by quenching. 
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Figure 70. On-Off behavior of hybrid pore with Cu(II)  
Plotted by Wadim Weber (RG Prof. Stein, TU Darmstadt) 
Next, a titration experiment is implemented to evaluate the sensitivity of immobilized 
peptide 4 towards Cu(II), Ni(II) and Zn(II). With the addition of increasing concentrations of 
Cu(II), a decrease of fluorescence intensity within the pore is investigated (Figure 71a). Using 
according concentrations of Ni(II) towards immobilized peptide 4, no decrease in fluorescence 
intensity is determined. Only an 10 fold increase in Ni(II) concentration results in a detectable 
decrease in fluorescence intensity (Figure 71b). Towards Zn(II), no decrease of fluorescence 
intensity can be detected (Figure 71c). These findings are supported by results from UV-Vis 
and fluorescence titration experiments. At pH 6.5 peptide 4, in solution and immobilized to 
PET foils, displays selectivity towards Cu(II) ions while Ni(II) binding is weak and Zn(II) 
binding not present. A detectable decrease in CLSM measurements of fluorescence intensity 
with addition of Cu(II) requires mikromolar concentrations which indicates a low sensitivity 
of CLSM measurements. 
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 (a) (b) 
 
(c)  
 
Figure 71. Titration using Cu(II), Ni(II) and Zn(II) 
(a) Addition of 10 µM – 100 µM CuSO4 solution in 
100 mM MES buffer pH 6.5 to peptide-coupled solid-
state nanopores (b) addition of 10 – 1000 µM NiSO4 
solution in 100 mM MES buffer pH 6.5 and (c) three-
point titration with buffer – 100 µM ZnSO4 solution in 
100 mM MES buffer pH 6.5 - buffer 
 
 
 
8.4.2. I-V- measurements 
Using current/voltage, I/V measurements (5.3.3.1), the hybrid system of immobilized peptide 
4 to conically shaped nanopores, is investigated in regard to sensor sensitivity towards Cu(II), 
Ni(II) and Zn(II) ions. The set-up is illustrated in Figure 72. 
(a) (b) 
  
Figure 72. Measurement set-up, I/V 
Before the addition of Cu2+ to the electrolyte solution, a rectifying behavior of the pore is 
determined (Figure 73a). For positive voltage polarity, as increase in ion condution is present 
with a decrease for negative voltage polarity leading to an asymmetric I-V curve.235 With the 
addition of Cu(II) a increase of positive current is visible. With formation of the 
peptide 4-Cu(II) complex a positive charge on the pore surface is generated changing the ion 
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transport. While the rectifying condition represents an “off state”, the transport characteristics 
of the pore are switched on with Cu(II) addition. Adding Ni(II) and Zn(II) does not result in a 
change of the rectifying, “off-state” condition (Figure 73a). The successive increase of positive 
current starts with Cu(II) ion concentrations in the femtomolar range (Figure 73b) illustrating 
an extreme sensitivity of I-V measurements. Applying the on-off conditions from microscopy 
experiments, the behavior seen in 8.4.1 is confirmed. The addition of Cu(II) leads to an 
increase in current while addition of EDTA decreases the current to the ground state 
indicating a full reversibility of Cu(II) binding to the immobilized peptide.  
 
(a) (b) 
  
(c)  
 
Figure 73. I-V measurements of hybrid sensor system 
(a) I-V titration response for the system to addition of 
Cu(II), Ni(II) and Zn(II) (b) response for different Cu(II) 
concentrations and (c) on/off re-usability of the sensor 
with Cu(II) and EDTA. Measuring and plotting by Ivana 
Duznovic 
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9. Conclusion and Outlook: Development of a hybrid nanosensor 
At the introduction, six bullet points, that need to be considered for the synthesis and 
establishment of a sensor from scratch, were imposed:  
 
1. Screening for the available ATCUN motifs in literature 
2. Design of a peptide structure that can be covalently coupled to the solid-state material 
3. Synthesis and characterization of the ATCUN peptides 
4. Investigation of binding properties towards Cu(II), Ni(II) and Zn(II) 
5. Immobilization of the peptide to the solid support 
6. Characterization of the hybrid material 
Screening literature, we came across the motif Xn-(Dns)-β-Ala-His-Ser-Ser-NH2 from the lab of 
Imperiali99 (1) and designed a scructure which offered structural components for the 
immobilization to nanopores of PET membranes, 5/6-FAM-DAP-c-His-mPEG4 and variants 
(peptides 1-4) (2). Successful synthesis is done implementing the standard fmoc-SPPS 
protocol, purification using the RP-HPLC technique and characterization of the purified 
product using ESI.MS (3). 
 
(4) First, binding properties of the peptides in solution are characterized. pH titration studies 
revealed optimal Cu(II) and Ni(II) binding to be strongly dependent on the pH value. For 
peptides 1, 2 and 4 a pH of ≥ 8, is sufficient for complete Cu(II) binding with formation of 1:1 
square-planar ATCUN-like complexes. For the binding and coordination of Ni(II), a pH 
of ≥ 10.55 is sufficient for all peptides 1-4. For the non-His containing Peptide 2, the Ala 
mutant, Cu(II) binding is sufficient only at pH values above 10.55. For design of a 
Cu(II)-selective sensor, tuning of the pH is evaluated to be an excellent tool. Therefore, pH 
titration experiments were reconsidered in regard to heavy-metal selectivity. The pH value of 
6.5 was evaluated to be optmimal for this aim. While Ni(II) binding of all peptides is minimal, 
Cu(II) binding is efficient, displaying the pH50 value for peptides 1 and 2, which are used for 
immobilization to the nanopores. We were able to determine a limit of detection, LOD, 
towards Cu(II) binding at pH 6.5 in solution to be 13.5 nM, emphasizing a high sensitivity. 
Imperiali’s lab identified the integration of β-amino acids to shift the binding preferences 
towards Cu(II) but they do not take into account that the ATCUN motifs are strongly pH 
dependent.99 We integrated the β-Ala moiety but did not see a preference for Cu(II). In the 
overall study, applying the optimal pH values for Cu(II)- and Ni(II) binding, there is a 
preference towards Ni(II) binding seen for all peptides 1-4. Several research groups 
investigated the influence of the amino acids in position 1 and 2 coming to the conclusion that 
the pka of these residues impact preferences towards Cu(II) and Ni(II) with low pKa values 
enhancing Cu(II) affinities.236,237 In regard to the selectivity of the sensor application, no 
binding towards Zn(II) is evaluated from titration experiments.  
Furthermore, the design of ATCUN mutants was accomplished by synthesis of Asp and Ala 
mutants. ATCUN peptides are characterized by a His moiety at the third position238 and we 
investigated Cu(II) and Ni(II) behavior mutating this crucial amino acid. MS and titration 
experiments show, that there is a 1:1 Cu(II) and Ni(II) binding. Neupane et al. investigated 
linear and cyclic ATCUN motifs without the imidazole unit, coming to a similar conclusion. All 
cyclic and linear peptides show 1:1 binding towards Cu(II) and Ni(II) in a square-planar 
fashion.216 
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(5) The immobilization is successfully implemented using HATU/DIEA which was not 
described in literature before. Also, EDC/sulfo-NHS proved itself to be a successful 
immobilization method but due to pre-activation of the reaction solution is evaluated to be 
inferior to HATU/DIEA coupling. 
 
(6) AFM and CLSM were also used for proving the success of immobilization and to 
characterize the hybrid system as described in (5). Using AFM, the phase difference images 
prove presence of the peptide within the nanopores of the PET foil with comparison to a blank 
foil. Using the fluorophore, attached to peptide 4, CLSM studies were carried out, underlining 
the ability of the peptide to bind Cu(II) when immobilized on the surface of the nanopores. 
With that result, miniPEG4 is affirmed to be an adequate linker usefull for immobilization 
while preserving an intact sensing unit. Furthermore, CLSM studies show the selectivity 
towards Cu(II) binding in comparison to binding Ni(II) and Zn(II). Additionaly, the sensor is 
exposed to an on/off study aiming to show re-usability. We confirmed a regeneration using 
EDTA of the sensor system for at least 7 iterations. I-V measurements are performed to 
underline and verify results from microscopy studies. Adding Cu(II) to the electrolyte 
solution, the hybrid system switches from an “off” state showing rectification, to an increased 
current. This increase is detectable form Cu(II) concentrations as low as within the 
femtomolar range underlining an extreme sensitivity. The selectivity is proven with addition 
of Ni(II) and Zn(II) to the hybrid system, not resulting in an increased current. Furhtermore, 
on/off studies in from I/V measurements reassure finding from CLSM experiments. The 
robustness is confirmed with CLSM showing fluorescence signal of the immobilized peptide in 
the nanopores of the PET foil over several months with storage of the foils at 8 °C in water. 
 
Looking at Cu(II) sensors from literature, we were able to optimize the present systems. One 
example for a fluorescent copper sensor grafted to a surface is stated by Zheng et al.239 They 
made use of the ATCUN motif with the design of Dns-Gly-His-Lys(NC) (NC – nitrocinnamate 
for interaction with the PEG gel) and inserted the motif into a cross-linked polyethylene glycol 
hydrogel (PEG). While the Cu(II) efficiently and selectively quenched the fluorophore 
restoring for re-usability of the sensor takes 18 hours. Another recent example is the design of 
a ATCUN Cu(II) sensor Cys-Gly-Gly-Gly-His immobilized to nanoporous membrane to 
construct a ion-selective electrodes (ISE). This hybrid system by Papp et al. shows a good 
linearity within the range of 103 M-1 – 106 M-1 M-1.240 Furthermore, α-HL was intensively 
studied towards Cu(II) sensing. With a detection limit of 12 nM presented by Guo et al. 
designed a sensitive and selective nanopore sensor.241 For the integration into a sensoring 
device, nanopores within a solid-state material display numerous advantages especially in 
regard to stability which is not given using biological nanopores.  
 
As for future prospects of our sensor, there are various possibilities. Studies with complex 
and/or real samples would be the next step. Starting off, complex systems, e.g. buffer 
solutions spiked with different heavy metals or serum samples could be used to define 
selectivity and sensitivity of the hybrid pore system. Next off, environmental probes from 
lakes, soil or from humans such as blood and urine samples could be investigated. Integration 
into a real device would be the final step in the development of a senor. 
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10. Results and Discussion: DNA scission and sequencing of ATCUN-like peptides 
Literature reports show that the ATCUN motif based on the general structure Xaa-Xbb-His 
linearizes supercoiled DNA10 which enables further possible applications for our hybrid 
nanosensor. The advantageous use of our proposed nanopore system would result in a one-
step method to linearize supercoiled DNA and within this step, filter out the linearized DNA 
with the translocation through the pore (Figure 74). The system will be designed to hold back 
nicked and supercoiled DNA. Therefore, restriction enzymes as well as extensive purification 
of the linearized form can be bypassed. Furhtermore, using I/V measurements, the system 
could be used as a sequencing device. The translocation of the linearized DNA will generate a 
current signal. This signal is dependent on the base translocating through the pore making 
sequencing a possible target. The importance of new sequencing devices is introduced in 
3.4.4. 
 
Figure 74. Proposed sensor design for DNA scission 
The ability to promote linearization is based on the generation of reactive oxidative species 
which cleaves the DNA, introduced in 3.4.3. The following scheme illustrates the proposed 
mechanism from chapter chapter 3.4.3. Zimmerman et al. investigated the auto-oxidation of 
ascorbate in the presence of Cu(II) and O2 having toxic affects on the bacteria Serratia 
marcescens. The proposed redox scheme can be adapted to the cleavage activity of the ATCUN 
like peptides.242 
 
Figure 75. Mechanism towards DNA scission 
Redox scheme adapted from Zimmerman et al.242 
The process of DNA linearization consists of three subsequent steps in which both DNA 
strands from a dsDNA plasmid (closed circular form) need to be broken. Breaking of the first 
strand will lead to a nicked form whereas breaking of the second strand in proximity (around 
10 bp) to the first cut will result in linearized dsDNA.243  
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All three forms can be visualized on an agarose gel. Since the supercoiled form III is extremely 
packed and shows a small volume, the movement across the agarose gel when current is 
applied, is extremely fast. The linear form I moves according to its size and can be evaluated 
by adding a protein ladder with defined masses (in kilobases, kb). The nicked form II is the 
relaxed state from breaking one strand of supercoiled dsDNA. It is the largest in size and thus 
moves the slowest.  
 
Figure 76. Linear, nicked and supercoiled dsDNA 
(a) shows the three conformations of DNA, I – linear, II – nicked and III – supercoiled form and their movement 
across an agaorse gel (b) 
The set-up of DNA scission experiments is based on a protocol introduced by Jin et al. altering 
the conditions to our need.207  
 
10.1. Scission of plasmid pUC19 
Based on published results which describe the use of GGH and KGGH towards linearization of 
pUC19,207 we were aiming to prove scission behavior of our designed peptides 1-4 since to our 
knowledge, no reports on their behavior is known. The used plasmid pUC19 contains 2686 
base pairs (bp). As shown in Figure 75, Cu2+ and Ascorbate, Asc, contribute to the generation 
of ROS but linearization of plasmids require the Cu(II) to be coordinated through the ATCUN 
motif207 and are therefore investigated to the contribution to the linearization effect. 
Therefore, these components are applied as samples towards a negative control to exclude 
scission of pUC19 using only Cu(II) or Asc or Cu(II) and Asc. Furthermore, samples of only 
Cu(II) or Asc combined with peptide 4 are investigated to show that adding only one 
component is not efficient. BamHI-HF, Bam, is used as the restriction enzyme to guarantee 
linearization for further comparison on the gel. The result of our negative control seen in 
Figure 77 using peptide 4 and peptides 1 – 3 (SI Figure 40) display no scission towards 
pUC19. Only the system containing Cu2+ and Asc (Figure 77) show a result, found also in 
literature. Adding both components to a plasmid sequence will lead to so-called “smearing” of 
the DNA described in literature.104 Using Asc only, nicked pUC19 is seen after 6 h incubation 
time, however no linearized DNA is determined.  
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Figure 77. Negative samples of pUC19, Cu2+ and ascorbate 
Next, we evaluated if scission is accomplished adding the peptide to the mixture. Peptide 1-
Cu(II) + Asc shows sufficient linearization of pUC19 within 4 h (SI Figure 42). Furthermore, 
both non-His containing peptides, peptide 2 and peptide 3, show efficient linearization of 
pUC19 in addition to Asc and Cu(II) within 4 h (SI Figure 43). Additionaly, 
peptide 4-Cu(II) + Asc shows scission of pUC19 and was further used to evaluate a sufficient 
concentration of the components.  
Figure 78 shows that using 100 µM peptide 4 (the according concentrations for Cu(II) and Asc 
are presented in 5.5) leads to sufficient scission becoming visible within 30 minutes. At this 
time point, no supercoiled DNA is visible anymore. Looking into 2 h and 4 h reaction time, a 
decrease of the intensity of nicked DNA is evaluated with an intensifying band for linearized 
DNA. The obtained results of scission efficiency using 125 µM peptide 4 do not differ from the 
100 µM experiments. Using 150 µM the nicked band seems to disappears after 4 hours which 
would lead to the conclusion that only linearized pUC19 is obtained. Since the DNA bands 
show extreme low intensities, and therefore cannot be evaluated correctly, 150 µM is not 
chosen for further experiments but 100 µM peptide and the according Asc and Cu(II) 
concentrations. 
 
Figure 78. Scission of pUC19 using different concentrations 
In the next step we investigated the 30 minute range in which the supercoiled DNA is 
completely converted to nicked and linearized DNA. Figure 79 shows the steady 
disappearance of supercoiled DNA (III) within 20 minutes with a corresponding increase in 
the nicked DNA form (II). The linearized DNA (I) becomes visible after 10 minutes reaction 
time. All following experiments are conducted for 4 hours to ensure sufficient linearization. 
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Figure 79. Scission of pUC19 with peptide 4 - copper complex at different time points 
 
While using Ni(II) at the same conditions as Cu(II) to linearize pUC19, no scission can be 
observed for all peptides, peptide 1-4 (see peptide 1-Ni(II) and peptide 4-Ni(II) in SI Figure 
41 SI Figure 42 and peptide 2-Ni(II) and peptide 3-Ni(II) inSI Figure 43) as well as for our 
negative controls (SI Figure 41). All four designed peptides 1-4 cut dsDNA of the supercoiled 
plasmid pUC19 adding Cu(II) and Asc while Ni(II) and Asc does not lead to linearization. 
Ni(II) disability to cut DNA is ascribable to the differing redox properties nickel exhibits in 
biological systems, proteins and peptides.12 Nickel needs to be in a trivalent oxidation state 
and reduced to Ni2+ to fulfill the requirements for the reaction using ascorbate.244 
Determination of the preferred region of scission, pUC19 
According to literature data (mentioned in 3.4.3), where the scission behavior of the general 
motif Gly-Gly-His and mutants was studied towards a small oligonucleotide, the preferable 
region for linearization of dsDNA by ATCUN complexes is described to be at A/T rich 
regions.108 Since the peptide structures of our designed motifs differ from those presented in 
literature, we were interested in this preference. Furthermore, we set up an experiment to 
evaluate a distinct region of scission towards a whole plasmid. Thus, the pUC19 plasmid was 
segmented into three areas (Figure 81). Area A, contains 800 bp, B 930 bp and C, comprises 
1070 bp. The three areas are defined by using reverse, rv and forward, fw primers and 
analyzed by polymerase chain reaction, PCR. Fragments which are not affected by scission of 
peptides 1-4 will be amplified by PCR and thus visible within the agarose gel. The plasmid, 
pUC19 is incubated with the reaction solution, containing peptides 1 – 4, Cu(II) and Asc for 4 
h and the linearized band cut from the gel. The DNA is extracted and exposed to PCR using 
the primer pairs for each region. The results can be seen in Figure 81.  
The positive samples which contain intact, supercoild dsDNA  of pUC19 show applicability of 
the designed experiment. Applying PCR for region A with pUC A fw and PUC A rv a band at 
around 800 bp is visible within the agarose gel. For region B, pUC B fw and pUC B rv lead to a 
band at the height of almos 1 kb and applying pUC C fw and pUC C rv for area C, a band at a 
little over 1 kb is obtained. All three with bands for each region in the corresponding height of 
the ladder (Figure 81c). 
Peptides 1 and 4 are displayed in Figure 81a and b. For both peptides, sufficient amplification 
of region A and B can be evaluated while no amplification of C becomes visible with a missing 
band in the agarose gels. Additionaly, the experiment was conducted using the non-His 
containing peptides, peptide 2 and peptide 3. The results towards segementation of pUC19 
are seen in SI Figure 44, indication the same behavior for peptide 3 with region C not visible 
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in the agarose gel. For peptide 2, the Ala mutant, all fragments, A, B and C are seen in the gel 
with the band for region C showing significantly less intensity compared to A and B. Table 33 
summarizes the appearance of bands for regions A, B and C using all peptides. 
Usage of fw and rv primers induce amplification of a defined DNA segment only when the 
sequence is intact. A non-appearance of a band after PCR results from an incontinuous DNA 
sequence. Therefore, we can come to the conclusion that within the C region, there is a break 
of the DNA sequence which thus leads to insufficient amplification. 
 
Figure 80. Map of pUC19 with areas A, B and C 
  
 A B C 
P 1    
P 2    
P 3    
P 4    
Table 33. Evaluation of areas A, B and C of 
pUC19 amplyfied by PCR regarding peptide 
scission 
 
 
Figure 81. pUC19 segmentation in three areas 
The linearized pUC19 is amplified using PCR into three segments. Linearization by (a) peptide 4 (b) peptide 1 and 
positive sample (c) 
Segment A B C 
Primer reverse pUC A rv pUC B rv pUC C rv 
Primer forward pUC A fw pUC B fw pUC C fw 
Table 34. pUC19 segmentation, three fragments 
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Using a nanodrop, concentrations of DNA can be evaluated using UV-Vis absorption spectra. 
Concentrations of the three fragments, A, B and C from the positive experiment reveal similar 
concentrations of the amplified regions within 41.2 – 47.3 ng/µl while for peptides 1, 3 and 4 
a significant lower values for region C (15 – 20 ng/µl) are apparent. This supports findings 
from the agarose gels. Region C is not amplified sufficiently, again confirming that within this 
region, the scission takes place. 
Area A (ng/µl) B (ng/µl) C (ng/µl) 
P1 50.2 47.2 21.4 
P3 37.5 37.2 15.1 
P4 72. 5 83.3 17.7 
pos. 41.2  47.3 45.0 
Table 35. Nanodrop results of pUC19 regions A, B and C 
 
 
Figure 82. Segmentation of region C 
As we got an indication that peptides 
1, 2 and 4 specifically cut the dsDNA 
at region C, the next step was to 
narrow down the region of the cutting 
position within the fragment C. For 
this purpose, region C was divided into 
five smaller segments (Figure 82). 
The results from the segmentation 
(Figure 83) indicate that there is no 
defined point of scission because all 
fragments are visible in the agarose 
gel. We can therefore conclude that 
scission is most likely performed in 
area C of pUC19 while within that 
region there is not a defined sequence 
succession where the plasmid DNA is 
cut.  
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Figure 83. Agarose gel showing PCR of segmentated region C 
 
 
 
 A B C D E F G 
Segment 
size (kb) 
650 540 330 870 760 1070 1070 
Primer 
reverse 
pUC C3  pUC C4 pUC C5 pUC C1 pUC C2 pUC C rv 
pUC C rv, 
positive 
sample 
Primer 
forward 
pUC C fw 
Table 36. Segmentation of area C of pUC19 
 
10.2. Scission of pASK and pACY 
To clarify if this approach is applicable to other dsDNA plasmids, we selected pASK (pASK-
IBA3) and pACY (pACY-CT2). As pUC19, pASK shows an ampicillin resistance (AmpR) while 
pACY is resistant against chloramphenicol (CmR). The scission ability of peptides 1 – 4 
towards these plasmids was proven. In Figure 84 results of the time-resolved scission behavior 
of the peptide 1-Cu(II) and peptide 4-Cu(II) complex towards pASK and pACY are shown. For 
peptide 4-Cu(II) scission experiments, an equal intensity of nicked and linearized DNA 
becomes visible with the linearized band intensifying for pASK within 4 hours. 
Peptide 1-Cu(II) complexes exhibit equal concentrations of nicked and linearized DNA for 
both plasmids, pASK and pACY remaining equal over the time course of 4 hours.  
Furthermore, scission of pAKS and pACY using peptide 2-Cu(II) and peptide 3-Cu(II) can be 
seen in SI Figure 45. Results from peptide 3, the Asp-mutant, are in accordance to findings 
from peptides 1 and 2 with scission ability visible showing equal concentrations of nicked and 
linearized DNA over a scission time of 4 hours.  
Peptide 2 shows little scission ability. Bands with equal intensities indicating linearized and 
nicked DNA can be observed after 30 minutes. However, unexpectedly no bands can be 
observed at a later time point indicating a denaturing process of the DNA. Therefore, all other 
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scission experiments for peptide 2-Cu(II) towards pASK and pACY are evaluated at only 30 
minutes of reaction time. 
 
Figure 84. Scission of pASK and pACY using peptide 4 and peptide 1 + Cu2+ and Asc 
*linearized and nicked bands are covered by fluorescence of 5/6-FAM from peptide 4 
With positive scission results of both dsDNA plasmids, pASK and pACY were segmented 
according to pUC19 to evaluate possible sites for scission. 
 
Determination of the preferred region of scission, pASK 
In order to identify the scission segment of pASK, the plasmid was divided into four parts: A 
(710 bp), B (1120 bp), C (790 bp) and D (1400 bp) (Figure 85). Mapping pASK, four 
corresponding primer pairs, rv and fw, were used (pASK A fw and rv, pASK B fw and rv, pASK 
C fw and rv and pASK D fw and rv). For peptide 4, regions A, B and C are sufficiently 
amplified and visible in the agarose gel whereas region C is not visible (Figure 86). Similar 
data is obtained for peptide 2-Cu(II) and peptide 3-Cu(II) (SI Figure 46). Again, regions A, B 
and C are visible in the agarose gel with region D not amplified and thus not visible. Only 
peptide 1 shows a different behavior with all bands corresponding to the regions A, B, C and 
D (SI Figure 46). 
* 
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Figure 85. Map of pASK plasmid with segments A, B, C and D 
AmpR refers to ampicillin resistance 
 A B C D 
P 1     
P 2     
P 3     
P 4     
Table 37. Evaluation of areas A, B, C and D 
of pASK amplyfied by PCR regarding 
peptide scission 
 
 
 
 
Figure 86. Segmentation of pAKS using peptide 4 + Cu2+ and Asc 
  
 A (PA) B (PB) C (PC) D (PD) 
Primer reverse pASK A rv pASK B rv pASK C rv pASK D rv 
Primer forward pASK A fw pASK B fw pASK C fw pASK D fw 
Table 38. Forward and reverse primers for segmentation of pASK 
 
 
Determination of the preferred region of scission, pACY 
Similar to pUC19 and pASK, the plasmid pACY was defined into three regions, A (540 bp), B 
(2240 bp) and C (2070 bp). Results of the amplification for the corresponding regions after 
scission using peptides 1-4-Cu(II) + Asc show amplification only of region A, whereas region 
B and C are not visible in the agarose gel (Figure 88). 
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Figure 87. Map of pACY showing three segments A, B and C 
 
 
 A B C 
P 1    
P 2    
P 3    
P 4    
Table 39. Evaluation of areas A, B, and C of 
pACY amplyfied by PCR regarding peptide 
scission 
 
 
Figure 88. Scission of pACY using peptides 1 - 4 with Cu2+ and Asc 
Segment A B  C  
Primer reverse pACY A rv pACY B rv pACY C rv 
Primer forward pACY A fw pACY B fw pACY C fw 
Table 40. Forward and reverse primers for segmentation of pACY 
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Looking into the occurrence of AATT and TTAA within the segmented regions and the plasmid 
sequences itself, the following values are determined: 
Plasmid Sequence Region A  Region B Region C Region D 
Total repetitions 
found 
pUC19 
AATT 
0 × 
0% 
3 × 
43% 
4 × 
57% 
- 7 
TTAA 
1 × 
3% 
8 × 
62% 
5 × 
38% 
- 13 
TT 
64 × 
31% 
68 × 
33% 
91 × 
44% 
- 208 
pASK 
AATT 
3 × 
23% 
4 × 
31% 
4 × 
31% 
6 × 
46% 
13 
TTAA 
7 × 
33% 
5 × 
24% 
9 × 
43% 
8 × 
38% 
21 
TT 
97 × 
33% 
93 × 
31% 
80 × 
27% 
105 × 
35% 
296 
pACY 
AATT 
3 × 
13% 
7 × 
30% 
16 × 
70% 
- 23 
TTAA 
2 × 
9% 
9 × 
39% 
13 × 
57% 
- 23 
TT 
41 × 
14% 
148 × 
49% 
199 × 
39% 
- 302 
Table 41. AATT, TTAA and TT sequence regions in pUC19, pASK and pACY 
Please note that the regions are overlapping an the addition of the number of repetition does not equal the value 
from the last column 
The nucleotide sequence of region C of pUC19 displays AATT 57% and TTAA 38%, region D 
of pASK AATT 46% and TTAA 38%. For pACY region A is amplified and thus visible in the 
agarose gel, this region exhibits AATT 13% and TTAA 9%. Looking at these figures, a certain 
preference for the A/T rich regions can be evaluated. Coming back to Figure 9 the 
AATT/TTAA preference is discussed with a sequence of an ATCUN motif carrying a lysine 
unit. Since the design peptides 1-4 do not exhibit this group, regions including only the TT 
sequence are also evaluated. The results are comparable to AATT and TTAA regions with the 
sequence TT displaying the highest occurrence within the cut areas. For further evaluation, 
structural studies have to be designed. 
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10.3.  Towards the design of a sensor system for sequencing of DNA 
After determining a specific region in which 
pUC19 is cut using peptides 1, 2 and 4, we 
were aiming to develop a solid-state hybrid 
system in order to be able to filtrate the 
supercoiled DNA from the linearized form 
without the need for restriction enzymes. The 
experiment set-up is illustrated in Figure 89.  
First, we designed an experiment using 
passive diffusion using the gradient from the 
left chamber to the right chamber. While on 
the left side, all reaction components, pUC19, 
Cu(II) and Asc are added in buffer solution, 
the right chamber only contains only the 
buffer.  
Figure 89. DNA sequenching experiment set-up 
The presented results in Figure 90 show efficient scission of pUC19 using immobilized 
peptide 4 to conically shaped nanopores. Therefore, the scission ability of the designed 
peptide remains intact. However, no DNA, neither linear nor nicked DNA was found in the 
right chamber of the set-up, indicating that there is no translocation of DNA material through 
the pores. 
 
Figure 90. DNA scission through nanopores using passive diffusion 
In the next step, we decided to apply a voltage to the system. Using -50 mV we wanted to 
translocate the negatively charged DNA to the cathode, from left to right chamber. 
Unfortunately, the application of a external force did not result in the translocation of DNA 
but again showed efficient scission of pUC19 (Figure 91). 
 
Figure 91. DNA scission through nanopores using -50 mV, peptide 1 immobilized 
Having used only conically shapes nanopores, we decided to alter the pore geometry. 
Additionaly, we increase the voltage applied to our system. The results of an experiment set-
up using -1 V, cylindrically shaped nanopores with diameters of 100 nm, 200 nm and 300 nm 
are summarized in Figure 92. Again, results are comparable to the conically shaped 
nanopores. No DNA is found to travel to the right chamber. 
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Figure 92. DNA scission through nanopores using cylindrical nanopores with -1 V, peptide 1 immobilized 
 
In the next step, we added mechanical force. Therefore, we investigated two syringe types and 
pressed the reaction solution through the pores of the PET nanopores. Results from both 
experiments show translocation of the DNA through the pores, but only generation of nicked 
DNA. While the main weakness of syringe 1 is the short contact time of the reaction solution 
with the immobilized peptide in the pores of the PET foil, syringe 2 was evaluated to 
circumvent this disadvantage. Also, pores displaying a smaller diameter were chosen for the 
syringe 2 trying to hold back nicked DNA. Unfortunately, the altering of the syringe system 
did not result in linearized DNA. 
 
Figure 93. DNA scission through nanopores using syringes, peptide 1 immobilized 
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11. Conclusion and Outlook: DNA scission and sequencing of ATCUN-like peptides 
Summarizing the presented outcomes a preference in scission of plasmids carried out by 
copper-complexes of ATCUN-like peptides was determined. This preference was found for 
pUC19, which was segmented into areas A, B and C to be within region C. For pASK, a 
preference was determined for region D, with the plasmid segmented into four areas A, B, C 
and D. The last plasmid from the scission experiments, pACY, was segmented into three areas 
A, B and C with scission taking place in regions B and C. While literature refers to preference 
of A/T rich sequences determined by scission of short DNA strands, these findings indicate an 
even more distinct binding and scission mechanism. Additionaly, looking into the sequences 
and the occurrence of AATT/TTAA and TT regions, findings emphasize the scission preference 
for these base-pair appearances. 
The ability of explicit and selective binding is of immense interest in regard to diagnostic 
applications. Consequently, ATCUN-like peptides fulfill several important factors for 
development of metallonucleases. They also show a constraining molecular shape to fit the 
minor groove of DNA. This ability is of great interest for desired targeting specific domains of 
DNA.245 Dr. Uerpmann et al. designed a cylinder binding to DNA in specific orientations 
opening up new target routes for DNA cleavage.246  
The search for new anti-cancer drugs is a great field of interest. The most widely used 
anticancer chemotherapeutics are platinum-metallodrugs.247 These structures exhibit 
cytotoxicity and dose-limiting toxic side effects making them flawed. The exploration of other 
transitions metals for anticancer applications is ongoing. Especially copper, Cu2+ represents an 
interesting candidate. Since it is an endogenous metal, it may be less toxic compared to Pt and 
may lead to less side effects.248 The aforementioned advantages of ATCUN-like peptides and 
our findings on selective DNA cleavage make them interesting candidates in search for new 
anticancer drugs.  
In regard to the generation of a device for DNA scission and translocation, we were able to 
perform several experiments that indicate a way to pursue. We were able to show successful 
scission of supercoiled plasmid DNA through immobilized peptide 4 and peptide 1. In the 
future, altering the pore geometry or using other solid-state nanopore systems, the 
translocation may be successful. Traversi et al. were able to translocate circular plasmid DNA, 
pNEB (2713 bp) through graphene based nanopores. They emphasize the applicability of 
graphene nanoribbons towards DNA sequencing due to the thickness of only 0.335 nm.249 
While this thickness corresponds to only two base pairs of a DNA strand, our PET foil exhibits 
a thickness of 12 µm making translocation extremely difficult. It was Kaya et al. that 
successfully translocated a 50 bp DNA sequence through PET foils that were 12 µm thick. The 
fabricated conically shaped nanopores with a tip opening of 20 nm and a base of 800 – 900 
nm making use of different concentrations of methanol added to etching solution to obtain 
this exact pore size.250 These examples show that there are numerous parameters that affect 
DNA translocation but also yield hope that we can be succesfull in our aim of generating a 
sequencing device in the nearest future. 
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12. Materials 
12.1. Chemicals 
IUPAC Abbreviation/name used 
(2H2)Water, deuterium oxide D2O 
(2S,3S)-1,4-Bis(sulfanyl)butane-2,3-diol DTT 
(4-Sulfanylphenyl)acetic acid MPAA 
1,1,1,2,2,2-Hexafluoro-2-propanol HFIP 
1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-
b]pyridinium 3-oxid hexafluorophosphate 
HATU 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide EDC 
1-Hydroxy-7-azabenzotriazole HOAt 
1-palmitoyl-2-oleoyl-sn-glycero-3-phophocholine POPC 
2-(N-Morpholino)ethanesulfonic acid MES 
2,2,2-Trifluoroacetic acid TFA 
2,2,2-Trifluoroethanol TFE 
2,5-Dihydroxyacetophenone 2,5-DHAP / DHAP 
2-[2-[bis(carboxymethyl)amino]ethyl-
(carboxymethyl)amino]acetic acid; sodium 
(Disodium) EDTA 
2-Amino-2-(hydroxymethyl)-1,3-propandiolactate Tris acetate 
2-Amino-2-(hydroxymethyl)propane-1,3-diol Tris 
2-hydroxy-3-mercapto-propionic acid hmp 
2-Methylpiperidine 2-Methylpiperidine 
3-(4—hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid Sinapinic acid 
3-(Cyclohexylamino)-1-propanesulfonic acid CAPS 
3‘,6‘-dihydroxy-1-oxospiro[2-benzofuran-3,9‘-xanthene]-5-
carboxylic acid 
5/6 FAM 
Acetic acid AcOH 
Acetonitrile ACN 
Alternating D-galactose and 3,6-anhydro-alpha-L-
galactopyranose 
Agarose 
Bovine Serum Albumin BSA 
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Carbonic diamide Urea 
Coomassie brilliant blue R-250 Coomassie blue 
Copper(II) sulfate CuSO4 
Diaminomethanal Urea 
Dichloromethane DCM 
Diethyl azodicarboxylate DEAD 
Dimethyl sulfoxide DMSO 
Ethoxyethane Diethyl ether 
Fluoro-N,N,N’,N’-tetramethylformamidinium 
hexafluorophosphate 
TFFH 
Formic acid FA 
Hydrochloric acid HCl 
Isopropyl alcohol Isopropanol 
Magnesium acetate MgOAc 
Methanal Formaledhyd 
Methanol Methanol 
N,N-Dimethylformamide DMF 
N-[Tris(hydroxymethyl)methyl]glycine Tricine 
N-cyclohexyl-3-aminopropanesulfonic acid CAPS 
n-Dodecyl β-D-maltoside DDM 
N-ethyl-N-(propan-2-yl)propan-2-amin DIEA 
N-hydroxysuccinimide NHS 
Nickel(II) sulfate NiSO4 
N-Methyl-2-pyrrolidone NMP 
Octylglycoside OG 
Piperidine Piperidine 
Potassium acetate KOAc 
Potassium dihydrogen phosphate K2HPO4 
Propane-1,2,3-triol Glycerol 
Sodium acetate NaOAc 
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Sodium carbonate Sodium carbonate 
Sodium dihydrogen phosphate Na2HPO4 
Sodium dodecyl sulfate SDS 
Sodium hydroxide NaOH 
sodium; (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-
oxo-2H-furan-3-olate 
Sodium ascorbate, Asc 
Sodiumhydroxide NaOH 
Tetrahydrofuran THF 
Trifluoroacetic acid TFA 
Triphenylphosphine PPh3 
Tris(2-carboxyethyl)phosphine hydrochloride TCEP 
Zinc(II) sulfate ZnSO4 
α-Cyano-4-hydroxycinnamic 4-HCCA 
Table 42. Chemicals. 
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12.1.1. Amino Acids 
Fmoc protected 
amino acids 
Chemical name Single/Three 
letter code 
Fmoc-Ala-OH×H2O N-α -(9-Flouenylmethyloxycarbonyl)-L-alanine, 
monohydrate 
A  /  Ala 
Fmoc-Arg(Pbf)-OH N-α -(9-Flouenylmethyloxycarbonyl)-N’-2,2,4,6,7-
pentamethyldihydrobenzofuran-5-sulfonyl-L-
arginine 
R  /  Arg 
Fmoc-Asn(Trt)-OH N-α -(9-Flouenylmethyloxycarbonyl)-N-beta-trityl-L-
asparagine 
N  /  Asn 
Fmoc-Asp(OtBu)-
OH 
N-α -(9-Flouenylmethyloxycarbonyl)-L-aspartic 
acid β-t-butyl ester 
D  /  Asp 
Fmoc-Cys(Trt)-OH N-α -(9-Flouenylmethyloxycarbonyl)-S-trityl-L-
cysteine 
C  /  Cys 
Fmoc-Cys(Acm)-OH N-α -(9-Flouenylmethyloxycarbonyl)-S-(acetyl-
aminomethyl)-L-cysteine 
C  /  Cys 
Fmoc-Gln(Trt)-OH N-α -(9-Flouenylmethyloxycarbonyl)-N-ɣ-trityl-L-
glutamine 
Q  /  Gln 
Fmoc-Glu(OtBu)-
OH×H2O 
N-α -(9-Flouenylmethyloxycarbonyl)-L-glutamic-
acid-ɣ-t-butyl ester monohydrate 
E  /  Glu 
Fmoc-Gly-OH N-α -(9-Flouenylmethyloxycarbonyl)-glycine G  /  Gly 
Fmoc-His(Boc)-OH N-α-(9-Fluorenylmethyloxycarbonyl)-N-im-(t-
butyloxycarbonyl)-L-histidine 
H  /  His 
Fmoc-Ile-OH N-α -(9-Flouenylmethyloxycarbonyl)-L-isoleucine I  /  Ile 
Fmoc-Leu-OH N-α -(9-Flouenylmethyloxycarbonyl)-L-leucine L  /  Leu 
Fmoc-Lys(Boc)-OH N-α-(9-Fluorenylmethyloxycarbonyl)-N-ɛ-t-
butyloxycarbonyl-L-lysine 
K  /  Lys 
Fmoc-Met-OH N-α -(9-Flouenylmethyloxycarbonyl)-L-methionine M  /  Met 
Fmoc-Phe-OH N-α -(9-Flouenylmethyloxycarbonyl)-L-
phenylalanine 
F  /  Phe 
Fmoc-Pro-OH×H2O N-α -(9-Flouenylmethyloxycarbonyl)-L-proline, 
monohydrate 
P  /  Pro 
Fmoc-Ser(tBu)-OH  N-α -(9-Flouenylmethyloxycarbonyl)-O-t-butyl-L-
serine 
 
S  /  Ser 
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Fmoc-Thr(tBu)-OH  N-α -(9-Flouenylmethyloxycarbonyl)-O-t-butyl-L-
threonine 
T  /  Thr 
Fmoc-Trp(Boc)-OH N-α -(9-Flouenylmethyloxycarbonyl)-N-in-t-
butyloxycarbonly-L-tryptophan 
W  /  Trp 
Fmoc-Tyr(tBu)-OH N-α -(9-Flouenylmethyloxycarbonyl)-O-t-butyl-L-
tyrosine 
Y  /  Tyr 
Fmoc-Val-OH N-α -(9-Flouenylmethyloxycarbonyl)-L-valine V  /  Val 
Fmoc-Thz-OH (S)- N-α -(9-Flouenylmethyloxycarbonyl)-
thiazolidine-4-carboxylic acid 
 
Fmoc-L-Phe-L-
Ser[PSI(Me, 
Me)Pro]-OH 
(S)-3-(N-(9-Flouenylmethyloxycarbonyl)-L-
phenylalaninyl)-2,2-dimethyloxazolidine-4-
carboxylic acid 
 
N-Acetyl-L-alanine (2S)-2-acetamidopropanoic acid  
Table 43. Amino acids 
 
12.1.2. Resins 
Resin Loading (mmol/g) Supplier 
AmphiSpheres 40 RAM 0.38 Agilent Technologies 
TentaGel R RAM 0.18 Rapp polymere GmbH 
2-Chlorotritylchlorid  0.966 Carbolutions 
Table 44. Resins used for SPPS 
 
 
Figure 94. Rink amide linker (RAM) 
 
 
Figure 95. 2-Chlorotritylresin 
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12.2. Buffers and Standard Solutions 
12.2.1. KcvNTS 
12.2.1.1. Native chemical ligation  
pH Name Ingredients  Organic solvent 
7.0 – 7.5 
Buffer A: HFIP ligation 
buffer 
 
4 M Urea 
0.1 M Na2HPO4 
150 mM TCEP 
100 mM MPAA 
1/3 HFIP 
7.0 – 7.5 
Buffer B: TFE ligation 
buffer (1) 
8 M Urea 
0.2 M Na2HPO4 
150 mM TCEP 
100 mM MPAA 
1/3 TFE 
4.0 
Buffer C: Thz 
conversion  
8 M Urea 
0.2 MNa2HPO4 
150 mM TCEP 
100 mM MPAA 
200 mM Methoxyamine 
30 mM TCEP (additionally) 
2/3 TFE 
7.0 – 7.5 
Buffer D: TFE ligation 
buffer (2) 
8 M Urea 
0.2 M Na2HPO4 
150 mM TCEP 
100 mM MPAA 
2/3 TFE 
Table 45. Buffers for native chemical ligation 
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12.2.1.2. SDS PAGE 
pH Name Ingredients 
7.00 Reducing sample buffer 
12% SDS 
6% mercaptoethanol 
30% glycerol 
0.05% Coomassie blue G-250 
150 mM Tris/HCl 
7. 00 Nonreducing sample buffer 
12% SDS 
30% glycerol 
0.05% Coomassie blue G-250 
150 mM Tris/HCl 
8.25 Cathode buffer (10x) 
1 M Tris 
1 M Tricine 
1% SDS 
8.9 Anode buffer 
1 M Tris 
0.225 M HCl 
Table 46. Buffers for SDS Page 
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Name Ingredients 
Coomassie stain 
0.025% Coomassie blue G-250 
10% acetic acid 
90% water 
Fixing solution 
50% methanol 
10% acetic acid 
100 mM ammonium acetate 
Sensitizing solution 
0.005% Sodium thiosulfate 
In water 
Incubation solution 
0.1% silver nitrate 
In water 
Development solution 
0.036% formaldehyde 
2% sodium carbonate 
In water 
Stopping solution 
50 mM EDTA 
In water 
Table 47. Solutions for SDS Page. Coomassie and silver stain 
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12.2.2. ATCUN-like peptides 
12.2.2.1. Amino Acid Analysis 
pH Name Ingredients 
5.75 Buffer E 
50 mM NaAc 
In water 
6.00 Buffer F 
50 mM NaAc 
in 300 ml H2O 
ad 1000 ml acetonitrile 
Table 48. Buffers for AAA 
 
12.2.2.2. Titration and structural studies 
pH Name Ingredients 
6.50 
MES buffer,  
100 mM 
1.952 g MES, free acid 
Ad 100 ml H2O 
Adjust pH using NaOH solution 
8.00 
Phosphate buffer 
100 mM 
50.00 ml 0.4 M K2HPO4 
46.8 ml 0.4 M NaOH 
Ad 200 ml H2O 
8.00 
TRIS buffer, 
100 mM 
0.6052 g TRIS base 
Ad 50 ml H2O 
Adjust pH using NaOH 
10.55 
TRIS buffer, 
100 mM 
0.6052 g TRIS base 
Ad 50 ml H2O 
Adjust pH using NaOH 
10.55 
CAPS buffer, 
100 mM 
1.1066 g CAPS 
Ad 50 ml H2O 
Table 49. Buffers for titration experiments 
For I/V measurements, the MES buffer (100 mM) is spiked with 100 mM KCl. 
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12.2.2.3. DNA studies 
pH Name Ingredients Supplier 
7.4 
TRIS HCl buffer 
(Stock solution, 1 
M) 
60.57 g Tris base 
32.5 ml HCl (12 M) 
Ad 500 ml water 
/ 
7.9 CutSmart buffer 
50 mM Potassium acetate 
20 mM TRIS-acetate 
10 mM Magnesium acetate 
100 µg/ml BSA 
New England Biolabs 
n/a Phusion® HF buffer n/a New England Biolabs 
8.5 TAE buffer (50 x) 
40 mM Tris free base 
2 mM Disodium EDTA 
20 mM glacial acetic acid 
/ 
Table 50. Buffers for DNA studies 
 
 
pH Name Ingredients Supplier 
8.8 Elution buffer NE 5 mM Tris/HCl Macherey-Nagel 
5.0 – 6.0 Binding buffer NTI 
Guanidinium thiocyanate 
30 – 45% 
Macherey-Nagel 
n.A. Wash buffer NT3 Ethanol Macherey-Nagel 
n.A. Resuspension buffer A1  Macherey-Nagel 
n.A. Lysis buffer A2 
Sodium hydroxide 
solution 
Macherey-Nagel 
n.A. Neutralization buffer A3 Guanidine hydrochloride Macherey-Nagel 
n.A. Wash buffer AW 
Guanidine hydrochloride 
 2-propanol 
Macherey-Nagel 
8.5 Elution buffer AE 5 mM Tris/HCl Macherey-Nagel 
Table 51. Buffers and solutions for DNA purification 
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12.3. Plasmids 
pUC19 – supplier: ThermoFisher Scientific 
pASK-IBA3plus (pASK) – supplier: IBA, BioTAGnology Cat. No.: 2-1402-000  
pACYCT2 (pACY) – was gifted from Luc Ponchon Addgene plasmid #45799 
 
12.4. Purification Kits 
Application Name of kit Supplier 
Gel extraction 
NucleoSpin® Gel and PCR 
Clean-up 
Macherey-Nagel 
PCR purification 
NucleoSpin® Gel and PCR 
Clean-up 
Macherey-Nagel 
DNA purification 
NucleoSpin® Plasmid DNA 
purification 
Macherey-Nagel 
Table 52. DNA purification kits 
 
12.5. Primer 
12.5.1. For pUC19 
Name  Sequence Binding site 
pUC A fw TCTCATGACCAAAATCCCTTAACGTGAG 2237 .. 2264 
pUC A rv GAGCGGTATCAGCTCACTCAAGG 324 .. 347 
pUC B fw CTTTCCTGCGTTATCCCCTGATTCTG 280 .. 305 
pUC B rv GGTCTGACGCTCAGTGGAACG 2269 .. 2289 
pUC C fw TATCCCCTGATTCTGTGGATAACCG 291 .. 315 
PUC C rv CCACTCGTGCACCCAAVTGATC 1389 .. 1410 
pUC C1 GTGCCACCTGACGTCTAAGAAAC 1140 .. 1162 
pUC C2 CCTCTGACACATGCAGCTCCCGG 1033 .. 1055 
pUC C3 TGGCTTAACTATGCGGCATCAG 925 .. 946 
pUC C4 ATTCAGGCTGCGCAACTGTTG 816 .. 836 
pUC C5 TGGCGTAATCATGGTCATAGCTG 610 .. 632 
Table 53. Primer for pUC19 
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12.5.2. For pASK-IBA3 (pASK) 
Name Sequence Binding site 
pASK A fw TTTGTCTGCCGTTTACCGCTAC 321 .. 342 
pASK A rv CCACTCGTGCACCCAACTGATC 1051 .. 1072 
pASK B fw TCTCATGACCAAAATCCCTTAACGTGAG 2514 .. 2541 
pASK B rv GCTTAATGCGCCGCTACAGG 365 .. 384 
pASK C fw GGTGCCTCACTGATTAAGCATTGG 1780 .. 1803 
pASK C rv GGTCTGACGCTCAGTGGAACG 2546 .. 2566 
pASK D fw AACGCTGGTGAAAGTAAAAGATGCTG 1023 .. 1048 
pASK D rv 
CACATTTAAGTTGTTTTTCTAATCCGCAGATGATCAAT
TCAAGGC 
2380 .. 2425 
Table 54. Primer for pASK-IBA3 
 
 
12.5.3. For pACYCT2 (pACY) 
Name Sequence Binding site 
pACY A fw TGTCTCATTCCACGCCTGACACTC 2185 .. 2209 
pACY A rv CCGGAAGCTTCTCATTAGGCACCGGGATCTCGA 2702 .. 2724 
pACY B fw 
GGGCTTGTTAGCAGCCGGATCTCACAGCGGTTTCTTT
ACCAGACTCGAG 
322 .. 346 
pACY B rv TCAAATGTAGCACCTGAAGTCAGCC 2587 .. 2611 
pACY C fw AGATCTCAATGGATATCGGCCGG 273 .. 296 
pACY C rv GTGTCAGGCGTGGAATGAGACAAAC 2157 .. 2181 
Table 55. Primer for pACYCT2 
The primers were kindly designed by Alexander Gräwe (RG Stein, TU Darmstadt)  
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13. Appendix 
13.1. Supporting Information 
Supporting Information: Synthesis and characterization KcvNTS 
 
 
SI Figure 1. LC-MS overview of fragment B 
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SI Figure 2. RP-HPLC of Hmp fragment in OG, crude product 
RP-HPLC of crude product gradient: 60% eluent B to 99% in 30 minutes with a flow of 1 ml/min on the MultoHigh 
BIO 300 column at 30 °C 
 
 
 
SI Figure 3. Second ligation using SA as MALDI-TOF MS matrix 
The spectra is recorded in the LP mode 
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SI Figure 4. Second ligation using different methods for MALDI-TOF MS 
(a) Displays the Thinlayer method using MeOH as the solvent for the sediment of the second ligation and (b) using 
1 mM OG in H2O + 0.1% TFA. (c) shows the Threelayer method with MeOH as the solvent and (d) 1 mM OG in H2O 
+ 0.1% TFA for dissolving the sediment. All spectra are recorded in the LP mode 
 
 
SI Figure 5. Comparison of DHAP and Thinlayer method for investigation of sediment from second ligation 
Using DHAP as the matrix for MALDI-TOF MS of the sediment from the second ligation results in a spectra 
displaying little peaks (a) with (b) the Thinlayer method with MeOH as a solvent showing numerous peaks in areas 
> 4000 m/z 
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SI Figure 6. SDS PAGE Coomassie stain of second ligation 
A B C D E F G G L1 L2 
Start 
30 
min 
1 h 2 h 4 h 8 h  24 h Sediment 
Colored 
protein 
ladder 
Uncolored 
protein 
ladder 
SI Table 1. Samples for SDS PAGE of the final product KcvNTS 1 
 
 
SI Figure 7. SDS PAGE Coomassie stain of ligation solution and positive samples 
 
A B C D E F G 
ligation 
product 
1.2 
KcvNTS 
in 
lipids 
KcvNTS in 
nanodiscs 
ligation 
product 2 
(solution) 
ligation 
product 2,  
Vivaspin 
centri-
fugation 
ligation 
product 2 
(solution 
other batch) 
ligation 
product 2 
(sediment) 
SI Table 2. Samples for SDS PAGE of the final product KcvNTS 2 
L1 – uncolored protein ladder 
L2 – colored protein ladder 
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SI Figure 8. CD spectra using POPC lipids 
(a) blank sample POPC (b) ligation TFE sample using POPC and the extrusion method 
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Supporting information: Development of a hyvrid nanosensor 
To further evaluate the applicability of the AAA method, a validation was conducted. 
 
SI Figure 9.Amino Acid Standard 
Method: linear gradient of 2% to 20% buffer B in 30 minutes using a flow of 1 ml/min and the MultoKrom C18 
column at 45 °C. 
Number 1 2 3 4 5 6 7 8 9 10 11 
Retention time 
(min) 
6.7 10.4 16.5 17.9 17.9 21.3 22.1 27.0 27.7 28.7 29.6 
SI Table 3. Retention times of amino acids during AAA 
 
 
SI Figure 10. Injections of sample 
Method: linear gradient of 2% to 20% buffer B in 30 minutes using a flow of 1 ml/min and the MultoKrom C18 
column at 45 °C. 1 in the chromatogram, the His moiety of the sample, shows a retention time of 17.0 minutes. 
11 
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SI Figure 11. UV VIS titration of Cu(II) to peptide 1 in TRIS buffer pH 8.00 
UV-VIS titration experiments of peptide 1 (1 mM peptide, in Tris buffer pH 8). (a) increase in absorption upon 
addition of 0.1 equivalents Cu(II) (CuSO4, in water), wavelengths of 400 - 800 nm. (b) extinction coefficient of the 
peptide 1-Cu(II) complex vs. equivalents of Cu(II) added. 
 
 
SI Figure 12. UV VIS titration of Ni(II) to peptide 1 in TRIS buffer pH 10.55 
UV-VIS titration experiments of peptide 1 (1 mM peptide, in Tris buffer pH 10.55). (a) increase in absorption upon 
addition of 0.1 equivalents Ni(II) (NiSO4, in water), wavelengths of 300 - 800 nm. (b) extinction coefficient of the 
peptide 1-Ni(II) complex vs. equivalents of Ni(II) added. 
 
 
SI Figure 13. UV-Vis Titration of Ni(II) to peptide 1 in MES buffer pH 6.5 
UV-VIS titration experiments of peptide 1 (1 mM peptide, in MES buffer pH 6.5). (a) increase in absorption upon 
addition of 0.1 equivalents Ni(II) (NiSO4, in water), wavelengths of 300 - 500 nm. (b) extinction coefficient of the 
peptide 1-Ni(II) complex vs. equivalents of Ni(II) added. 
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SI Figure 14. Benesi Hildebrand plot of Cu(II) and Ni(II) titrations to peptide 1 at optimal pH values 
UV VIS titration experiments of 1 mM peptide 1 in (a) Tris buffer pH 8.0 and addition of Cu(II) and (b) Tris buffer 
pH 10.55 and addition of Ni(II). 
 
 
 
SI Figure 15. Benesi Hildebrand plot for peptide 1-Cu(II) and peptide 1-Ni(II) binding at pH 6.5 
 
 
 
  
(a)         (b) 
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SI Figure 16. Cu(II) titration to peptide 2 at pH 8 in 100 mM Tris buffer 
(a) Increased absorption of peptide 2 solution upon addition of Cu(II) between 390 – 800 nm to visualize 
absorption of the peptide 2-Cu(II) complex. (b) describes increase of the extinction coefficient in regard to 
equivalents of copper added to the peptide solution. (c) shows the Benesi Hildebrand plot with a correlation 
coefficient of R2 = 0.9987. Ʌmax for the peptide 2opper complex is 501 nm. 
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SI Figure 17. UV VIS titration of Cu(II) to peptide 3 at optimal pH 
(a) Increased absorption of peptide 3 solution upon addition of Cu(II) between 400 – 800 nm to visualize 
absorption of the peptide 3-Cu(II) complex. (b) describes increase of the extinction coefficient in regard to 
equivalents of copper added to the peptide solution. (c) shows the Benesi Hildebrand plot with a correlation 
coefficient of R2 = 0.9754. Ʌmax for the peptide 2opper complex is 584 nm. 
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SI Figure 18. UV VIS titration of Ni(II) to peptide 2 at optimal pH 
(a) Increased absorption of peptide 2 solution upon addition of Ni(II) between 300 – 800 nm to visualize 
absorption of the peptide 2-Ni(II) complex. (b) describes increase of the extinction coefficient in regard to 
equivalents of nickel added to the peptide solution. (c) shows the Benesi Hildebrand plot with a correlation 
coefficient of R2 = 0.9296. Ʌmax for the peptide nickel complex is 436 nm. 
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SI Figure 19. UV VIS titration of Ni(II) to peptide 3 at optimal pH 
(a) Increased absorption of peptide 3 solution upon addition of Ni(II) between 350 – 800 nm to visualize 
absorption of the peptide 3-Ni(II) complex. (b) describes increase of the extinction coefficient in regard to 
equivalents of nickel added to the peptide solution. (c) shows the Benesi Hildebrand plot with a correlation 
coefficient of R2 = 0.9878. Ʌmax for the peptide nickel complex is 441 nm. 
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SI Figure 20. MS of peptide 1-Cu(II) complex 
 
Species Calculated m/z Measured m/z 
[M+H+]+ (M = C25H43N7O10) 602.31 602.33 
[M+2H+]2+ 301.66 301.67 
[M+Na+]+ 624.64 624.31 
[M+K+]+ 640.75 640.28 
[M-2H+Cu+H+]+ 664.19 664.25 
[M-2H+Cu+Na+]+ 686.17 686.23 
SI Table 4. MS of peptide 1-Cu(II) complex. Calculated and measured m/z 
  
 
 - 138 - 
 
 
SI Figure 21. MS of peptide 2-Cu(II) complex  
The following table shows the calculated and measured masses for species shown in this 
figure. 
Species Calculated m/z Measured m/z 
[M+H+]+ (M = C22H41N5O10) 536.2926 536.3258 
[M+Na+]+ 558.2746 558.2895 
[M+K+]+ 574.2485 574.2633 
[M-H+Cu+H+]+ 598.2144 598.2439 
[M-H+Cu+Na+]+ 620.1960 620.2132 
[M+Na+Cu+K+]+ 660.1679 660.1562 
SI Table 5. MS of peptide 2-Cu(II) complex. Calculated and measured masses (m/z) 
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SI Figure 22. MS of peptide 3-Cu(II) complex 
The following table shows the calculated and measured masses for species shown in this 
figure. 
Species Calculated m/z Measured m/z 
[M+H+]+ (M = C23H41N5O12) 580.2824 580.2821 
[M+Na+]+ 602.2644 602.2633 
[M-H+Cu+H+]+ 642.2042 642.2059 
[M-H+Cu+Na+]+ 664.1862 664.1838 
[M+Na+Cu+K+]+ 704.1577 704.1339 
SI Table 6. MS of peptide 3-Cu(II) complex. Calculated and measured masses (m/z) 
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SI Figure 23. MS of peptide 4-Cu(II) complex 
Species Calculated m/z Measured m/z 
[M+H+]+ (M = C44H51N7O15) 918.35 918.33 
[M+Na+]+ 940.90 940.31 
[M+2H+]2+ 459.68 459.67 
[M-3H+Cu+H+]+ 979.42 979.24 
[M-3H+Cu+Na+]+ 1001.25 1001.22 
[M-4H+Na+Cu+Na+]+ 1023.41 1023.21 
[M-5H+2Na+Cu+Na+]+ 1049.39 1045.19 
SI Table 7. MS of peptide 4-Cu(II) complex. Calculated and measured masses m/z 
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SI Figure 24. MS of peptide 1-Ni(II) complex 
Species Calculated m/z Measured m/z 
[M+H+]+ (M = C25H43N7O10) 602.31 602.33 
[M+Na+]+ 624.64 624.31 
[M+K+]+ 640.75 640.28 
[M+2H+]2+ 301.66 301.67 
[M-H+Ni+H+]+ 658.33 658.26 
[M-H+Ni+Na+]+ 680.22 680.23 
SI Table 8. MS of peptide 1-Ni(II) complex. Calculated and measured masses m/z 
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SI Figure 25. MS of peptide 2-Ni(II) complex  
The following table shows the calculated and measured masses for species shown in this 
figure. 
Species Calculated m/z Measured m/z 
[M+H+]+ (M = C22H41N5O10) 536.2926 536.2661 
[M+Na+]+ 558.2746 558.2441 
[M-H+Na+Na+]+ 580.2565 580.2276 
[M-H+Ni+H2O+H+]+ 611.2307 611.2631 
SI Table 9. MS of peptide 2-Ni(II) complex. Calculated and measured masses (m/z) 
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SI Figure 26. MS of peptide 4-Ni(II) complex 
Species Calculated m/z Measured m/z 
[M+H+]+ (M = C44H51N7O15) 918.35 918.33 
[M+Na+]+ 940.90 940.31 
[M+2H+]2+ 459.68 459.67 
[M-2H+Ni+H+]+ 974.59 974.25 
[M-2H+Ni+Na+]+ 996.25 996.23 
SI Table 10. MS of peptide 4-Ni(II) complex. Calculated and measured masses m/z 
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SI Figure 27. UV VIS spectra of Cu(II) titration to peptide 4 in MES buffer pH 6.5 
The absorption maximum of the peptide-copper complex is determined to be at around 550 nm. As seen in the 
figure, the absorption of the fluorophore, 5/6-FAM interferes with the absorption maximum of the complex. An 
accurate evaluation of the titration data is not given 
 
(a)                                    (b) 
 
SI Figure 28. pH-dependent titration studies on peptide 1 
(a) Absorption spectra for different pH values of 1 mM peptide 4 in water + 1 equ Cu(II). (b) Absorption spectra for 
different pH values of 1 mM peptide 1 in water + 1 equ Ni(II). 
 
 
 
SI Figure 29. Structure of MES 
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SI Figure 30. MES buffer pH 6.5 at different excitation wavelengths 
 
 
SI Figure 31. Copper titration to 5/6 FAM solution 
1 µM 5/6-FAM in water, addition of equivalents of Cu(II) (CuSO4, in water)  
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SI Figure 32. Fluorescence titration of copper to peptide 4 in PBS buffer pH 8.00 
Fluorescence titration experiment of peptide (0.1 µM in PBS buffer pH 8.0) (a) decrease in fluorescence intensity 
upon the addition of Cu(II) to the peptide solution (b) change in fluorescence intensity vs. Cu(II) equivalents added 
to the peptide solution. 
 
 
SI Figure 33. Fluorescence titration of nickel to peptide 4 in CAPS buffer pH 10.55 
 
Fluorescence titration experiment of peptide 4 (0.025 µM in CAPS buffer pH 10.55) (a) decrease in fluorescence 
intensity upon the addition of Ni(II) to the peptide solution (b) change in fluorescence intensity vs. Ni(II) 
equivalents added to the peptide solution. *At the excitation of 494 nm, CAPS buffer absorbs , interfering the 
spectra 
  
* 
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SI Figure 34. Stern-Volmer Plot of peptide 4 with Cu(II) at pH 6.5 
(a) plot of F0/F vs. concentration of Cu(II) to determine the quenching constant from the slope. (b) logarithmic plot 
to determine binding constant. Fluorescence titration was executed in 100 mM MES buffer pH 6.5 with an 
excitation at 494 nm and emission at 518 nm 
 
 
 
SI Figure 35. Stern-Volmer plot of peptide 4 with Ni(II) at pH 6.5 
(a) plot of F0/F vs. concentration of Ni(II) to determine the quenching constant from the slope. (b) logarithmic plot 
to determine binding constant. Fluorescence titration was executed in 100 mM MES buffer pH 6.5 with an 
excitation at 494 nm and emission at 518 nm 
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SI Figure 36. Stern-Volmer plot of peptide 1 with Cu(II) at pH 8.0 
(a) plot of F0/F vs. concentration of Cu(II) to determine the quenching constant from the slope. (b) logarithmic plot 
to determine binding constant. Fluorescence titration was executed in 100 mM PBS buffer pH 8.0 with an excitation 
at 494 nm and emission at 518 nm 
 
 
SI Figure 37. Stern-Volmer Plot of peptide 4 with Ni(II) at pH 10.55 
(a) plot of F0/F vs. concentration of Ni(II) to determine the quenching constant from the slope. (b) logarithmic plot 
to determine binding constant. Fluorescence titration was executed in 100 mM MES buffer pH 6.5 with an 
excitation at 494 nm and emission at 518 nm 
 
 
SI Figure 38. Limit of detection of Cu(II) and Ni(II) 
To a 1 µM peptide 4 solution (100 mM MES pH 6.5) (a) copper is added in concentrations of 0.67 – 60.22 nM (b) 
nickel is added in concentrations of 6.67 – 733.33 nM.  
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SI Figure 39. Fluorescence and brightlight image of cylindrical nanopores 
(a) shows fluorescence image of a PET foil with cylindrical nanopores with a diameter of 200 µm and peptide 4 
coupled. Laser details: Emission at 488 nm and excitation at 515 – 530 nm. (b) shows the brightlight image of the 
same foil section 
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Supporting Information: DNA scission of ATCUN-like peptides 
 
 
SI Figure 40. Negative samples of peptides 2 - 4 towards pUC19 
 
Lane A B C D E F G H I J K L 
Sample pUC19 + peptide 1 pUC19 + Peptide 2 pUC 19 + Peptide 3 
Time  +Cu2+ +Asc +Ni2+  +Cu2+ +Asc +Ni2+  +Cu2+ +Asc +Ni2+ 
SI Table 11. Negative samples of peptides 2 - 4 towards pUC19 
 
 
SI Figure 41. Scission of pUC19 using the peptide 4 – Ni(II) and peptide 1 – Ni(II) complexes and negative samples 
Lane A B C D E F G 
Sample pUC19 Ni2+ Ni2+ Asc P4 and Ni2+ P1 and Ni2+ 
Time 6 h 0 h 6 h 0 h 6 h 
SI Table 12. Negative samples and scission of pUC19 and peptide 4 – Ni(II) and peptide 1 – Ni(II) complexes 
 
  
 
  - 151 - 
 
 
SI Figure 42. Scission of pUC19 using peptide 1-Cu(II)/-Ni(II) and peptide 4 –Ni(II) 
Lane A B C D E F G H I J K L 
Sample Peptide 1 + Asc + Cu2+ Peptide 1 + Asc + Ni2+ Peptide 4 + Asc + Ni2+ 
Time 0 h 0.5 h 2 h 4 h 0 h 0.5 h 2 h 4 h 0 h 0.5 h 2 h 4 h 
SI Table 13. Scission of pUC19 using 100 µM peptide 1 copper and nickel complexes and peptide 4 nickel complexes 
 
 
 
SI Figure 43. Scission of pUC19 using peptide 2-Cu(II)/-Ni(II) and peptide 3-Cu(II)/-Ni(II) complexes 
 
Lane A B C D E F G I 
Sample Peptide 2 + Asc + Cu2+ Peptide 3 + Asc + Cu2+ 
Time 0 h 0.5 h 2 h 4 h 0 h 0.5 h 2 h 4 h 
 
Lane J K L M N O P Q 
Sample Peptide 2 + Asc + Ni2+ Peptide 3 + Asc + Ni2+ 
Time 0 h 0.5 h 2 h 4 h 0 h 0.5 h 2 h 4 h 
SI Table 14. Scission of pUC19 using peptide 2 and peptide 3 with Cu and Ni 
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SI Figure 44. pUC19 segments ABC after linearization using peptide 2 and 3 
(a) shows segmentation of linearized pUC19 after scission using peptide 2 with P.A/P.B and P.C representing the 
positive pUC19 samples where no linearization took place. (b) shows peptide 3 with positive samples, respectively. 
Segment A B C 
Primer reverse pUC A rv pUC B rv pUC C rv 
Primer forward pUC A fw pUC B fw pUC C fw  
SI Table 15. Primers used for pCU19 segmentation 
 
 
 
SI Figure 45. pASK and pACY scission with peptide 2-Cu(II) and peptide 3-Cu(II) 
 
Lane A B C D E F G H I J K L 
Sample 
pASK, peptide 3 + 
Cu2+ + Asc 
pASK, peptide 2 + 
Cu2+ + Asc 
pACY, peptide 3 + 
Cu2+ + Asc 
pACY, peptide 2 + 
Cu2+ + Asc 
Time 0.5 h 2 h 4 h 0.5 h 2 h 4 h 
0.5 
h 
2 h 4 h 
0.5 
h 
2 h 4 h 
SI Table 16. pASK and pACY scission with peptide 2 and peptide 3 
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SI Figure 46. Segmentation of pASK using peptide 1 – 3 for DNA scission 
A – D represent cutting of pASK prior to PCR using peptide 1, a – d peptide 2 and e – h peptide 3, PA – PD 
represents the positive sample with no cutting of plasmid DNA 
 
 A (PA; a; e) B (PB; b; f) C (PC; c; g) D (PD; d; h) 
Primer reverse pASK A rv pASK B rv pASK C rv pASK D rv 
Primer forward pASK A fw pASK B fw pASK C fw pASK D fw 
SI Table 17. Reverse and forward primers used for segmentation pASK 
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